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Natural products are chemical compounds which are produced by microorganisms, 
animals and plants and display a wide range of biological properties and structural 
motifs. It is sometimes impossible to study and fully understand their biological 
functions and chemical properties without having access to a practical synthetic route, 
because they are often produced in the organism in too small quantities. 
Total synthesis is the name given to the preparation in the laboratory of complex 
natural products from commercially available and simple starting materials. 
Biomimetic synthesis represents one method used to develop strategies toward the 
total synthesis of natural products, and takes inspiration from the way these 
compounds are synthesised by nature inside living organisms. This branch of 
chemistry aims to understand the biosynthesis and use this information to develop not 
only feasible, but also practical, laboratory synthesis. 
The first part of this thesis describes the total synthesis of a dimeric thymol derivative 
isolated from Arnica sachalinensis. Our investigations toward the successful synthesis 
of this natural product allowed us to confirm the feasibility of the proposed 
biosynthetic pathway and to gain insight into the reactivity of the plausible 
biosynthetic intermediates.  
Biomimetic diversity-oriented synthesis aims to mimic the way nature synthesises 
groups of structurally diverse compounds from a common biosynthetic intermediate. 
The ability to reproduce this in the laboratory would allow synthetic chemists to 
rapidly and efficiently explore chemical space using minimum quantities of resources. 
The second part of this thesis describes our efforts towards the development of a 
unified strategy to access a group of prenylated phenylpropanoid natural products from 
Illicium plants. We envisage that the success obtained in the preparation of a small 
selection of our molecular targets could be expanded on the synthesis of the most 





This thesis is regarded with the biomimetic total synthesis of phenolic natural products 
and describes two different projects.  
Chapter 1 introduces phenolic natural products, the most important biosynthetic 
pathways for their formation and some examples of relevant biomimetic syntheses. A 
short introduction to dimeric and pseudo-dimeric natural products can also be found 
in this chapter. Specific introductions can be found at the start of Chapters 2 and 3. 
Chapter 2 describes the total synthesis of a dimeric thymol derivative isolated from 
Arnica sachalinensis (which we have named “thymarnicol”). Inspired by the 
biosynthesis proposed by Passreiter and co-workers, we tested and confirmed the 
feasibility of a key hetero-Diels–Alder dimerisation step. During our investigations, 
we gained significant new insights into the origin and reactivity of thymarnicol. The 
final oxidative cyclisation has been found to occur spontaneously upon exposure to 
visible light in air. 
Chapter 3 discusses our efforts to develop a divergent biomimetic synthetic strategy 
towards a family of prenylated phenylpropanoid natural products isolated from 
Illicium genus plants. Our first biomimetic approach revealed the chemical instability 
of our proposed key intermediates. Therefore, a revised approach was trialled, 
allowing the total synthesis of a small set of natural products and related structures. 
We envisage that this strategy could be exploited by accessing a large number of 
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1 General Introduction 
This thesis details the total synthesis of a dimeric thymol derivative and efforts towards 
developing a unified synthetic strategy toward an entire class of structurally diverse 
prenylated phenylpropanoids. All these molecular targets are, or can be derived from, 
compounds containing mono or polyhydroxylated aromatic rings. This chapter 
provides a general introduction to phenolic natural products, the most important 
biosynthetic pathways leading to their formation and some pertinent examples of 
biomimetic total syntheses. A short preface to dimeric and pseudo-dimeric natural 
products will also be given. Specific introductions can be found at the beginning of 
chapters 2 and 3. 
1.1 Phenolic Natural Products 
Naturally occurring phenolic compounds are a broad class of low weight organic 
compounds containing one or more hydroxy groups connected to an aromatic ring. 
According to the definition given by Haslam in 1994, this term should be used as a 
descriptor for water-soluble plant phenolic compounds having molecular masses from 
500 to 3000–4000 Da and possessing twelve to sixteen hydroxy groups on five to seven 
aromatic rings per 1000 Da.1 However, compounds of lower molecular weight bearing 
multiple hydroxy substituents on one or more aromatic rings are often referred to as 
polyphenols.2 Although natural phenols are widely distributed in nature (animals, 
plants, bacteria and fungi) they are particularly common in plants, where they are the 
most abundant secondary metabolites.3 They are synthesised by the plant during 
normal development and under stressed conditions, such as infection, wounding or 
exposure to UV radiation.4 This huge class of compounds includes stilbenes, phenolic 
acids, flavonoids, anthrones, coumarins, lignans, curcuminoids, chalcones and many 
others (some representative members of these groups are depicted in figure 1.1). 
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Figure 1.1: Representative phenolic natural products.  
Phenolic compounds have been used by humans for millennia. The first reported use 
of them probably dates back to the ancient Greeks of the archaic period (ca. 800–500 
BC), when they were used in the conversion of animal skin into leather. The first 
mention in literature is accredited to Theophrastus of Eressus (371–286 BC), who 
referred to them as “vegetable tannins” in his Historia Plantarum plant encyclopedia.2 
The determination of the (poly)phenolic nature of these vegetable tannins was not a 
simple matter prior to the development of appropriate analytical techniques. In fact, 
their wide distribution in nature and the diversity in their composition made it difficult 
to recognise them as members of this group of compounds. It wasn’t until the 20th 
century that this class of metabolites started to be properly studied and characterised.2 
Part of the reason why there has been a growing interest in the study of phenolic natural 
products is their implication in various domains of commercial and social interest. In 
particular, phenolic compounds play a significant role in human health due to their 
biological activities, which includes antifungal, antioxidant, radical scavenging and 
anti-cancerous activity.5 A famous example is represented by resveratrol (figure 1.1) 
and the so-called “French paradox”.6 This refers to the apparently paradoxical 
observation that French people have a relatively low incidence of coronary heart 
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diseases, despite having a diet very rich in saturated fats. Among the various 
hypotheses to explain this phenomenon, there is the relatively high levels of 
consumption of red wine in France. Wines, in particular red varieties, are a source of 
low levels of resveratrol. The average intake of wine among French people, though, 
would probably not provide enough resveratrol to have a significant effect and there is 
still a lack of medical consensus about whether there really is a connection between 
the moderate consumption of alcoholic beverages and low heart disease incidence.7 
Nevertheless, the wine industry took advantage of the French paradox, promoting a 
marketing campaign which instilled in the population the idea that drinking wine leads 
to beneficial effects. 
1.2 Biomimetic Synthesis 
The ability of nature to produce complex molecules has fascinated and inspired 
synthetic chemists since the beginning of the 20th century. Various names and 
definitions for the concept of biomimicry have been proposed since the late 1950s 
onward.8,9 With regard to the specific field of synthetic organic chemistry, Eugene Van 
Tamelen was the first to define biomimetic chemistry, in 1961.10 He gave this name to 
a small yet important body of emerging work to synthesise natural products in a way 
which could plausibly occur in nature. He also made a distinction between the so called 
“biogenetic-type” and “physiological-type” syntheses. Van Tamelen defined as 
“biogenetic-type” a synthesis which was  
 
“designed to follow, in at least its major aspects, biosynthetic pathways proved, or 
presumed to be used in the natural construction of the end product”10 
 
He then added:  
 
“biogenetic-type syntheses are thus to be distinguished from physiological-type 
syntheses, in which not only plausible bio-organic substitutes are employed, but also 
specific conditions of temperature, pH, dilution etc., which supposedly compare to 
those obtained in a living cell”10 
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According to Van Tamelen’s definition, the work described in this thesis falls into the 
“biogenetic-type” category. Firstly, the synthetic design is inspired by a mixture of 
known and proposed biosynthetic pathways. Secondly, emphasis is in the overall 
strategy used by nature and on the key intermediates, which are prepared using 
conventional synthetic techniques. The starting material and the exact order of the 
transformations in the synthesis does not need to match the ones proposed to occur in 
nature. Furthermore, the key intermediates may be modified with respect to the natural 
ones to improve selectivity and/or reactivity, in the absence of enzymatic regio/stereo-
control in the laboratory. Finally, as our focus is on strategy, the reactions will be 
conducted using common synthetic techniques rather than under physiologically 
reasonable conditions, and the precise reagents used are not considered important. 
 
1.3 Biosynthesis of Natural Phenolic Compounds 
Phenolic natural products can be derived from several metabolic pathways, which 
perhaps explains their prevalence in nature. An overview of these biosynthetic 
pathways (acetate, mevalonate, methylerythritol phosphate, and shikimate) will be 
given in this general introduction chapter, along with a short discussion about 
compounds of mixed origin (scheme 1.1). 
 
Scheme 1.1: Overview of the major biosynthetic pathways. 
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Particular attention will be dedicated to the mevalonate, methylerythritol phosphate, 
and shikimate pathways, as they lead to the proposed biosynthetic precursors to the 
specific natural product targets discussed in this thesis. (A selection of our target 
compounds, which we aim to access in racemic form, is shown in figure 1.2). 
 
Figure 1.2: A selection of our natural product targets. 
1.3.1 Polyketide Biosynthesis 
Phenolic natural products can be produced via the acetate pathway, the products of 
which are often identified from the 1,3-oxygenation pattern within the aromatic rings, 
resulting from the various possible intramolecular Claisen and aldol reactions of the 
growing poly-β-ketoester chain. Methylenes flanked by two carbonyls are activated by 
specific enzymes, which also fold the substrate in the correct conformation to allow 
reactions to occur with high regioselectivity, with a natural tendency to form strain-
free six-membered rings. Tautomerisation and dehydration then allow for 
aromatisation of these six-membered rings. A simple example is represented by the 
biosynthesis of orsellinic acid. This compound is synthesised in nature from the 
polyketide chain resulting from the formal addition of an acetyl-CoA and three 
malonyl-CoA units (scheme 1.2).11 
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Scheme 1.2: Biosynthesis of orsellinic acid. 
1.3.2 Biomimetic Polyketide Synthesis 
The first reported biomimetic synthesis of a natural product is probably Collie's 
synthesis of orcinol in 1893. In this work Collie demonstrated the ability of linear 
polyketide chains to form cyclic aromatic frameworks through sequences of 
condensation reactions.12 Collie successfully synthesised orcinol from dimethylpyrone 
1.8 by treating it with an aqueous solution of barium hydroxide to give diacetylacetone 
1.9. Upon acidification of the crude reaction mixture, Collie isolated orcinol, as a result 
of an aldol condensation to give cyclic intermediate 1.10, which that tautomerised to 
afford the aromatic product orcinol (scheme 1.3).  
 
Scheme 1.3: Collie’s biomimetic synthesis of orcinol. 
The low overall yield of this relatively simple transformation reflects the natural 
tendency of polyketides to give non-selective and uncontrolled reactions. For this 





1.3.3 Terpenoid Biosynthesis 
The terpenoids and steroids constitute a large and structurally diverse class of natural 
products derived from the combination of C5 isoprene units: isopentenyl 
pyrophosphate (IPP) and dimethylallyl pyrophosphate (DMAPP). The relative 
amounts of IPP and DMAPP are regulated via the enzyme isopentenyl diphosphate 
isomerase (E1), which is responsible for the isomerisation of IPP to produce DMAPP, 
a reactive electrophile. Regular terpenoids are the result of the head-to-tail union of 
isoprene fragments and are classified as hemiterpenes (C5), monoterpenes (C10), 
sesquiterpenes (C15), diterpenes (C20), sesterpenes (C25), triterpenes (C30) etc. The 
isoprene units may be derived from two different pathways: the mevalonate pathway, 
starting with three molecules of acetyl-CoA, and the more recently discovered 
methylerythritol phosphate pathway, which uses pyruvic acid and glyceraldehyde-3-
phosphate, as shown in scheme 1.4.11 
 
Scheme 1.4: The two routes to the formation of the isoprene units. 
1.3.4 Thymol Biosynthesis 
Thymol is a naturally occurring monoterpene found as one of the major constituents 
in Thymus vulgaris and many other plants as a white crystalline solid with pleasant 
aromatic odour. The antimicrobial and antioxidant properties of thymol have been 
demonstrated in numerous studies.13,14 This compound is of particular interest in this 
thesis as it represents the starting point in the proposed biosynthesis of (±)-thymarnicol 
1.1, one of our molecular targets, discussed in chapter 2. 
 23 
The head-to-tail union of a molecule of DMAPP with an IPP fragment produces 
geranyl pyrophosphate (GPP), precursor to the acyclic, cyclic and aromatic 
monoterpenes, of which thymol is a representative member.11 The biosynthesis of 
thymol has been proven to start from isoprene units coming from the mevalonate 
pathway with an isotope labelling experiment performed by Yamazaki and co-
workers.15 The synthesis of GPP is catalysed by the enzyme geranyl diphosphate 
synthase (E1) and it is believed to involve addition of IPP to allylic cation 1.11 formed 
by elimination of pyrophosphate from DMAPP and stereoselective loss of a proton, to 
give an E-configured alkene. Linalyl pyrophosphate (LPP) and neryl pyrophosphate 
(NPP) are isomers of GPP and are likely to be in equilibrium with it through 
elimination and recombination of pyrophosphate at different positions of allylic cation 
1.12. Allylic cation 1.12 can give rise to acyclic monoterpenes, often found as 
components of volatile oils used in flavouring and perfumery, or undergo 
intramolecular electrophilic addition to produce menthyl cation 1.13, precursor to 
cyclic terpenoids. In the case of the γ-terpinene biosynthesis, this cation undergoes a 
[1,2]-hydride shift to form terpinen-4-yl cation 1.14. Finally, the loss of a proton, 
mediated by the enzyme γ-terpinene synthase (E2) provides γ-terpinene (scheme 1.5). 
 
Scheme 1.5: Biogenesis of γ-terpinene. 
The synthesis of thymol from γ-terpinene is somewhat speculative, but it is widely 
believed to involve aromatisation to p-cymene, which has been proved to be 
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synthetically feasible,16 followed by oxidation at C2 (scheme 1.6).
17 The autoxidation 
of γ-terpinene to p-cymene led Granger and co-workers to propose that it proceeds via 
non-enzymatic aromatisation.18 Later studies by Croteau and Poulose demonstrated 
that intact leaves from young thyme plants can convert isotopically labelled exogenous 
γ-terpinene into p-cymene and subsequently thymol.17,19 
 
Scheme 1.6: Formation of thymol from γ-terpinene. 
1.3.5 Biomimetic Synthesis of Terpenoids 
Most biomimetic total synthesis of complex polycyclic aromatic (and non-aromatic) 
terpenoids take advantage of a pre-installed aromatic moiety  and focus on the 
assembly of the aliphatic polycyclic framework.20-22 This is not surprising, as the 
assembly of the aromatic ring(s) from the terpene chain requires several synthetic steps 
and suffers from potential selectivity issues (see thymol biosynthesis in section 1.3.4 
on pages 22-23 for an example). The most used and reliable method for the biomimetic 
construction of the aromatic ring from aliphatic terpenoids perhaps is the oxidation of 
a cyclohexane ring coupled with migration of a geminal methyl group, as exemplified 
by the work of Cartier (scheme 1.7).23  
 
Scheme 1.7: Examples of aromatisation of terpenoid moieties.23 *Crude yield 
This method, however, requires superstoichiometric amounts of oxidant and generally 
suffer from poor yields and very narrow substrate scope. Given the wide range of 




1.3.6 Shikimate Pathway: Biosynthesis of Phenylpropanoids 
Phenylpropanoids are compounds characterised by the presence of a six-membered 
carbon ring with a three-carbon chain (C6C3). Like the closely related phenylethanoids 
(which feature a C6C2 moiety) they are biosynthetically derived from the shikimate 
pathway through modification of the aromatic amino acids phenylalanine or tyrosine. 
The shikimate pathway (scheme 1.8) starts with the coupling of phosphoenolpyruvate 
(PEP), a glycolysis product, and erythrose-4-phosphate 1.15, from the pentose 
phosphate cycle, to form 3-deoxy-D-arabino-heptulosonate-7-phosphate 1.16, with     
the intervention of 3-deoxy-D-arabino-heptulosonate-7-phosphatase (E1).11,24 
Tetrahydropyran 1.16 is then converted into ketone 1.17 in a 3-dehydroquinate 
synthase (E2) mediated sequence beginning with oxidation of the C5 alcohol, followed 
by enolisation and E1cB-type elimination of phosphate. The cyclohexane ring of 1.17 
is then formed through reduction of the C5 ketone, ring opening and aldol addition.24-
27  
 
Scheme 1.8: Biogenesis of phenylpropanoids. 
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Dehydration alpha to the carboxylic acid functionality of ketoacid 1.17 followed by 
reduction of the carbonyl group then gives shikimic acid, the first key intermediate of 
this pathway. In plants these two steps are catalysed by a single bifunctional 3-
dehydroquinate dehydratase-shikimate dehydrogenase enzyme (E3).24 Shikimic acid 
is then phosphorylated by ATP, reaction mediated by the shikimate kinase enzyme 
(E4), to give shikimic acid 3-phosphate 1.18. This is then converted into 5-
enolpyruvylshikimate-3-phosphate 1.19 through the addition of an enolpyruvate unit 
from PEP, mediated by 5-enolpyruvylshikimate-3-phosphate synthase (E5). The 
subsequent chorismate synthase (E6) mediated 1,4-elimination of hydrogen phosphate 
forms chorismic acid, the second key intermediate. Chorismic acid can then follow 
two divergent pathways, to ultimately give the amino acids tryptophan on the one hand 
and phenylalanine and tyrosine on the other.11,24 The phenylpropanoids are products of 
the phenylalanine/tyrosine branch of the synthesis. Chorismic acid undergoes a formal 
Claisen rearrangement, mediated by chorismate mutase (E7) to produce prephenic 
acid. The formation of phenylalanine and tyrosine from prephenic acid can then follow 
different pathways depending on the organism. In plants two different enzymes, 
prephenate dehydratase (E8) and prephenate dehydrogenase (E9), catalyse the 
decarboxylation of prephenic acid. In the case of E8 the loss of CO2 is paired with 
dehydration, to produce phenylpyruvate 1.20 while E9 catalyses the oxidative 
decarboxylation to 4-hydroxyphenylpyruvate 1.21, accompanied by the reduction of 
NADP+ to NADPH. Finally, phenylpyruvate and 4-hydroxyphenylpyruvate 
aminotransferases (E9 and E10 respectively) catalyse the transamination of amino 
acids 1.20 and 1.21 using a PLP (pyridoxal phosphate) cofactor to produce the amino 
acid phenylalanine and tyrosine, precursors to a wide range of natural products.24 In 
plants, a frequent first step is the elimination of ammonia from the side-chain to 
generate trans-cinnamic acid in the case of phenylalanine and 4-coumaric acid in the 
case of tyrosine, reaction mediated by the enzyme phenylalanine ammonia lyase (E12). 
These acids contain the basic (C6C3) structure for the phenylpropanoids, which are 
components of several structural polymers (lignin and suberin for example) and are 
precursors for many classes of natural products, including flavonoids, isoflavonoids, 
coumarins, lignans, cinnamic aldehydes and chalcones (figure 1.3). 
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Figure 1.3: Examples of classes of classes of compounds derived from phenylpropanoids. 
1.3.7 Biomimetic Synthesis of Phenylpropanoids 
An excellent example of a biomimetic synthesis of a phenylpropanoid natural product 
is represented by Chapman’s synthesis of carpanone.28 After isolating carpanone, 
Brophy and co-workers proposed a plausible biosynthetic pathway for its formation 
through the oxidative dimerisation of the co-isolated natural product carpacin via a  
ββ-phenolic coupling followed by an intramolecular Diels–Alder cycloaddition.29 
Chapman managed to mimic this hypothesis starting from demethylcarpacin 1.22 
using a Pd(II) mediated oxidative coupling, which readily gave the proposed 




Scheme 1.9: Chapman’s synthesis of (±)-carpanone. 
1.3.8 Meroterpenoids 
Meroterpenoids are hybrid natural products containing a partial terpenoid structure, 
the prefix “mero” means “part” or “fragment”, although in the literature this term is 
sometimes used solely for compounds of mixed polyketide and terpenoid origin.30 This 
class of secondary metabolites includes numerous compounds derived from plants, 
animals, bacteria and fungi.30-32 A sub-family is represented by the terpenophenolics, 
that are part terpenoids and part phenols. Representative members of this group are α-
tocopherol, tetrahydrocannabinol and mycophenolic acid (figure 1.4).  
 
Figure 1.4: Representative examples of meroterpenoids. 
1.3.9 Biosynthesis of Meroterpenoids 
The biosynthesis of meroterpenoids generally starts with the assembly of the 
polyketide chain, followed by prenyltransferase enzymes-directed prenylation of the 
polyketide followed by stereoselective epoxidation of a double bond in the newly 
introduced chain and cyclisation of the terpenoid moiety.30 There are also instances in 
which meroterpenoids are produced in nature by assembly of pre-cyclised units 
coming from the two pathways. The structural diversity within this class of compounds 
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is due to the differences in the mechanism of the cyclisation reactions, which is strictly 
controlled by specific enzymes and usually affords a single product. Further 
differentiation is produced by the differences in the polyketide starting moieties and 
by various post-cyclisation modifications by both heme and non-heme iron dependent 
oxygenases.30 An example of this is represented by the meroterpenoid territrem A,33 
the biosynthetic speculation of which31 is based on analogy with the proven one for 
pyripyropene A from nicotinic acid.34 The shikimate derived building block in this 
synthesis is proposed to be 4-hydroxybenzoic acid, which, after condensation with two 
molecules of malonyl-CoA would give pyranone 1.24. This could then undergo 
prenyltransferase-catalysed farnesylation with subsequent stereoselective epoxidation 
of the terminal alkene to afford epoxide 1.25. Polyene cyclisation of the terpenoid 
moiety would then produce compound 1.26. Finally, a series of post-cyclisation 
modifications, including oxidations and methylations, would generate territrem A 
(scheme 1.10). 
 
Scheme 1.10: Proposed biosynthesis of territrem A. 
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1.3.10 Biomimetic Synthesis of Meroterpenoids 
A recent example of biomimetic synthesis of a meroterpenoid, involving the coupling 
of pre-cyclised terpene and polyketide moieties is represented by Lee’s total synthesis 
of guajadial and psidial A.35 Inspired by a biosynthetic hypothesis proposed by Liu 
and co-workers,36 Lee successfully completed a biomimetic total synthesis. 
Diformylphloroglucinol 1.27 was subjected to a three-component reaction along with 
benzaldehyde and the naturally occurring and commercially available cyclic terpene 
caryophyllene. After extensive screening of reaction conditions, it was found that 
heating a mixture of the three components at 100 °C for 15 hours in the presence of a 
5% aqueous solution of PTS resulted in a 25% combined yield of guajadial and psidial 
A. The transformation was proposed to involve aldol condensation between 
diformylphloroglucinol 1.27 and benzaldehyde followed by hetero-Diels–Alder 
cycloaddition of the resulting o-quinone methide 1.28 with caryophyllene (scheme 
1.11). 
 
Scheme 1.11: Lee’s synthesis of guajadial and psidial A. 
 
1.4 Dimeric and pseudo-Dimeric Natural Products 
Some of the targeted natural products in this thesis are dimers or derivatised dimers. 
Therefore, this section aims to give a very brief introduction to dimeric and pseudo-
dimeric natural products and a relevant example of biomimetic synthesis. 
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Greer and co-workers, in 2004, surveyed around 3000 articles about natural products 
and concluded that around 17% of them included molecules that can be referred to as 
“dimers” or “derivatised dimers” and 7% possess bilateral symmetry (i.e. they possess 
C2, Cs or C2V point groups).
37 The other 10% includes molecules lacking of symmetry 
but formed as a result of the combination of two identical monomeric units and, 
sometimes, post-dimerisation modifications. The number of reported isolations of 
dimeric or pseudo-dimeric natural products was extremely low before 1960, but has 
dramatically increased in recent decades. That is because, before then, the 
identification of dimers, especially the ones possessing bilateral symmetry, was 
particularly difficult, as their spectra are usually very similar to those obtained for the 
corresponding monomers.38 Furthermore, most dimeric and pseudo-dimeric natural 
products are rather complex frameworks, making the structure assignment 
challenging. In the 1970s the development of 2D NMR and mass spectrometric 
techniques made the identification of these natural products easier, leading to a larger 
number of reported isolations. Following that, the number of total syntheses of such 
compounds has risen significantly: synthetic organic chemists are attracted by dimeric 
natural products due to their biological activity and often impressive complexity. In 
particular, biomimicry has been used to emulate the way nature generates complexity 
(new bonds, rings and stereocentres) in a single step through dimerisation reactions. 
These include radical reactions, Diels–Alder, Michael additions, esterifications, [2+2], 
[4+4] and [6+6] cycloadditions, and many others (some selected examples are depicted 
in figure 1.5). 
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Figure 1.5: Examples of dimeric and pseudo-dimeric natural products. 
1.4.1 Biosynthesis of Dimeric Natural Products 
Nature has developed this strategy for different reasons: as mentioned, dimerisation is 
an efficient way of increasing complexity very rapidly, generating a new molecule by 
simply coupling together two identical monomers already available in the organism. 
Furthermore, as a result of the dimerisation, the newly formed molecule often 
possesses very different physical properties with respect to the starting material. This 
could result in different interactions with endogenous or exogenous targets, leading to 
a benefit for the organism itself. 
1.4.2 Biomimetic Synthesis of Dimeric Natural Products 
Nature has the ability of achieving complete regio and/or stereo-selectivity in the 
dimerisation, either through the use of enzymes or taking advantage of the natural 
reactivity in non-enzymatic reaction pathways.39 From a biomimetic point of view, in 
the laboratory this task is often more difficult to achieve, thus synthetic chemists often 
either take advantage of the inherent selectivity of the reaction or  use protecting or 
activating groups,40,41 still retaining the overall strategy. 
A nice example of biomimetic total synthesis of a dimeric natural product is 
represented by 2001 Nicolaou’s synthesis of hybocarpone,42 a compound isolated from 
the lichen Lecanora hybocarpa.43 Nicolaou and co-workers identified its dimeric 
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nature and proposed a possible biosynthetic pathway involving a single electron 
transfer (SET) mediated dimerisation. This hypothesis was plausible as Yamamoto 
previously reported the isolation of 6-methylcristazarin,44 a putative monomeric unit 
(scheme 1.12). The highly oxygenated structure of 6-methylcristazarin, though, raises 
questions about the feasibility of achieving a regioselective coupling. To overcome 
this issue, Nicolaou and co-workers chose naphthazarin 1.29 as the monomeric unit in 
their biomimetic synthesis. This key intermediate was prepared in 7 steps from known 
aromatic aldehyde 1.30 and then subjected to ceric ammonium nitrate (CAN), a single 
electron transfer (SET) oxidant reagent, leading to the formation of hexamethyl 
hybocarpone. This transformation is believed to proceed through activation of 
naphthazarin 1.29 via a single electron transfer process to form the very reactive 
radical-cationic species 1.31, which could undergo dimerisation and loss of two 
protons to afford bridged dimer 1.32. Selective hydration and protonation of this 
species were then invoked to furnish hexamethyl hybocarpone, as shown in scheme 
1.12. Finally, cleavage of the six methyl-ether protecting groups completed the 
synthesis. 
 
Scheme 1.12: a) Hybocarpone and its plausible monomeric precursor 6-methylcristazarin. 
b) Nicolaou’s total synthesis of hybocarpone.  
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2 Total Synthesis of (±)-Thymarnicol 1.1 
 
2.1 Introduction 
2.1.1 Thymarnicol: a Dimeric Thymol Derivative 
Thymol derivatives are widely distributed within the Asteraceae family of plants and 
have been widely used for taxonomic treatment on tribal and sub-tribal level for 
decades.45 In 1998 Passreiter and co-workers reported the isolation of a series of simple 
thymol derivatives (some of which showed interesting bioactivity as contact allergens) 
from the flower-heads of Arnica sachalinensis,46 a plant endemic to north-east Asia 
(selected examples are shown in figure 2.1).47 
  
Figure 2.1: Selected examples of thymol derivatives. 
Further investigation led to the identification of a structurally more complex racemic 
terpenoid, which showed promising antifeedant activity against the larvae of 
Spodoptera litura, a major pest for many agricultural crops.48 As this metabolite was 
not given a name by the isolation team, we propose “thymarnicol” a portmanteau of 
Arnica and thymol as a suitable name. This compound features a new 
spiro[benzofuran-pyranobenzofuran] ring system bearing four stereocenters and a 
variety of oxygen functionalities (figure 2.2), which make it a significant synthetic 
challenge and, therefore, a particularly attractive target for synthetic organic chemists. 
               
Figure 2.2: (±)-Thymarnicol 1.1. 
During the analysis of the 13C NMR data in the structural determination of (±)-
thymarnicol 1.1, Passreiter and co-workers recognised the presence of ten pairs of 
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carbons, which indicated that compound (±)-1.1 could be a pseudo-dimer. Similarities 
between the fragmentation pattern in its mass spectrum (EI as ionisation mode) with 
respect to other previously isolated compounds indicated that (±)-thymarnicol46,49 1.1 
is likely to be biosynthetically derived from thymol. At the time of isolation the relative 
stereochemistry remained unclear, although it was reasonable to assume that a cis 
configuration at C-9 and C-8 was likely as all previously reported hydrated 
pyrano[2,3]benzofuran ring systems were found to be cis-annelated.50-52 It was only in 
2001 that the relative stereochemistry was elucidated via X-ray crystallography by 
Passreiter and co-workers.53  
2.1.2 Passreiter’s Biosynthetic Proposal 
Besides recognising (±)-thymarnicol 1.1 as a dimeric thymol derivative, Passreiter and 
co-workers also proposed a plausible biosynthetic pathway for its formation. In their 
hypothesis, thymol, or an acyl-protected variant of it, could undergo a series of 
oxidations to give alkene 2.2 and aldehyde 2.3, both known structures46. Either of these 
two structures could then be converted into enal 2.4, which could then undergo hetero-
Diels–Alder cycloaddition to provide dihydropyran (±)-2.5. This could then, after 
cleavage of the acyl groups, undergo a double cyclisation to form lactol (±)-2.6, which 
features the pentacyclic framework of (±)-thymarnicol 1.1. Finally, a highly selective 
enzyme-mediated benzylic oxidation could occur to complete the biosynthesis of (±)-
thymarnicol 1.1 (scheme 2.1). 
Scheme 2.1: Passreiter’s biosynthetic proposal. 
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2.1.3 Alternative Biosynthetic Pathways 
Inspired by this biosynthetic hypothesis the Lawrence group started a biomimetic 
investigation into the first total synthesis of this dimeric natural product. Our synthetic 
strategy is based on the hetero-Diels–Alder dimerisation of an enal akin to compound 
2.4, but it offers different possibilities in the subsequent steps. Passreiter proposed an 
early stage double deprotection/cyclisation of dihydropyran dimer (±)-2.5 and a late 
stage enzyme-mediated benzylic oxidation to install the tertiary alcohol with the 
desired stereoselectivity at C8. We reasoned that an alternative could be represented 
by the diastereoselective epoxidation of the double bond on dihydropyran (±)-2.5 to 
give oxidised dimer (±)-2.7, followed by the double deprotection/cyclisation sequence 
(scheme 2.2). A diastereoselective dihydroxylation instead of an epoxidation would 
give the same final result.  
 
Scheme 2.2: Proposed alternative pathway for (±)-thymarnicol 1.1. 
 
The origin of the diastereoselctivity could be rationalised based on the relative stability 
of the two conformers of (±)-2.5, with the conformer where the aromatic substituent is 
in a pseudo-equatorial position likely to be more stable (A values for Ph= 3.0 kcal/mol, 
formyl= 0.8 kcal/mol). Approach of the oxidant to the less hindered face of this lower 
energy conformer would yield the configuration observed in the natural product 
(scheme 2.3). 
 
Scheme 2.3: Proposed rationalisation for the diastereoselective oxidation. 
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A closer look to the literature revealed another intriguing possibility. In the discussion 
about the biosynthesis of (±)-thymarnicol 1.1 in the isolation paper, Passreiter and co-
workers mentioned lactol (±)-2.1 (figure 2.1 on page 34) to support the existence of 
their proposed acrolein monomer 2.4 (see scheme 2.1 on page 35). Lactol (±)-2.1 was 
originally isolated in 1969 by Bohlman and co-workers from the roots of plants from 
the Helenium species47 and subsequently from various Asteraceae plants, the family 
which Arnica sachalinensis belongs to.54 This compound has been reported in the 
literature to be “not stable, and co-exist in equilibrium with a small amount (around 
20%) of its hemiacetal-opened aldehyde form 2.8, based on its 1H NMR spectrum”.55 
The opened aldehyde form of lactol (±)-2.1  is the unprotected version of monomer 
2.4 proposed by Passreiter, so we wondered if the instability of this compound could 
be toward dimerisation. If this was the case, the hetero-Diels–Alder cycloaddition 
would provide lactol (±)-2.9, which could then follow either of the two routes having 
epoxide (±)-2.10 or pentacyclic compound (±)-2.6 as intermediates to give                    
(±)-thymarnicol 1.1. A picture of the various possibilities is shown in scheme 2.4.  
Scheme 2.4: Possible biosynthetic pathways to (±)-thymarnicol 1.1. 
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Intrigued by this possibility, we designed a strategy which would allow us to 
investigate all these possible pathways. To do that, we needed to access both (±)-lactol 
2.1 and a suitably protected enal 2.4, the former being in principle accessible by 
deprotecting the latter. Enal 2.4, in turn, could be prepared via a sequence of oxidation 
of primary alcohol 2.11 to the aldehyde and methylenation through a well-established 
procedure.56 We envisaged that primary alcohol 2.11 could be synthesised through 
selective o-metalation and ring opening of ethylene oxide from protected phenol 2.12. 
The choice of the phenolic protecting group in compound 2.12 would enable the 
required regioselectivity in this key carbon-carbon bond forming step. Protected 
phenol 2.12, in turn, could be accessed via protection of the commercially available 
and very cheap m-cresol (scheme 2.5). 
 
Scheme 2.5: Proposed retrosynthetic analysis to access lactol (±)-2.1 and enal 2.4. 
2.2 Literature Precedent 
We envisaged that the two main challenges in our planned synthesis were the hetero-
Diels–Alder cycloaddition and the oxidation/cyclisation sequence. Herein we present 
an overview of relevant literature precedent. 
2.2.1 Dimerisation Literature Precedent 
With respect to the hetero-Diels–Alder dimerisation, there are some interesting 
examples in the literature with α-aryl-enones.57-59 For example, in 1981 Overman and 
co-workers made an interesting observation while investigating the Diels–Alder 
cycloaddition of acylamino-1,3-dienes with a series of different substituted 
dienophiles.57 When diene carbamate 2.13 and an excess of acrylate ether 2.14 were 
heated under reflux in toluene, the expected cyclohexene (±)-2.15 was isolated in 69% 
yield. Unexpectedly, however, dihydropyran (±)-2.16, which is the product of the 
hetero-Diels–Alder dimerisation of enal 2.14, was isolated in 43% yield (scheme 2.6).  
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Scheme 2.6: Overman’s unexpected observation. 
To the best of our knowledge, the hetero-Diels–Alder dimerisation of α-aryl-enals has 
been reported just twice. The first example was reported in 1993 by Laitalainen and 
co-workers,60 wherein atropaldehyde 2.17 (i.e., 2-phenylpropenal) was prepared via 
selenium dioxide allylic oxidation of styrene 2.18. They observed that the purified, 
neat, atropaldehyde 2.17 dimerised quantitatively within two days at room temperature 
to give (±)-dihydropyran 2.19 (scheme 2.7). 
 
Scheme 2.7: Preparation of (±)-dihydropyran 2.19. 
The most promising precedent is perhaps the discovery made by Davies and co-
workers. In 2005 they described the Lewis acid catalysed formal inverse electron 
demand hetero-Diels–Alder reaction between α-aryl-α,β-unsaturated aldehydes with 
cyclopentadiene.61 During their investigations they treated a series of differently 
substituted enals and five equivalents of cyclopentadiene with dimethylaluminium 
chloride as a Lewis acid catalyst (one example is shown in scheme 2.8).  
 
Scheme 2.8: Example of Davies’ Lewis acid catalysed Diels–Alder. 
A series of enals was employed to explore the substrate scope of this reaction, some 
of which needed to be prepared. Davies reported that enal 2.20, one of their substrates, 
“must be used immediately, because it is very prone to dimerisation” (scheme 2.9). 
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Scheme 2.9: Davies’ observation. 
This result, along with Laitalainen’s observation, indicated a natural tendency of α-
aryl-substituted enals to undergo hetero-Diels–Alder dimerisation. However, given the 
limited number of substrate examples, no assumption could be made with regard to 
the effect of different substituents on the aromatic ring. 
2.2.2 Oxidation/Cyclisation Literature Precedent 
With respect to the oxidation/cyclisation sequence there are some interesting 
precedents on the use of DMDO (dimethyldioxirane) in the diastereoselective 
epoxidation of dihydropyrans, followed by either inter or intra-molecular ring opening 
with oxygen-based nucleophiles. A very interesting example is represented by the 
work of Tan and co-workers on the stereoselective synthesis of benzannulated 
spiroketals.62 Spiroketal 2.21 was prepared in a one-pot procedure from glucal 2.22 
through diastereoselective epoxidation with DMDO at −78 °C to give epoxide 
intermediate 2.23, which readily underwent intramolecular ring opening with retention 
of stereochemistry at C1 upon warming of the reaction mixture to room temperature 
(scheme 2.10). This example fits very well with our planned synthesis as it encloses 
the oxidation and ring opening in a single step. 
 
Scheme 2.10: Tan’s one pot oxidation/cyclisation and comparison with (±)-thymarnicol 1.1. 
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2.3 Previous Work 
In 2013, Dr Sam Drew (Australian National University) started this project by 
following the previously discussed proposed biomimetic strategy. The first step of the 
synthesis involved protecting the very cheap (£0.36/g) m-cresol with a suitable ortho-
directing group, as required for the next step. The MOM (methoxymethyl) group was 
chosen, as it has been reported to give excellent ortho regioselectivity for the alkylation 
upon lithiation using n-butyllithium and, in the specific case of m-cresol, tert-
butyllithium.63,64 m-Cresol was thus converted into its MOM-ether using a literature 
procedure.64 Treatment with MOM-chloride and three equivalents of Hünig’s base in 
dichloromethane afforded MOM-ether 2.24 in 78% yield on an eleven-gram scale 
(scheme 2.11). 
 
Scheme 2.11: Preparation of MOM-cresol 2.24 by Sam Drew. 
MOM-ether 2.24 was then converted into primary alcohol 2.25 through directed ortho-
metalation using a small excess of tert-butyllithium and in-situ quenching of the 
aryllithium with two equivalents of ethylene oxide in the presence of lithium bromide 
(2.12). 
 
Scheme 2.12: Preparation of primary alcohol 2.25 by Sam Drew. 
This reaction was performed on different scales, with the yield decreasing slightly 
from 90% of isolated product to 81% internal standard 1H NMR yield, upon scaling-
up the reaction from 1 to 4.6 grams. Alcohol 2.25 was always the only isolated product, 
with no formation of other regioisomers observed. With this in hand, attention was 
then turned to the oxidation/methylenation sequence. This was a well-established one-
pot procedure,56 involving Parikh–Doering oxidation of a primary alcohol to the 
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aldehyde followed by methylenation at the α-position using the Eschenmoser salt. 
Treatment of alcohol 2.25 with sulfur trioxide/pyridine complex produced aldehyde 
2.26, the formation of which was detected by TLC analysis. After allowing the starting 
material to be fully consumed, the Eschenmoser salt was added as a solid and the 
reaction was left to proceed to completion (scheme 2.13).  
 
Scheme 2.13: One pot preparation of enal monomer 2.27 by Sam Drew. 
This afforded 1.9 grams (75% yield) of clean enal monomer 2.27, which was 
immediately used to investigate several dimerisation conditions. After extensive 
screening of conditions, it was found that the best conditions for the hetero-Diels–
Alder dimerisation are heating enal monomer 2.27 at 80 °C in the presence of ~0.5 
equivalents of potassium carbonate (scheme 2.14). Reactions conducted without the 
base resulted in the formation of complex mixtures of compounds, presumably due to 
the loss of one of both the MOM-groups on the monomer and/or dimer. 
 
Scheme 2.14: Preparation of dihydropyran (±)-2.28 by Sam Drew. 
This key biomimetic dimerisation afforded dihydropyran (±)-2.28 in 77% yield on a 
1.5-gram scale, providing material with which to investigate the two possibilities of 
deprotection/oxidation and oxidation/deprotection previously discussed (see section 
2.1.3 on pages 36-37) (scheme 2.15). 
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Scheme 2.15: The two alternative pathways to (±)-thymarnicol 1.1. 
The cleavage of the MOM protecting groups was first attempted with boron trifluoride 
diethyl etherate but this led to decomposition.65 A similar result was obtained upon 
treatment with trimethylsilyl (TMS)-chloride/sodium iodide66 as a way to generate 
TMS-iodide in situ. In this case 1H NMR analysis of the crude reaction product clearly 
showed removal of the MOM groups; however, it was not possible to isolate any of 
the multiple products. 
The early oxidation approach was then undertaken. Attempts to oxidise dihydropyran 
(±)-2.28 with m-CPBA met with failure, resulting in the formation of a complex 
mixture of unidentified products. As previously discussed (see section 2.2.2 on page 
40), there was promising literature precedent for the DMDO epoxidation of 
dihydropyrans structurally related to our substrate.62,67 Thus, treating 50 mg of 
dihydropyran (±)-2.28 with a freshly prepared DMDO solution afforded epoxide          
(±)-2.29 as a 1:1 diastereomeric mixture (scheme 2.16). The complete lack of 
diastereoselectivity was disappointing and therefore purification of this epoxide was 
not carried out.  
 
Scheme 2.16: Preparation of epoxide (±)-2.29 by Sam Drew. 
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2.4 Results and Discussion 
As a result of these previous investigations within the group, when undertaking this 
project attention was devoted to two main areas: the oxidation of dihydropyran           
(±)-2.28 and the removal of the MOM-protecting groups. With respect to the oxidation, 
bulkier epoxidising and dihydroxylating agents needed to be tested on dihydropyran 
(±)-2.28 to install the desired stereochemistry required for the molecular target. 
Concerning the removal of the MOM groups, there was the need to test more 
conditions on both the unoxidised and oxidised dimers (±)-2.28 and (±)-2.29. 
Therefore, there was the requirement for a reasonable amount of material to be tested, 
thus a repetition of the entire synthesis was necessary. 
2.4.1 Repetition and Optimisation of the Previous Synthesis 
The first step of the synthesis, involving MOM-protection of m-cresol, was performed 
under the same conditions and on the same scale as previously used, with identical 
result (see scheme 2.11 on page 41). An improvement was achieved for the                       
o-lithiation/ring-opening of ethylene oxide. This reaction was scaled up from 4.6 to 6 
grams, and the yield increased from an internal standard 1H NMR yield of 81% to 84% 
of purified product (see scheme 2.12 on page 41). The one-pot oxidation/ 
methylenation sequence (see scheme 2.13 on page 42) was also repeated on different 
scales, giving variable results, with the yield typically decreasing upon scaling up     
(900 mg, 90% : 1.9 g, 75%). Finally, the dimerisation was replicated in the optimised 
conditions (see scheme 2.14 on page 42) giving as the best result a 77% isolated yield 
on a 1.5-gram scale (scheme 2.17). 
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Scheme 2.17: Optimisation of the synthesis of dihydropyran (±)-2.28. 
2.4.2 Stereoselective Oxidations 
In the previous work the epoxidation of dihydropyran (±)-2.28 had been successfully 
accomplished on a small scale using freshly prepared DMDO, although with no 
diastereoselectivity. The preparation of DMDO, though, is typically rather inefficient, 
yielding dilute acetone solutions (~0.1 M) in less than 3% yield.68 Furthermore, the 
prepared solution needs to be stored at low temperature (−10 to −20 °C) for no longer 
than a week, and its concentration needs to be assayed immediately prior to use.68 An 
alternative is to generate the active DMDO species in situ using acetone and Oxone 
(KHSO5) under biphasic conditions.
69 This reaction proceeds by nucleophilic addition 
of Oxone to the carbonyl group of acetone with subsequent loss of hydrogen sulfate. 
The transfer of oxygen to the substrate then forms the oxidised product and regenerates 
acetone (scheme 2.18), therefore the epoxidation can, in principle, be catalytic in 
ketone. Although this does not constitute an advantage in the case of acetone, it 
represents a potential for catalytic, asymmetric epoxidation using chiral (and more 
expensive) ketones. 
 
Scheme 2.18: Cycle for the epoxidation with in situ generated DMDO. 
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This approach does, however, suffer from some limitations; to ensure high yields, a 
large excess of acetone is usually required and a slow addition of Oxone is essential to 
avoid its reaction with DMDO itself (scheme 2.19). 
 
Scheme 2.19: Undesired reaction of Oxone with DMDO. 
Furthermore, a careful control of the pH with a buffer is necessary to suppress the 
autodecomposition of Oxone at high pH and to compensate for the formation of acid 
during the production of DMDO.69 With this in mind, the epoxidation of dihydropyran 
(±)-2.28 was attempted with in situ generated DMDO. Using a modified literature 
procedure,70 reaction of dihydropyran (±)-2.28 with a large excess of acetone in a 
biphasic solvent system (CH2Cl2/aqueous NaHCO3) and three equivalents of slowly 
added Oxone successfully afforded epoxide (±)-2.29. Unsurprisingly, this reaction 
proceeded with no diastereocontrol to afford a 1:1 mixture of diastereoisomers in 76% 
yield on a 45-mg scale (scheme 2.20). 
 
Scheme 2.20: Formation of epoxide (±)-2.29 with in situ generated DMDO. 
Given this result, we decided to investigate the use of bulkier oxidants to achieve the 
desired diastereoselectivity. As discussed earlier, the in-situ generation of dioxiranes 
can be applied to catalytic enantioselective epoxidations. The Shi ketone,71 a fructose-
derived commercially available ketone, has been widely used in the epoxidation of 
substituted alkenes to give moderate to excellent enantioselectivity. Therefore the 
oxidation of dihydropyran (±)-2.28 using a modified literature procedure was 
performed.72 The outcome of this reaction proved to be highly dependent on the pH 
(controlled using a buffer), the rate of addition of Oxone, stoichiometry and 
concentration. With the optimised conditions in hand, the reaction afforded epoxide 
(±)-2.29 in 82% crude yield in a 5:4 diastereomeric ratio (scheme 2.21). This small 
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degree of diastereoselectivity was judged to not be promising enough to pursue this 
route. 
  
Scheme 2.21: Formation of epoxide (±)-2.29 with the in situ generated dioxirane of the Shi ketone. 
We then turned our attention to the dihydroxylation of dihydropyran (±)-2.28. A first 
trial with a small scale Sharpless asymmetric dihydroxylation using AD-mix-β gave a 
mere 10% consumption of the alkene starting material after 24 h. Thus the catalytic 
Upjohn oxidation was then attempted on a small scale, following a modified literature 
procedure.73 Treatment of dihydropyran (±)-2.28 with a substoichiometric amount of 
osmium tetroxide and stoichiometric quantities of N-methylmorpholine-N-oxide 
(NMO) as the terminal oxidant afforded lactol (±)-2.30 a 2:1 mixture of two 
compounds (scheme 2.22). Based on analysis of the crude 1H NMR spectrum, it is 
believed that these were presumably epimers at the lactol position.  
 
Scheme 2.22: Preparation of lactol (±)-2.30. 
Column chromatography afforded diastereomerically pure lactol (±)-2.30 as the sole 
isolated product. Unfortunately, analysis of 2D NMR spectra, including NOESY 
experiments, did not give conclusive results on determining the relative 
stereochemistry. Repetitive attempts on recrystallising lactol (±)-2.30 using a variety 
of solvent systems and derivatising the two hydroxyl groups on (±)-2.30 with phenyl 
isocyanate met with failure. Interestingly, it was noticed that simply storing a sample 
of lactol (±)-2.30 in deuterated chloroform for five days resulted in complete loss of 
one of the two MOM protecting groups of lactol (±)-2.30. The same result could be 
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obtained by adding a small amount of aqueous HCl (~2 equivalents) to the NMR 
sample. Unfortunately, it was not possible to determine which of the two MOM-groups 
was removed, and increasing the temperature to 40 °C failed in removing the residual 
protecting group. Attempts on forcing the reaction by adding more acid resulted in 
decomposition. 
With limited success in achieving diastereoselectivity in the oxidation of dihydropyran 
(±)-2.28, our attention was turned to removal of the MOM-ethers on both dihydropyran 
(±)-2.28 and epoxide (±)-2.29. It was envisaged that the double deprotection of the 
latter could potentially afford thymarnicol (±)-1.1 through a deprotection/cyclisation 
sequence based on promising literature precedent, which was discussed in section 
2.2.2 on page 40. 
2.4.3 Deprotection Attempts 
The deprotection was initially attempted on epoxide (±)-2.29. Silica-supported sodium 
hydrogen sulfate (NaHSO4•SiO2) has been reported to be a heterogeneous catalyst for 
“simple, efficient and selective deprotection of phenolic methoxymethyl ethers”,74 
including aldehyde-containing substrates (some examples are depicted in figure 2.3). 
 
Figure 2.3: Examples of NaHSO4•SiO2-mediated MOM-deprotection on aldehyde substrates.74 
This appeared to be promising, as in the previous deprotection tests the immediate 
disappearing of the aldehyde peak in the 1H NMR spectra seemed to suggest that this 
functional group played a role on the instability of the substrates or products of the 
reactions. Therefore, epoxide (±)-2.29 was dissolved in anhydrous CH2Cl2 and treated 
with NaHSO4•SiO2 freshly prepared using a literature procedure;
75 unfortunately, this 





Scheme 2.23: Attempted deprotection of epoxide (±)-2.29 with NaHSO4•SiO2. 
 
A more interesting result was obtained with the in-situ generation of TMSI. Using a 
modified literature procedure,66 epoxide (±)-2.29 was dissolved in a 1:1 mixture of 
dichloromethane and acetonitrile and treated with TMSCl and NaI (10 equivalents 
each) for 20 minutes at 0 °C. Column chromatography afforded a colourless oil in 86% 
yield, which contained bis-lactone 2.31 as a 1:1 mixture of diastereoisomers based on 
analysis of the 1H and 13C NMR spectra. Bis-lactone meso-2.31 could be purified via 
recrystallisation to afford a colourless solid in 36% yield (scheme 2.24), the structure 
of which was confirmed by X-ray crystallography. It was not possible, however, to 
obtain an analytically pure sample of the other diastereoisomer. 
 
Scheme 2.24: TMSCl/NaI deprotection of epoxide (±)-2.29. 
The mechanism of the reaction leading to the two diastereomeric bis-lactones 2.31 is 
speculative, but it is proposed to initially involve cleavage of the MOM protecting 
groups, followed by double cyclisation to afford thymarnicol-type structure (±)-2.32. 
Under the Lewis acidic reaction conditions cation (±)-2.33 could form and then 
undergo a first [1,2]-hydride shift to afford oxonium ion (±)-2.34, which could then, 
after a second [1,2]-hydride shift, produce the observed lactones 2.31 (scheme 2.25). 
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Scheme 2.25: Proposed mechanism for the formation of bis-lactones 2.31. 
The deprotection was then attempted on the unoxidised dihydropyran dimer (±)-2.28 
under the same reaction conditions (TMSCl/NaI) used for epoxide (±)-2.29, but in this 
case it gave a complex mixture of compounds, with no product isolated. Another 
attempt was made with the milder Lewis acid TMSBr at −78 °C in CH2Cl2, with the 
same disappointing result.76  
In 1986 Hiyama and co-workers reported a mild procedure for the deprotection of 
alkoxymethyl aryl ethers using P2I4.
77 The procedure was applicable to a wide range 
of substrates bearing different functional groups, including esters, ethers, ketones and 
aldehydes. In this case, subjecting our substrate (±)-2.28 to the literature reaction 
conditions77 resulted in decomposition. We then turned our attention to deprotection 
conditions with the use of Brønsted acids. Treating dihydropyran (±)-2.28 with glacial 
acetic acid in toluene at 90 °C,78 or  trifluoroacetic acid79 led to the formation of several 
unidentified products in which the MOM groups appeared to stay intact and immediate 
loss of the aldehyde peak was observed on the crude 1H NMR spectra. Subjecting 
dihydropyran (±)-2.28 to hydrolysis using both catalytic and stoichiometric HCl in 
acetone, isopropanol or tetrahydrofuran had the same result. Finally, an interesting 
result was obtained using methanol as the solvent: reacting dihydropyran (±)-2.28 with 
two equivalents of HCl at room temperature resulted in the formation of acetal            
(±)-2.35 as a 1:1 mixture of diatereoisomers in 92% isolated yield (scheme 2.26). 
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Scheme 2.26: Deprotection of dihydropyran (±)-2.28 using HCl in methanol. 
A possible mechanism for the formation of acetal (±)-2.35 is shown in scheme 2.27. 
We suggest that initial removal of the MOM protecting groups and mono-cyclisation 
could form lactol (±)-2.9, which under Brønsted acidic conditions could undergo 
protonation to give oxonium ion (±)-2.36. A [1,2]-hydride shift could then occur, 
forming a second ring-opened oxonium (±)-2.37, which, after cyclisation and the 
addition of two molecules of solvent would afford the observed products. 
Scheme 2.27: Proposed mechanism for the formation of acetal (±)-2.35. 
The results obtained in the attempted deprotection of dihydropyran (±)-2.28 and 
epoxide (±)-2.29 demonstrated the acid instability of the products of their hydrolysis. 
The immediate loss of the aldehyde peak observed in some cases in the 1H NMR 
spectra after addition of the acid suggested that the aldehyde functionality could play 
a role in this instability. 
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With these results in hand, we reasoned that if we could mask the aldehyde functional 
group on epoxide (±)-2.29 and/or dihydropyran (±)-2.28, this would prevent the 
formation of lactols (±)-2.32 (see scheme 2.25 on page 50) and (±)-2.9 (see scheme 
2.27 on page 51), thus avoiding the hydride shifts ultimately leading to the previously 
discussed undesired reactions. A possible approach could involve olefination of 
dihydropyran (±)-2.28 through Wittig reaction. At this point both the MOM-
deprotection/oxidation or oxidation/deprotection sequences could be investigated, 
before revealing the aldehyde to complete the synthesis. 
To test if this alternative approach was feasible, we first performed a Wittig olefination 
on aldehyde (±)-2.28 using a modified literature procedure.80 A THF solution of 
dihydropyran (±)-2.28 was treated with a suspension of deprotonated Wittig reagent at 
0°C for three hours. The reaction was quenched before complete consumption of the 
starting material, as TLC analysis indicated the formation of several products. Column 
chromatography afforded an isolated yield of 14% of alkene (±)-2.38, along with 9% 
of recovered starting material (±)-2.28 (scheme 2.28). This alternative route to                  
(±)-thymarnicol 1.1 was pursued no further, as the identification of the side-products 
of this reaction was not possible and the yield was not considered to be sufficient.  
 
 










2.5 Protecting-Group Free Approach 
At this point it was clear that the choice of the MOM protecting group had seriously 
undermined the synthesis, therefore we decided to investigate the alternative proposed 
biomimetic strategy discussed in section 2.1.3 on page 37. This involved the known 
natural product lactol (±)-2.1 as the monomeric precursor to (±)-thymarnicol 1.1. This 
alternative approach was based on the hypothesis that the reported instability of lactol 
(±)-2.155 could be due to dimerisation. This possibility was very appealing, as it would 
allow both the oxidation/cyclisation and cyclisation/oxidation alternative pathways to 
(±)-thymarnicol 1.1 from dihydropyran dimer (±)-2.9, the former potentially occurring 
in one-pot (scheme 2.29). 
 
Scheme 2.29: Protecting group-free biomimetic approach. 
2.5.1 Deprotection of enal 2.4 
We started our investigation with an attempt to access lactol (±)-2.1 directly through 
deprotection of MOM protected enal monomer 2.27 (scheme 2.30).55 
 
Scheme 2.30: Initial approach to access lactol (±)-2.1. 
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Initial attempts on removing the MOM group on enal 2.27 using P2I4,
77 silica supported 
NaHSO4,
74 TMSBr76 and acetic acid78 gave complex mixtures of unidentified 
products. Different reaction conditions were then tested on the HCl-mediated 
deprotection: using DMSO as solvent failed to remove the MOM group, while THF 
gave a complex mixture of products. Finally, cleavage of the MOM-ether on 2.27 was 
carried out using concentrated HCl in methanol at room temperature. This resulted in 
the formation of methyl acetal (±)-2.39 and dimethyl acetal 2.40, the latter formed 
through the addition of two molecules of solvent to starting material 2.27 (scheme 
2.31). 
 
Scheme 2.31: HCl deprotection of enal 2.27. 
Although this reaction failed to give lactol (±)-2.1 directly, there was literature 
precedent for its formation via acidic deprotection of acetal (±)-2.39. Unfortunately 
the specific reaction conditions are not clearly stated in the literature.47,55,81 Therefore 
we carried out attempts to deprotect the acetal using HCl at different concentrations in 
THF, however no formation of expected product (±)-2.1 was observed. 
2.5.2 Alternative Approach for the Synthesis of Lactol (±)-2.1 
Having failed to access lactol (±)-2.1 by directly deprotecting enal 2.27, we decided to 
try an alternative approach. It was envisaged that phenol 2.41, potentially prepared via 
the deprotection of MOM-ether 2.25, could be subjected to an oxidation/methylenation 
sequence converting it into enal 2.8 which, as previously discussed, has been reported 
to co-exist in equilibrium with lactol (±)-2.1 (scheme 2.32). 
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Scheme 2.32: Alternative pathway for the formation of lactol (±)-2.1. 
Diol 2.41 was successfully prepared by simple hydrolysis of MOM-ether 2.25 with     
6 M aqueous HCl in a 4:1 mixture of methanol and dichloromethane. This reaction 
was conducted on a variety of scales, giving reproducible high yields, up to 97% when 
scaled up to 2 g of product (scheme 2.33). 
 
Scheme 2.33: Deprotection of MOM-ether 2.25. 
With diol 2.41 in hand, the same oxidation/methylenation sequence used for the 
synthesis of MOM-protected enal 2.27 was performed. The first trials using the one-
pot procedure gave complex mixtures of products, therefore it was decided to quench 
an aliquot of the reaction mixture after 30 minutes, before adding the Eschenmoser 
salt, in order to identify potential issues. Column chromatographic purification of the 
first aliquot gave acetal (±)-42 in 16% yield. Column chromatography purification of 
the remaining crude mixture after reaction with the Eschenmoser salt afforded a small 
quantity of targeted lactol (±)-2.1 in 14% yield (scheme 2.34). 
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Scheme 2.34: Preparation of lactol (±)-2.1. 
The formation of acetal (±)-2.42 explains, at least in part, the low yield of lactol               
(±)-2.1 obtained in this reaction. The conditions were not optimised, because, as 
reported in literature, lactol (±)-2.1 proved to be unstable.55 It was not possible to 
obtain any other characterisation data than the 1H NMR spectrum (see page 263), 
which matched the one reported in literature (see page 264 for a comparison). When 
lactol (±)-2.1 was stored at room temperature, multiple new peaks appeared in the          
1H NMR spectrum. Lactol dimer (±)-2.9 was identified as a component in the mixture. 
(scheme 2.35). 
 
Scheme 2.35: Dimerisation of lactol (±)-2.1. 
However, the conversion after five days was very poor (~82:18 starting material         
(±)-2.1 : dimer (±)-2.9) and lactol (±)-2.9 was not the only new compound in the 
mixture (see stacked 1H NMR spectra on page 265). Therefore, although this result 
demonstrates the chemical feasibility of this pathway, this approach was not 
considered synthetically practical, due to the low efficiency of the dimerization and 
the difficulties on accessing monomeric precursor (±)-2.1. 
This led us to re-consider the initial biomimetic strategy, bearing in mind the instability 
of the thymarnicol (±)-1.1 polycyclic framework to acids. Thus, we turned our 
attention to protecting groups which do not require acidic conditions for their removal. 
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2.6 Alternative ortho–Directing Protecting Group Approach 
A sensible alternative choice of protecting group appeared to be the carbamate group: 
besides being a known ortho-directing group for the metalation of arenes,82-84 it can be 
cleaved under basic,82,83 and reductive conditions.84,85 This would potentially allow us 
to use a synthetic sequence analogous to the one already developed with the MOM-
protected material. This would involve phenol protection of m-cresol to afford 
carbamate 2.43 followed by ortho-lithiation and ring opening of ethylene oxide to give 
primary alcohol 2.44 (scheme 2.36). 
 
Scheme 2.36: Planned approach with the carbamate protecting group. 
Protection of m-cresol was smoothly achieved with N,N-diethylcarbamoyl chloride 
under standard conditions, affording N,N-diethylcarbamate 2.43 in 91% yield on a        
5-gram scale (scheme 2.37). 
 
Scheme 2.37: Preparation of N,N-diethylcarbamate 2.43. 
With this in hand, a modified literature procedure was used to attempt the ortho-
lithiation and quenching of the aryl lithium with ethylene oxide. Unfortunately, the 
only product isolated from this reaction was phenol 2.45, presumably resulting from 
an anionic equivalent of the Fries rearrangement, which had been previously observed 
on the same substrate (scheme 2.38).86 This is proposed to proceed via the 
intramolecular nucleophilic addition of aryl carbanion 2.46 which results from the 
ortho-lithiation into the carbonyl group of the carbamate, with consequent transferring 
of the amide group (scheme 2.38). Therefore, this approach was abandoned. 
 58 
 
Scheme 2.38: Formation of amide 2.45. 
 
2.7 Base-Labile Protecting-Groups 
Given our failure to identify a phenol protecting group which is both an ortho-director 
and removable under non-acidic conditions, we decided to design a new synthetic 
strategy toward the proposed monomeric precursor 2.4 to (±)-thymarnicol 1.1.  
Silyl ethers are known to be readily cleaved under mild acidic and basic conditions, as 
well as by fluoride. Catalytic palladium (II) can also be used, particularly in the 
deprotection of t-butyldimethylsilyl- (TBS) ethers.87 This vast array of different 
possible deprotection conditions led us to select the TBS group as a suitable protecting 
group to proceed with our investigation toward the total synthesis of (±)-thymarnicol 
1.1.  
Another option was represented by the acetyl group. This is present in a number of 
natural products, and in particular it has been found in several compounds extracted 
from plants of the Asteraceae family, some of which have been co-isolated with         
(±)-thymarnicol 1.1.46,88 Furthermore, as discussed in the introduction to this chapter, 
(±)-thymarnicol 1.1 has been proposed by Passreiter to be biosynthetically derived 
from an acyl (acetyl or isobutyrate) protected thymol 2.4. These characteristics, as well 
as the fact that it is a base-labile protecting group, made us consider it a suitable 
candidate for its use in our biomimetic synthesis. 
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Our new synthetic strategy to enals 2.47 and 2.48 is depicted in scheme 2.39: we 
hypothesised that both TBS and acetyl-protected alcohols 2.49 and 2.50 could be 
accessible via selective mono-protection of diol 2.41. This was a compound we already 
had access to, as it was an intermediate in the preparation of lactol  (±)-2.1 (see scheme 
2.33 on page 55). Primary alcohols 2.49 and 2.50 could then be converted into enals 
2.47 and 2.48 through the well-established oxidation/methylenation sequence. 
 
Scheme 2.39: Proposed approach for the synthesis of TBS and acetyl-protected enals 2.47 and 2.48. 
2.7.1 Synthesis of Enal Monomer 2.47 
The TBS-protected enal 2.47 was first targeted. 
Initial attempts to access primary alcohol 2.49 in one step via selective mono-
protection of diol 2.41 with one equivalent of TBS-Cl failed. Thus a two-step 
procedure was trialled.89 Both hydroxyl groups on diol 2.41 were protected using 2.5 
equivalents of TBS chloride under standard conditions. This afforded bis-ether 2.51 in 
95% yield on the largest scale attempted (1 gram of purified product). The primary 
alcoholic group of phenolic ether 2.51 was then revealed using iodine in methanol, a 
very selective procedure for the TBS-deprotection of primary and secondary 
alcohols,90 affording mono-protected compound 2.49 in 92% yield on a 300-mg scale 
(scheme 2.40).  
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Scheme 2.40: Preparation of primary alcohol 2.49. 
Alcohol 2.49 was then converted into enal 2.47, using the previously employed one-
pot Parikh–Doering oxidation followed by methylenation using the Eschenmoser salt. 
This transformation afforded 170 mg of enal monomer 2.47 in an unoptimised 51% 
yield (scheme 2.41). 
 
Scheme 2.41: One-pot synthesis of enal 2.47. 
2.7.2 Studies on the Dimerisation of Enal Monomer 2.47 
With this material in hand, several dimerisation conditions were screened with varying 
reaction temperature: attempts to dimerise enal 2.47 by heating it at 80 °C in the 
absence of K2CO3 for two days resulted in almost complete consumption of the starting 
material. However, a yield of only 41% of dihydropyran dimer (±)-2.52 was calculated 
from the crude 1H NMR spectrum (with inclusion of dimethyl sulfone as an internal 
standard), as the formation of other unidentified and undesired products was observed 
(entry 1). Increasing the temperature to 140 °C and reducing the reaction time to 1 h 
gave a promising ~1:4 ratio between starting material 2.47 and product (±)-2.52, which 
was formed in a 53% 1H NMR yield (entry 2). Unfortunately, this result proved 
difficult to reproduce on a larger scale (140 mg): in this case the formation of acetal 
(±)-2.53 in a 67:33 d.r. was observed (entry 3), far before complete consumption of 
the starting material, presumably through migration of one of the TBS protecting 
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groups to the carbonyl group either before or after the Diels–Alder reaction (paths a 
and b respectively, scheme 2.42).  
 
Scheme 2.42: Proposed pathways for the formation of acetal (±)-2.53. 
Although it was envisaged that acetal (±)-2.53 could still be used in our synthesis, 
more test reactions were performed in an attempt to obtain selective conditions for the 
formation of either dihydropyran (±)-2.52 or acetal (±)-2.53. The effect of solvent and 
additives was then investigated. Running the reaction in a small volume of deuterated 
toluene failed to suppress the formation of acetal (±)-2.53 (entry 3). The reaction was 
then performed in the presence of two equivalents of K2CO3 at different temperatures. 
Lowering the temperature from 140 to 80 °C and prolonging the reaction time, 










Time (h)  (RSM:2.52:2.53)a 
— 80 46  4:41:0b 
2 — 140 3 48:20:31 
3 toluene-d8 (750 µM) 100 17 12:30:58 
4 K2CO3 (2 eq.) 140 2 16:26:56 
5 K2CO3 (2 eq.) 110 16 23:39:37 
6 K2CO3 (2 eq.) 80 40 13:62:24 
a
Products ratio. bInternal standard yield. 
Table 2.1: Screening of dimerisation conditions for enal (±)-2.47. 
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Using these optimised conditions, a larger scale reaction was performed. Enal 
monomer 2.47 was stirred, neat, at 80 °C in the presence of two equivalents of K2CO3 
for 48 hours. Unfortunately, only small quantities of pure dihydropyran (±)-2.52 (21% 
yield) and acetal (±)-2.53 (17% yield) as a 67:33 mixture of diastereoisomers were 
isolated after chromatographic purification in this case (scheme 2.43).  
 
Scheme 2.43: Dimerisation of TBS-protected enal 2.47 under optimised conditions. 
Having failed to find efficient conditions for the key dimerisation step with the TBS-
protected enal 2.47, we investigated the problem from a biomimetic standpoint, and 
turned our attention to the acetyl group. 
2.7.3 Synthesis of Enal Monomer 2.48 
Similarly to the TBS-protected enal 2.47, our initially planned synthesis for the acetyl 
protected enal monomer 2.48 involved selective phenolic protection of diol 2.41 
followed by one-pot oxidation/methylenation of primary alcohol 2.50 (see scheme 
2.39 on page 59). There was promising literature precedent for the selective acetyl 
protection of phenols in the presence of primary alcohols using 1-acetyl-v-triazolo  
[4,5-b]pyridine.91 Therefore we attempted the mono-protection of diol 2.41 following 
a modified literature procedure91 using one equivalent of triazol 2.54. TLC analysis of 
the crude reaction mixture showed the immediate formation of two different products, 
with increasing intensity of the corresponding spots. The reaction was monitored and 
quenched when no further change was observed (3 hours); however, the expected 
product was not observed in the crude 1H NMR spectrum. Column chromatography 
afforded only mono acetate 2.55 and diacetate 2.56 in 33 and 20% isolated yield 
respectively (scheme 2.44). 
 63 
 
Scheme 2.44: Attempted selective mono-protection of diol 2.41. 
The inability to directly access primary alcohol 2.50 led us to undertake an alternative 
approach which, even if not elegant, would have allowed us to use reliable chemistry 
to rapidly access material to investigate the subsequent steps. This involved TBS-
protection of primary alcohol 2.41 followed by acetylation of the phenol hydroxyl 
group of 2.57. Finally, cleavage of the silyl ether of acetate 2.58 would afford targeted 
primary alcohol 2.50, as shown in scheme 2.45. 
 
Scheme 2.45: Planned alternative synthesis of alcohol 2.50. 
Thus, primary alcohol 2.41 was protected as the TBS-ether under standard conditions 
using one equivalent of TBS-chloride, affording phenol 2.57 in 79% yield on a gram 
scale. This was then acetylated using acetic anhydride in pyridine, reaction which 
proceeded smoothly to give more than one gram of orthogonally protected compound 
2.58 in 97% yield (scheme 2.46). 
 
Scheme 2.46: Preparation of orthogonally protected compound 2.58. 
A preliminary attempt on the cleavage of the TBS group using TBAF as a fluoride 
source on a small scale gave as the only isolable product phenol 2.55. This is proposed 
to be formed via initial removal of the TBS group on compound 2.58 followed by 




Scheme 2.47: TBAF cleavage of TBS-ether 2.58. 
It was hypothesised that phenol 2.55 and alcohol 2.50 could co-exist in equilibrium, 
thus allowing us to perform the oxidation/methylenation sequence on the mixture. 
Therefore, phenol 2.55 was subjected to the Parikh–Doering oxidation/methylenation 
sequence, in the same conditions used previously. Unfortunately, though, only starting 
material was recovered (scheme 2.48), leading us to assume that either there isn’t an 
equilibrium taking place, or its position is almost completely toward phenol 2.55. This 
conclusion led us to attempt different conditions for the cleavage of the TBS group, 
with the aim of preventing the acetyl group migration.  
 
Scheme 2.48: Attempt of oxidation/methylenation of phenol 2.55. 
The TBS-deprotection of compound 2.58 using iodine in methanol at room 
temperature was then investigated by quenching the reaction after different times. 
Waiting after complete consumption of the starting material was observed resulted in 
the isolation of both esters 2.50 and 2.55 in a 1:1.5 ratio, while stopping the reaction 
too early resulted in minimal formation of unwanted phenol 2.55, but poor conversion. 
After optimisation it was found that the ideal reaction time was 4.5 hours for 1 gram 
of starting material, affording more than half a gram of alcohol 2.50 in 77% isolated 
yield. To prevent the migration of the acetyl group, which tended to occur slowly, even 
when storing the compound at low temperatures, alcohol 2.50 was immediately 
subjected to the Parikh–Doering oxidation followed by methylenation with the 
Eschenmoser salt. This reaction provided more than 300 mg of enal 2.48 to test the 
key dimerisation reaction (scheme 2.49). 
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Scheme 2.49: Preparation of enal monomer 2.48. 
The yield of this final transformation (60%) was not as good as the one obtained for 
MOM protected enal 2.27: that is due to the acetyl transfer previously discussed, which 
is occurring during the oxidation of alcohol 2.50, thus competing with it in the 
consumption of the starting material. 
2.7.4 Dimerisation of Enal 2.48 
Enal 2.48 proved to be quite prone to Diels–Alder dimerisation to form dihydropyran 
(±)-2.59 (see scheme 2.52 on page 66) when stored neat, even at −20 °C. However, 
the reaction in those conditions was not synthetically useful as the conversion was very 
poor even after several days. Increasing the temperature to 20 °C led to a faster reaction 
which, however, tended to reach a plateau at around 50-60% conversion after 5 days. 
The same conditions used for the MOM and TBS-protected enals were then applied: 
heating neat acetyl-protected enal monomer 2.48 at 80 °C for 20 hours with two 
equivalents of potassium carbonate resulted in complete consumption of the starting 
material and the formation of several compounds. The expected product was not 
observed in this case, and column chromatography afforded only small quantities of 
acetal (±)-2.60 and dihydropyran (±)-2.61 in a 63:37 diastereomeric ratio (scheme 
2.50). 
 
Scheme 2.50: Initial attempt on the dimerisation of enal (±)-2.48. 
While acetal 2.60 is presumably formed via intramolecular transfer of the phenolic 
acetyl group on enal 2.48 into its carbonyl, acetal (±)-2.61 is proposed to be formed in 
a similar way to TBS protected (±)-2.53, (see scheme 2.42 on page 61), where the 
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transfer could occur either before (path a) or after the Diels–Alder cycloaddition        
(path b) (scheme 2.51). 
 
Scheme 2.51: Proposed pathways for the formation of acetal (±)-2.61. 
The dimerisation was then carried out at a series of temperatures ranging from 30 to 
110 °C in the absence of a base. The optimal temperature was found to be 80 °C, giving 
the best compromise between reaction rate and selectivity in the formation of 
dihydropyran (±)-2.59. Stirring 500 mg of enal 2.48 at 80 °C for 42 hours gave 
complete conversion to dihydropyran (±)-2.59, based on internal standard 1H NMR 
(scheme 2.52). 
 
Scheme 2.52: Optimised dimerisation conditions. 
With the optimised conditions for the key biomimetic dimerization in hand, we 
immediately focused on exploring the deprotection step. 
2.7.5 Deprotection of Dihydropyran (±)-2.59 
We started our investigation on the pivotal deprotection of dihydropyran (±)-2.59 
using mildly basic hydrolytic conditions: stirring dihydropyran (±)-2.59 at room 
temperature until complete consumption of the starting material (4 hours) afforded 
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mono protected lactol (±)-2.62 as a 67:33 diastereomeric mixture in 57% yield, along 
with acetal (±)-2.61 (63:37 d.r.) in 22% yield (scheme 2.53). 
Scheme 2.53: NaHCO3 attempted deprotection of dihydropyran (±)-2.59. 
As the use of a mild base failed on removing both the acetyl groups, more forcing 
conditions were attempted. The hydrolysis was successfully accomplished by stirring 
substrate (±)-2.59 in THF with a 2 M sodium hydroxide aqueous solution. This 
reaction was performed in a variety of scales, giving as the best result 270 mg of 
unprotected lactol (±)-2.9 as a 78:22 mixture of diastereoisomers in 75% yield, 
calculated via 1H NMR spectroscopy using dimethylsulfone as an internal standard, as 
shown in scheme 2.54.  
 
Scheme 2.54: NaOH deprotection of dihydropyran (±)-2.59. 
Attempts on purifying the product with column chromatography, including with 
neutralised silica gel, resulted in a dramatic loss of material and failure to recover the 
product. Interestingly, though, the target molecule (±)-thymarnicol 1.1 was observed 
as a minor component in one of the fractions. 
With these results in hand, it was clear that the acetyl protecting group was a suitable 
choice: the dimerisation step, which could not be optimised for the TBS protected 
material, proved to work very efficiently and the deprotection, a major problem in the 
synthesis with the MOM group, was smoothly accomplished. With that in mind, we 
decided to design a shorter and more elegant synthesis for enal monomer 2.48.  
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2.8 Short Synthesis of Enal Monomer 2.48 
Although most steps in our first synthesis of the acetyl protected enal monomer 2.48 
were high yielding, the step economy was poor in comparison to our previous synthesis 
of the MOM-protected enal monomer 2.27 (7 steps vs 4 steps). This encouraged` us to 
re-consider the entire strategy. We envisaged that acetyl protected enal 2.48 could 
instead be accessed by a route commencing with acetylation of the commercially 
available 2-hydroxy-4-methylacetophenone 2.63. Ester 2.64 could then be converted 
into alkenyl triflate 2.65 to allow for a final palladium-catalysed formylation reaction 
to give enal monomer 2.48, as depicted in scheme 2.55.92-94 This would represent a 
very short (3 steps) synthesis for our monomeric precursor 2.48.  
 
Scheme 2.55: Proposed alternative synthesis of enal monomer 2.48. 
Accordingly, acetylation of phenol 2.63 under standard conditions proceeded 
smoothly to afford ketone 2.64 in 92% yield on a gram scale (scheme 2.56). 
 
Scheme 2.56: Acetylation of phenol 2.63. 
A modified literature procedure95 was used in an attempt to access alkenyl triflate 2.65. 
Unfortunately, treatment of acetyl protected phenol 2.64 with sulphonamide 2.66 
(known as Hendrickson–McMurry reagent) using lithium diisopropylamide (LDA) as 
a base resulted in a mixture of unidentified products (scheme 2.57). 
 
                   Scheme 2.57: Attempted preparation of alkenyl triflate 2.65. 
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An alternative route was considered. In 2003 Vetelino and co-workers reported the 
unexpected migration and oxidative cyclisation of substituted 2-acetophenone triflate 
2.67 under basic conditions.96 The migration was shown to occur very efficiently at 
low temperatures, while the subsequent cyclisation was achieved when raising the 
temperature to more than 50 °C (scheme 2.58). 
 
Scheme 2.58: Migration and oxidative cyclisation of triflate ester 2.67. 
 
We envisaged we could take advantage of this reactivity for the preparation of acetyl 
protected alkenyl triflate 2.65. Initial protection of starting material 2.63 as the triflate 
ester would afford ketone 2.68, followed by the triflyl group migration reaction 
performed at low temperatures to give alkenyl triflate 2.69.96 Finally, acetylation of 
the phenolic group on 2.69 would provide substrate 2.65 to attempt the formylation 
reaction (scheme 2.59).  
      
Scheme 2.59: Alternative pathways for the formation of alkenyl triflate 2.65. 
 
The protection of phenol 2.63 as the triflate ester under standard conditions proceeded 
smoothly affording 2 grams of product 2.68 in near quantitative yield, as shown in 
scheme 2.60. 
 
                                    Scheme 2.60: Triflation of phenol 2.63. 
We then started our investigation on the triflyl group migration using a modified 
literature procedure: treatment of ketone 2.68 with potassium tert-butoxide at 0 °C 
resulted, after optimisation, in a 53% yield of enol ether 2.69. An alternative procedure 
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was employed in an effort to improve this result using DBU as base, leading to a slight 
improvement on the yield (61% on an 85-mg scale) (scheme 2.61). 
 
Scheme 2.61: Potassium tert-butoxide mediated triflyl group migration. 
 
However, the scaling up of this reaction resulted in a dramatic drop in the yield, from 
61% for 140 mg to 25% for 400 mg of starting material used. Keeping in mind the 
additional step, this sequence was not considered sufficiently high yielding. As we 
were concurrently developing a new three-step synthetic approach to acetyl-protected 
enal monomer 2.48 from the same ketone starting material 2.63, this route was 
abandoned without attempting further optimisation. 
 
2.9 Final Synthesis 
2.9.1 Synthesis of Alkene 2.70 
We envisaged we could access our monomeric precursor 2.48 via oxidation of alkene 
2.70. A conventional two-step oxidation, involving initial oxidation to the allylic 
alcohol 2.71 followed by further oxidation to the aldehyde, would likely be 
problematic due to the facile acyl transfer to give undesired ether 2.72 (scheme 2.62). 
 
Scheme 2.62: Potential problem in a two-steps oxidation process. 
We envisaged we could overcome this issue by directly accessing enal 2.48 without 
revealing primary alcohol 2.71. Alkene 2.70 in turn could be prepared from the 
commercially available ketone 2.63 through initial acetylation of the phenolic 
hydroxyl group, already achieved in 92% yield (see scheme 2.56 on page 68), followed 
by methylenation. Alternatively, ketone 2.63 could be subjected to methylenation to 
give alkene 2.73 prior to phenolic protection, as shown in scheme 2.63. 
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Scheme 2.63: Proposed alternative synthesis of acetyl-protected enal monomer 2.48. 
 
Initial attempts to methylenate the previously prepared ketone 2.64 through a Wittig 
reaction gave a complex mixture of products. Therefore, we applied the same reaction 
conditions to unprotected phenol 2.63; treatment of ketone 2.63 with excess methyl 
triphenylphosphonium bromide and sodium hydride smoothly provided 9.7 grams of 
phenol 2.73 in 94% isolated yield. This was then protected as the acetyl ester under 
standard conditions affording up to three grams of alkene 2.70 (scheme 2.64).  
 
Scheme 2.64: Preparation of alkene 2.70. 
2.9.2 Allylic Oxidation of Alkene 2.70 
With alkene 2.70 in hand, we set out to investigate the allylic oxidation. The use of the 
chromium trioxide/dimethylpyrazole complex has been reported to be an operationally 
simple method for oxidising alkenes at the allylic position.97 Aldehydes could be 
accessed directly, without revealing the corresponding primary alcohol at any point. 
Therefore, this transformation was attempted following a modified literature 
procedure. Alkene 2.70 was added to a preformed solution of the chromium 
trioxide/dimethylpyrazole complex. Unfortunately, this reaction resulted in the 
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formation of a complex mixture of compounds, with no targeted enal 2.48 observable 
in the crude 1H NMR spectrum (scheme 2.65). 
 
Scheme 2.65: Attempted CrO3•dimethylpyrazole allylic oxidation of alkene 2.70. 
Selenium dioxide was then considered as an alternative reagent for the allylic 
oxidation. The first attempt was made using catalytic selenium dioxide and tert-butyl 
hydroperoxide as the terminal oxidant.98 Thus, alkene 2.70 was treated with sub-
stoichiometric amounts of selenium dioxide and excess tert-butyl hydroperoxide. This 
reaction proved to be very sluggish and was quenched after 5.5 hours at 40 °C, as no 
formation of the expected product was detected by TLC analysis. Column 
chromatography afforded recovered starting material 2.70 in 51% and undesired 
phenol 2.72 in 21% isolated yield (scheme 2.66).  
 
Scheme 2.66: Attempted allylic oxidation of alkene 2.70 with catalytic SeO2. 
We reasoned that it could be possible to prevent the unwanted acetyl group migration 
by adding to the same mixture a further reagent capable of oxidising alcohols to 
aldehydes. Surveying the literature we identified manganese as a potentially 
compatible oxidant.99 Therefore, the previous reaction was repeated under similar 
conditions in the presence of a large excess of manganese dioxide. Unfortunately, no 
formation of targeted enal 2.48 was observed in the crude 1H NMR spectrum after 24 
hours.  
We considered the use of super-stoichiometric selenium dioxide. Its use for the direct 
conversion of alkenes to enals with similar structure to our target 2.48 has been 
reported several times, although with invariably low yield (≤ 50%).60,61,100,101 The 
mechanism of the allylic oxidation has been proposed to involve initial ene-type 
reaction (which could be non-concerted) between the substrate (in scheme 2.67 alkene 
2.70 is used as an example) and selenium dioxide. A [2,3]-sigmatropic rearrangement 
then affords ester 2.74.102 At this point if under aqueous conditions hydrolysis occurs 
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to give the correspondent primary alcohol. Either the free alcohol or the selenyl-ester 
2.74 can undergo a second ene-type reaction/[2,3]-sigmatropic rearrangement 
sequence to give acetal 2.75, which would then be hydrolysed in the workup to afford 
enal 2.48 (scheme 2.67). 
 
Scheme 2.67: Proposed mechanism of the allylic oxidation with selenium dioxide.103 
It was therefore reasoned that performing the reaction in anhydrous conditions in the 
presence of an excess of selenium dioxide could lead to targeted aldehyde 2.48 without 
revealing primary alcohol 2.71 (see scheme 2.62 on page 70). We then screened a 
series of reaction conditions; summarised in table 2.2. Initial attempts at 60 °C in 
benzene in the presence of molecular sieves resulted in a sluggish reaction (entry 1). 
The use of ground activated molecular sieves proved to be essential, as the formation 
of complex mixtures of unidentified products was observed when reactions were 
performed without it. A 20 °C increase on the temperature lead to a significantly faster 
reaction (entry 2). The effect of time was investigated for reactions performed at        
110 °C with toluene as the solvent. The relative amounts of the two unwanted products 
lactone 2.76 and benzofuran 2.77 where found to increase with time (entries 3 and 4). 
Adding potassium carbonate in an attempt to compensate for the acidity of the 
molecular sieves resulted in complete suppression of reactivity (entry 5). The effect of 
the SeO2 stoichiometry was then investigated; using 1.5 equivalents of oxidant resulted 
in a faster and cleaner reaction (entry 6). Unfortunately, attempts to scale up this 
transformation resulted in a dramatic drop in the yield (entries 7 and 8).  
It was noticed that for scales larger than 100 mg run at 110 °C a 50% loss of mass was 
observed after chromatographic purification. This led us to hypothesise that 
decomposition at high temperatures had a big impact on the isolated yield. A slight 
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decrease in the temperature in a small scale reaction appeared to be beneficial, 
suppressing the formation of benzofuran side-product 2.77 (entry 9). It was found that 
the ideal temperature range to be 95-100 °C. Finally, the best compromise between 
yield, scale and reaction time was achieved using 1.5 equivalents of selenium dioxide 













1 1.2 60 110 
benzene/ 
molecular sieves 
   70 25:8:6c 
2 1.2  80  75 
benzene/ 
molecular sieves 
24  42:6:0c 
3 1.2 110 110 
toluene/ 
molecular sieves 
   3.5  58:16:26 
4 1.2 110 110 
toluene/ 
molecular sieves 
    5  39:36:25 
5 1.2 110 115 
toluene/K2CO3 
molecular sieves 
    4  No reaction 
6 1.5 110  60 
toluene/ 
molecular sieves 
3.5  50:4:0c 
7 1.5 110 190 
toluene/ 
molecular sieves 
5  23:0:9c 
8 1.5 110 500 
toluene/ 
molecular sieves 
    5 21:10:11c 
9 1.5 95 40 toluene 3.5  75:25:0 
10 1.5 100 415 
toluene/ 
molecular sieves 
6  24:6:6 c 
a





Table 2.2: Screening of SeO2 allylic oxidation conditions for alkene 2.70. 
 
With the optimised conditions in hand, we performed a series of reactions with                  
~1 gram of starting material, which reproducibly afforded our monomeric precursor 
2.48 in 20-25% internal standard crude 1H NMR yield. The best result obtained on this 
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scale after chromatographic purification was a 21% isolated yield of enal 2.48, with 
only small amounts of lactone 2.76 and benzofuran 2.77 isolated. (scheme 2.68). 
 
Scheme 2.68: Stoichiometric SeO2 allylic oxidation of alkene 2.70. 
Although the yield for this transformation was poor, it was possible to access more 
than 2 grams of monomer 2.48 through multiple batches by combining the crudes from 
different reactions and purifying them together. This represents a very short three steps 
synthesis for this key intermediate, thus there was the potential for a six or seven-step 
synthesis of the targeted natural product (±)-thymarnicol 1.1 from commercially 
available ketone 2.63. In fact, our previous investigations (see scheme 2.52 on page 
56) demonstrated that the Diels–Alder dimerisation of enal 2.48 proceeds smoothly 
and quantitatively to afford up to 500 mg of dihydropyran (±)-2.59 in a single batch. 
Furthermore, we had found suitable conditions for its deprotection, allowing us to 
access lactol (±)-2.9 (see scheme 2.54 on page 67). With the optimised conditions in 
hand, we set out to investigate the final transformations into natural product                              
(±)-thymarnicol 1.1. With the two alternatives of oxidation/cyclisation and 
cyclisation/oxidation available, we decided to attempt the oxidation of dihydropyran 
(±)-2.59 first. 
2.9.3 Oxidation of Dihydropyran (±)-2.59 
With dimer (±)-2.59 in hand, a small scale epoxidation was performed in the same 
reaction conditions previously developed: unsurprisingly, the in-situ generation of 
DMDO afforded epoxide (±)-2.78 as a 1:1 diastereomeric mixture, in 97% crude yield 
(scheme 2.69). A diastereomerically pure sample was isolated through 
chromatographic purification; however, attempts to determine the relative 
stereochemistry through 2D NMR analysis were unsuccessful. 
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Scheme 2.69: In-situ generated DMDO epoxidation of dihydropyran (±)-2.59. 
Due to the lack of diastereoselectivity in this reaction, this approach was abandoned. 
2.9.4 Preparation of (±)-Thymarnicol 1.1 
We hypothesised that the removal of the acyl groups prior to the oxidation could lead 
to conformational changes favouring the approach of the oxidant to the less hindered 
face. If so, oxidation of the double bond of lactol (±)-2.9, followed by cyclisation, 
could afford (±)-thymarnicol 1.1. Based on the literature precedent discussed in 
section 2.2.2 on page 40, the oxidation and cyclisation could occur in a single step. 
Alternatively, (±)-thymarnicol 1.1 could be prepared via cyclisation followed by 
benzylic oxidation, as proposed by Passreiter (scheme 2.70).  
 
*internal standard 1H NMR yield. 
Scheme 2.70: Potential six or seven-step synthesis of (±)-thymarnicol 1.1. 
As mentioned in section 2.7.5 on page 67, attempts to purify lactol (±)-2.9 by column 
chromatography met with failure. However, the presence of a small amount of               
(±)-thymarnicol 1.1 was detected in one of the fractions collected. Furthermore, the 
relative quantity of (±)-thymarnicol 1.1 with respect to the other components seemed 
to increase over time. This interesting observation suggests that in nature                               
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(±)-thymarnicol 1.1 could be formed as the result of autoxidation of lactol (±)-2.9. In 
an effort to find a synthetically suitable procedure for the formation of (±)-thymarnicol 
1.1, crude lactol (±)-2.9 was subjected to conditions which aimed to reproduce the 
attempted purification, when the formation of (±)-thymarnicol 1.1 was first observed. 
Lactol (±)-2.9 was stirred in an 80:20 mixture of hexane and ethyl acetate at room 
temperature with an equal amount in weight of silica gel. This resulted, after 48 hours, 
in a 45% conversion (entry 1). A fifteen-fold increase on the amount of silica gel gave 
a far slower reaction, with only 10% consumption of starting material (±)-2.9 after 44 
hours (entry 2). Attempts on increasing the reaction rate by performing by performing 
the reaction under oxygen atmosphere were unsuccessful (entry 3). The effects of light 
and solvent were then investigated (entries 4-9). No reaction was observed in the dark, 
both in the presence and absence of silica gel. Irradiating the reaction mixture with a 
lamp (11 W, 220-240 V, 50-60 Hz, 85 mA) resulted in faster conversion in the absence 
of silica gel than in its presence, and changing the solvent to methanol resulted in a 
slower transformation. All the information obtained were combined to determine the 
final reaction conditions; irradiating lactol (±)-2.9 in an 80:20 mixture of hexane/ethyl 
acetate at room temperature resulted in internal standard 1H NMR yield of 53% of            
(±)-thymarnicol 1.1. A 37% yield was calculated of an unknown compound, the 
structure of which was tentatively assigned as peroxide (±)-2.79 (vide infra) (entry 10). 
Finally, it was noticed that the ratio between (±)-thymarnicol 1.1 and compound               
(±)-2.79 changed with time (entries 11 and 12) (table 2.3), suggesting the latter could 
















1 Silica gel x1 20 hexane/EtOAc 48 45:45:10 
2 Silica gel x15 20 hexane/EtOAc     44 90:10:0 
3 Silica gel,  O2 20 hexane/EtOAc    48 87:13:0 
4 NO LIGHT 10 pet spirit/EtOAc 42 100:0:0 
5 
Silica gel x1 
NO LIGHT 
10 pet spirit/EtOAc    42 100:0:0 
6 LIGHT 10 pet spirit/EtOAc 46 25:50:25 
7 
Silica gel x2 
LIGHT 
10 pet spirit/EtOAc 46 49:40:11 
8 LIGHT 10 methanol 46 82:18:0 
9 
Silica gel x2 
LIGHT 
10 methanol 46 90:10:0 
10 LIGHT/air 10 hexane/EtOAc 40 0:57:35c 
11 LIGHT/air 130 hexane/EtOAc 64 0:66:34 
12 LIGHT/air 130 hexane/EtOAc 90 0:74:26 
a
The scale is referred to the amount of starting material used. 
b
Product ratio. cInternal standard yield. 
Table 2.3: Screening of conditions for the formation of (±)-thymarnicol 1.1. 
With these optimised conditions in hand, a larger scale reaction was performed using 
250 mg of lactol (±)-2.9 starting material. Analysis of the crude reaction mixture by 
1H NMR spectroscopy, with the inclusion of dimethyl sulfone as internal standard, 
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indicated a 57% yield of (±)-thymarnicol 1.1 and 21% of compound (±)-2.79 (scheme 
2.71).  
 
*internal standard 1H NMR yield  
Scheme 2.71: Formation of (±)-thymarnicol 1.1.  
Analytically pure samples of (±)-thymarnicol 1.1 and compound (±)-2.79 were 
obtained by preparative HPLC. After characterisation, the structure of peroxide                
(±)-2.79 was attributed to this unknown compound. Its molecular ion in the mass 
spectrum (ESI+) registered at m/z 357.13 was consistent with the molecular formula 
C20H20O6. The 
1H and 13C NMR spectra showed similarities with the ones of                      
(±)-thymarnicol 1.1, with a major difference. The signals in the 13C NMR spectra 
corresponding to the major epimers of (±)-thymarnicol 1.1 and compound (±)-2.79 
differ by 13.8 ppm. This is in good accordance with the difference in chemical shift 
reported for other systems where a benzylic hydroxyl group was replaced by a 
hydroperoxy group (figure 2.4).104 
 
Figure 2.4: a) Comparison of carbon chemical shifts of a benzylic alcohol and hydroperoxide.104 
b) Chemical shift for C8 in (±)-thymarnicol 1.1 and compound (±)-2.79. 
It is worth noting that both (±)-thymarnicol 1.1 and lactol (±)-2.9 were isolated as 
inseparable mixtures of epimers at the lactol position. It was found that the 
diastereomeric ratios calculated from the 1H NMR spectra were dependent on the 
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deuterated solvent used for the experiment. Some of the results are summarised on 
table 2.4. 
Solvent lactol (±)-2.9 (d.r.) (±)-thymarnicol 1.1 (d.r.) 
CDCl3 72:28 78:22 
(CD3)2CO 78:22 88:12 
CD3CN 66:34 77:23 
THF-d8 75:25 87:13 
DMSO-d6 83:17 — 
Table 2.4: Diastereomeric ratios for (±)-thymarnicol 1.1 and lactol (±)-2.9 in different deuterated 
solvents. 
A diastereomerically pure sample of (±)-thymarnicol 1.1 was obtained via 
recrystallisation from hot acetonitrile, and the structure of the natural product was 
confirmed by X-ray crystallography (figure 2.5). 
 
 
Figure 2.5: Crystal structure of (±)-thymarnicol 1.1. 
 
However, when the crystals were re-dissolved in deuterated acetone, reversion to the 
previously observed 78:22 d.r. was observed, thus (±)-thymarnicol 1.1 also exists as a 
mixture of diastereoisomers at the lactol position. Attempts to obtain authentic samples 
of natural (±)-thymarnicol 1.1 or the FID raw data from the isolation team in order to 
confirm this hypothesis were unsuccessful. 
The mechanism of the formation of (±)-thymarnicol 1.1 remains unclear, but the 
conditions in which it occurs strongly suggest that it is the result of an autoxidation 
process. Autoxidation upon exposure to light and atmospheric oxygen is not an 
uncommon process in nature.105-108 It is therefore hypothesised that (±)-thymarnicol 
1.1 could also be formed naturally as a result of a non-enzymatic oxidation. This 
obviously puts into question the credentials of (±)-thymarnicol 1.1 as a natural product. 
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The possibility that (±)-thymarnicol 1.1 could be an artefact of isolation offers 
different possible scenarios. For example, unprotected lactol (±)-2.9 could undergo 
cyclisation to afford the pentacyclic framework of (±)-thymarnicol 1.1 followed by 
benzylic oxidation (path a). Alternatively, an oxidation could occur initially, forming 
oxonium (±)-2.80, which could then undergo cyclisation (path b) (scheme 2.72). 
 
Scheme 2.72: Possible pathways for the formation of (±)-thymarnicol 1.1 from lactol (±)-2.9. 
 
We tested the possibility that the oxidative process might occur on the acylated lactol 
(±)-2.9 by subjecting acetyl protected dimer to the same conditions. Both in the 
presence of air or molecular oxygen we observed no reaction (scheme 2.73).  
 
Scheme 2.73: Attempted formation of (±)-thymarnicol 1.1 from protected dihydropyran (±)-2.59. 
It is therefore reasoned that the formation of (±)-thymarnicol 1.1 is likely to occur in 
nature after cleavage of the acyl groups. 
2.10 Computational Studies on the Diels–Alder Dimerisation 
The key step in our synthetic sequence toward (±)-thymarnicol 1.1 is the hetero-Diels–
Alder dimerisation. This reaction was performed with different enal starting materials, 
and in all cases the only product observed was the one resulting from a para-
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regiochemical orientation between the two monomeric partners; the formation of the 
meta-regioisomer was never detected (scheme 2.74). 
 
Scheme 2.74: Hetero-Diels–Alder dimerisation of differently substituted enals. 
Intrigued by the degree of selectivity observed in the dimerisation, we decided to 
investigate this aspect further. Dr Fernanda Duarte, a newly appointed computational 
chemist at the University of Edinburgh, performed DFT (Density Functional Theory) 
calculations at the ωB97X-D/6-31+G level of theory on our systems. For a simplified 
system (2.81) bearing no ortho-substituent there are eight different transition structures 
where the Alder–Stein mode is exo or endo, the dienophile adopts an s-cis or s-trans 
conformation and the regiochemical orientation is meta or para. With no exception, 
the para TSs have been found to be significantly lower in energy with respect to the 
meta TSs, due to lower distortion penalties and better orbital overlap. Surprisingly, the 
exo selectivity is observed for the majority of the transition states, due to better non-
covalent interactions between the two aromatic rings (see section 4.6.3 on pages 411-
416 for a more detailed discussion). However, the lowest energy TS in all the systems 
analysed (including the differently substitutes enals) was found to be the para-endo-s-
cis (scheme 2.75).  
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Scheme 2.75: The four endo TSs for the hetero-Diels–Alder dimerisation of our simulacrum. 
Energies calculated at 353 K. 
In the case of the simplified system 2.81, the para-endo-s-cis TS represents a rare 
example of C2-symmetric bis-pericyclic TS. The TS for the hetero-Diels–Alder 




    
  para-s-cis TS     para-s-cis TS for the dimerisation of enal 2.48 
Figure 2.6: para-s-cis TSs for the dimerisation of simplified simulacrum and enal 2.48. 
The details of the full computational analysis performed by Dr Fernanda Duarte can 













2.11 Concluding Remarks 
 
Inspired by Passreiter’s biosynthetic proposal we designed and explored alternative 
biomimetic pathways to (±)-thymarnicol 1.1. Investigations toward its total synthesis 
allowed us to confirm the chemical feasibility of the key biomimetic                         
hetero-Diels–Alder dimerisation of unprotected lactol (±)-2.1. A more synthetically 
practical dimerisation was achieved using suitably protected enals, in particular acetyl-
protected enal 2.59. After cleavage of the acyl groups on dimer (±)-2.59 the final 
oxidation to (±)-thymarnicol 1.1 was found to occur spontaneously in air (scheme 
2.76). 
Scheme 2.76: Investigated routes toward (±)-thymarnicol 1.1. 
In conclusion, we accomplished the first biomimetic total synthesis of (±)-thymarnicol 
1.1 in 6-steps from commercially available 2-hydroxy-3-methyl acetophenone 2.63. 
The synthesis started with a high yielding Wittig methylenation, followed by phenol 
protection with acetic anhydride and allylic oxidation with selenium dioxide to afford 
enal 2.48. The subsequent hetero-Diels–Alder cycloaddition afforded dihydropyran 
(±)-2.59 in near quantitative yield. Cleavage of the acetyl groups on dimer (±)-2.59 
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proceeded smoothly to give lactol (±)-2.9 as a mixture of epimers. Finally, the targeted 
natural product (±)-thymarnicol 1.1 was shown to be produced via a remarkably regio 
and stereo-selective oxidation process upon exposure to air and visible light (scheme 
2.77).  
 
Scheme 2.77: Total synthesis of (±)-thymarnicol 1.1. 
(±)-Thymarnicol 1.1 was found to be stereodynamic; it exists as a mixture of lactol-
epimers in solution but can exist as a single epimer in the solid state, as confirmed by 
single crystal X-ray diffraction studies. 
The unexpected reactivity observed in our attempts to cleave the MOM-groups on 
protected dihydropyran (±)-2.28 and epoxide (±)-2.29 gave insights about the 
instability of the framework of the natural product toward acidic conditions. Finally, 
the autoxidation process leading to the formation of (±)-thymarnicol 1.1 raised 









2.12 Future Work 
The main aspect of the project which needs to be investigated further is the likely 
mechanism of the final transformation leading to (±)-thymarnicol 1.1. Currently 
research is on-going to be able to identify some of the minor products of the 
autoxidation and to confirm the structure of compound (±)-2.79. The fact that the final 
oxidation requires irradiation with visible light suggests a radical mechanism 
involving molecular oxygen.108 A possible method to verify this hypothesis is the use 
of an automatically controlled manostat to measure the oxygen consumed during the 
reaction. It should be noted, however, that the inclusion of a small quantity of BHT 
decreased the rate of the reaction but did not suppress it. The addition to the reaction 
mixture of rose bengal as a photosensitiser did not result in an increase in the reaction 
rate, thus suggesting singlet oxygen is not involved in the process.  As no conclusive 
evidence has been obtained so far there is the need to access larger quantities of lactol 
(±)-2.9 to investigate this final step. Therefore, a scale-up and optimisation of the 
synthesis, together with a better HPLC method for the purification of (±)-thymarnicol 
1.1, are needed. With regard to the synthetic sequence, efforts will focus on the 
optimisation of the existing approach more than on the design of a shorter one. In 
particular, the allylic oxidation needs to be revised. An alternative to selenium dioxide 
could be the use of pentafluorobenzene selenic acid (figure 2.7), which has been 
reported to be an efficient reagent for the oxidation of alkenes at the allylic position to 
afford enals. The main advantage in the use of this reagent is its increased eneophilicity 
and therefore reactivity due to the per-fluorination of the benzene ring. However, the 
oxidation requires 2 equivalents of selenium reagent, for which there are no 
commercial sources and therefore needs to be prepared.109 Another possible alternative 
for the synthesis of enal 2.48 from alkene 2.70 would be the use of the Etard reaction, 
involving chromyl chloride as the oxidant110 (figure 2.7). Both these reagents allow 
the direct allylic oxidation of alkenes to enals without revealing the primary alcohol, 
and could therefore be suitable for our purposes. 
 
Figure 2.7: Pentafluorobenzene selenic acid and chromyl chloride. 
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3 Biomimetic Diversity-Oriented Synthesis of Prenylated 
Phenylpropanoids isolated from Illicium Plants 
3.1 Introduction 
3.1.1 Biomimetic Diversity Oriented Synthesis 
Bohacek et al. in 1996 estimated that the number of possible organic compounds with 
a molecular weight smaller than 500 Dalton is over 1060.111 It is clear that there is an 
enormous area of chemical space which has not yet been explored. Although it seems 
to be not possible to access all these structures, efforts have been made to develop 
strategies to rapidly explore chemical space.  An approach to this problem is the use 
of Diversity Oriented Synthesis (DOS), a strategy to generate molecular diversity from 
common starting materials. DOS aims to allow the synthesis of collections of 
compounds which differ in their molecular structure.112 This can be obtained with the 
use of different strategies. The most straightforward is the use of “appendage 
decoration”, which involves the use of coupling reactions to differently modify a 
common molecular framework. Another approach takes advantage of regio- and/or 
stereoselective reactions to generate different product isomers.  Finally, the use of 
divergent reaction pathways allows the generation of structural diversity through 
different regio- and/or chemoselective transformations. Thus, a single starting material 
is converted into one or more intermediates which, in turn, are modified further to 
generate a selection of products possessing diverse molecular architectures, as 
exemplified in scheme 3.1. 
Scheme 3.1: Schematisation of DOS. 
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Nature has the ability to rapidly access an incredible number of diverse structures 
starting from a relatively small number of simple building blocks. It is technically very 
challenging to try and imitate divergent biosynthetic pathways, but there exist recent 
successful examples of biomimetic divergent syntheses, for example by Tan,113 
Snyder114 and Shair.115,116 Shair and co-workers, for instance, exploied the potential of 
the divergent biomimetic approach in the synthesis of a group of Lycopodium 
alkaloids, accessed in a small number of steps from common intermediate 3.1 (scheme 
3.2).116 The unified strategy was based on a proposed biosynthetic network connecting 
the natural product targets. 
 
Scheme 3.2: Shair’s biomimetic divergent synthesis of Lycopodium alkaloids. 
This work shows how several complex natural products featuring diverse carbon 
skeletons can be rapidly accessed from the same synthetic intermediate. The rapid 
generation of complexity and diversity provides a significant advantage with respect 
to target oriented synthesis in terms of time and resources needed. 
3.1.2 Prenylated Phenylpropanoids from Illicium Genus Plants 
This project is concerned with the total synthesis of naturally occurring prenylated 
phenylpropanoids from Illicium plants. A large number of these compounds have been 
isolated starting from the early 80’s, with an increase in the number and complexity of 
new compounds discovered in the last five years.117-134 A small selection of prenylted 
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phenylpropanoids isolated from plants belongin to the Illicium genus are depicted in 
figure 3.1. 
 
Figure 3.1: Selected examples of prenylated phenylpropanoids. 
In the last few years there has been a growing interest in the prenylated 
phenylpropanoids. The natural abundance and structural complexity of these 
compounds, along with the wide range of bioactivities they display make them 
particularly attractive targets. Reported biological activities include anti-oxidant,131 
anti-viral,129 anti-inflammatory properties,122,126,127,130 significant cytotoxicity against 
some human cancer cell lines,124,129 proliferative activity in primary cell culture of 
osteoblast cells,133 and moderate neurite-outgrowth promoting activity in primary 
cultured rat cortical neurons.127 Interestingly, the reported specific optical rotation for 




even <5126,127,132). It is therefore possible that some of them could actually exist in 
nature as scalemic mixtures, with minor impurities affecting the observed optical 
rotation values. The interest of the scientific community toward this class of natural 
products resulted in the total synthesis of some of the most interesting members of this 






3.2 Previous Syntheses of Prenylated Phenylpropanoids from 
Illicium Plants 
This section describes work which has been done in other research groups on the 
synthesis of prenylated phenylpropanoids isolated from Illicium plants. 
3.2.1 Tricycloillicinone 1.4 
(−)-Tricycloillicinone 1.4 was a metabolite isolated in 1995 by Fukuyama and co-
workers from the wood of Illicium tashiroi.134 This compound features a tetracyclic 
framework containing three stereogenic centres, the relative stereochemistry of which 
was elucidated from nOe experiments. Fukuyama proposed that (−)-tricycloillicinone 
1.4 could be biosynthesised from the co-isolated natural product (−)-illicinone A 1.3 
by sequential cyclisation of the prenyl side-chain. Interestingly, the first semisynthesis 
of (−)-tricycloillicinone 1.4 was accomplished in 1984 Furukawa and collaborators 
eleven years before its first isolation from natural sources. They were investigating the 
reactivity of (−)-illicinone A 1.3, a natural product they had recently isolated,135 by 
irradiating it with a 400 W high pressure mercury lamp.136 The major product of this 
reaction was found to be a novel polycyclic compound, later named                                   
(−)-tricycloillicinone 1.4 by Fukuyama.134 The first total synthesis (as opposed to 
semisynthesis) of (±)-tricycloillicinone 1.4 was accomplished in 1998 by Danishefsky 
and co-workers from commercially available sesamol. This synthesis started with a 
highly efficient O-allylation to afford ether 3.4, followed by regioselective thermal 
Claisen rearrangement to give phenol 3.5, which was subsequently subjected to              
O-prenylation to provide the known natural product illicinole 3.6. The transformation 
of illicinole 3.6 into (±)-illicinone A 1.3 was then investigated using a number of 
different catalysts. It was found that the use of the bulky Lewis acid catalyst MABR 
(methylaluminum bis(4-bromo-2,6-di-tert-butylphenoxide)), developed by Yamamoto 
and co-workers,137 gave the best results in terms of regioselectivity, affording             
(±)-illicinone A 1.3 in 70% yield on a 40-mg scale.120 The final photochemical 
oxidation was performed under similar conditions to the ones reported in the literature, 
with an optimised yield of 35% (scheme 3.3).  
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Scheme 3.3: Danishefsky’s synthesis of (±)-tricycloillicinone 1.4. 
The mechanism of the reaction leading to (±)-illicinone A 1.3 was also investigated, 
using an isotopically labelled prenyl group, but no conclusive results were obtained. 
Different plausible mechanisms have been proposed by Danishefsky for this MABR-
mediated transformation.120 One possibility involves a dissociation/reassociation 
pathway, resulting overall in the migration of the prenyl group from the oxygen to C4. 
Alternatively, a Claisen rearrangement was proposed to occur in either the C2 or C6 
positions, to produce reverse-prenylated products 3.7 or 3.8. At this point the steric 
hindrance of the bulky catalyst, as well as the relative instability of the reverse-prenyl 
group, would play a role in favouring the Cope rearrangement, which in both cases 
would direct the prenyl group to the C4 position (scheme 3.4). 
 
Scheme 3.4: Proposed mechanism for the formation of (±)-illicinone A 1.3.120 
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Illicinone A 1.3 has been isolated multiple times from different Illicium plants, and has 
been found to exist as a single enantiomer in nature. It is noteworthy that the absolute 
stereochemistry varies depending on the species. For example, Illicinone A 1.3 exists 
as the levorotatory enantiomer in Illicium arborescens128 and some Illicium 
tashiroi134,136 species, while the opposite stereochemistry is encountered in Illicium 
anisatum.121  
3.2.2 (−)-Spirooliganones A 1.7 and B 3.9 
At the time we started our efforts to develop a unified synthetic strategy towards the 
synthesis of our molecular targets, only the synthesis of (−)-tricycloillicinone 1.4 had 
been reported. During our investigation, the synthesis of other prenylated 
phenylpropanoids was published, including the spirooliganones A 1.7 and B 3.9.         
(−)-Spirooliganones A 1.7 and B 3.9 were isolated in 1993 by Yu and co-workers from 
the roots of Illicium oligandrum and were found to display antiviral activity against a 
variety of viral strains.129 Spirooliganones A 1.7 and B 3.9 are a pair of epimers at C17, 
one of the two spiro carbons present in their rare dioxaspiro skeleton. Yu and 
collaborators proposed a biosynthetic pathway for the formation of these two 
compounds from allylated polyhydroxylated phenol 3.10. In their hypothesis, this 
compound could be regioselectively prenylated to afford dearomatised compound 
3.11, which would then undergo [1,3]-shift of the prenyl side-chain and 
diastereoselective epoxidation to give compound 3.12 with the required 
stereochemistry at C11. Spirocyclic compound 3.13 would then be formed via 
intramolecular cyclisation. SAM-mediated methylation would then install the required 
carbon atom for the subsequent formation of enone 3.14 through oxidation and 
dehydration of the newly introduced methyl side-chain. (−)-Spirooliganones A 1.7 and 
B 3.9 would then be produced via a hetero-Diels–Alder cycloaddition between enone 
3.14 and (−)-sabinene, a naturally occurring monoterpene. This last step is proposed 
to occur via a non-enzymatic process with high regio- but lack of stereo-control to 
produce the (−)-spirooliganones as a pair of epimers at C17 (scheme 3.5). 
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Scheme 3.5: Yu’s proposed biosynthesis of (−)-spirooliganones A 1.7 and B 3.9. 
To date the asymmetric total synthesis of (−)-spirooliganones A 1.7 and B 3.9 has been 
reported three times. The first total synthesis was accomplished by Xie and co-workers 
in 2014 in eight steps.138 The synthetic sequence involved a three component hetero-
Diels–Alder cycloaddition as the first step, rather than having this transformation at a 
later stage, as proposed by the isolation team in their biosynthetic hypothesis. Reaction 
between 1,3-cyclohexadione, formalin and (−)-sabinene afforded two diastereomeric 
tetracycles (17S)-3.15 and (17R)-3.15 with very little stereopreference. Each one of 
the two epimers was then subjected separately to the same sequence involving 
aromatisation, O-prenylation of the resulting phenol 3.16, Claisen-Cope 
rearrangements and O-allylation to afford ether 3.17. Highly diastereoselective 
Sharpless dihydroxylation of the prenyl side-chain gave diol 3.18, which underwent a 
Claisen rearrangement of the allylic group to produce phenol 3.19.  The synthesis of 
both (−)-spirooliganones A 1.7 and B 3.9 was finally achieved in 2% and 6% overall 




Scheme 3.6: Xie’s total synthesis of (−)-spirooliganones A 1.7 and B 3.9. 
In the same year, Tong and co-workers reported the enantioselective synthesis of         
(−)-spirooliganones A 1.7 and B 3.9 in twelve steps.139 The highlight in this synthesis 
was a one-pot Claisen rearrangement/hetero-Diels–Alder cycloaddition to construct 
the central tetracyclic core of the natural products. The synthesis started from 
commercially available 2,6-dihydroxybenzoic acid with acetonide formation and         
O-reverse prenylation to give acetal 3.20. Reduction of the acetonide followed by 
double protection with acetic anhydride afforded ether 3.21, which was then subjected 
to the one-pot Claisen rearrangement/ortho-quinone methide formation/hetero-Diels–
Alder sequence. This reaction cascade afforded spirocyclic compounds (17S)-3.22 and 
(17R)-3.22 in a 1:1 diastereomeric ratio. The mixture was subjected to highly 
diastereoselective Sharpless dihydroxylation, after which the two epimers were 
separated. The two diols were then converted separately into the corresponding 
spirooliganones in seven steps via installation of the allyl group, and oxidative 
dearomatisation through intramolecular spirocyclisation, with conditions similar to the 
ones employed by Xie and collaborators (scheme 3.7).  
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Scheme 3.7: Tong’s total synthesis of (−)-spirooliganones A 1.7 and B 3.9. 
The most recent synthesis of spirooliganones A 1.7 and B 3.9 was achieved in 2015 
by Yu and co-workers in eleven steps.140 The approach followed was very similar to 
the one employed by Tong, and mainly differed with regard to the installation of the 
allyl group, which was performed earlier in the synthesis. Yu and collaborators turned 
the poor diastereoselectivity achieved in their dihydroxylation to their advantage to 
prepare all eight possible diastereoisomers accessible when using (−)-sabinene as the 
dienophile.  
3.2.3 (+)-Illicidione A 1.5 and (+)-Illihendione A 3.23 
(+)-Illicidione A 1.5 was isolated by Liu and co-workers in 2011 from the stem bark 
of Illicium oligandrum and represents the first reported prenylated C6-C3 dimer from 
the Illicium plants.126 Two years later, (+)-illicidione A 1.5 was isolated for the second 
time by Hou and collaborators from the roots of Illicium henryi, together with                  
(+)-illihendione A 3.23, a closely related new dimeric structure.131 Hou and 
collaborators also co-isolated the simpler natural products (−)-illihenryfunone C 3.24 
and (+)-illihenrypyranone A 3.25. The former can be considered as a hydrated building 
block for (+)-illicidione A 1.5 and the latter is a hydrated diastereoisomer of the 
plausible monomeric unit for (+)-illihendione A 3.23. It is likely that in nature the two 
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dimeric structures are the result of a hetero- (1.5) and homo (3.23) Diels–Alder 
cycloaddition reaction of dienes 3.26 and 3.27 (scheme 3.8). 
 
Scheme 3.8: (+)-Illicidione A 1.5, (+)-illihendione A 3.23, and co-isolated compounds 3.24 and 3.25. 
When we started working on this project, the total synthesis of these compounds had 
not been reported. However, in 2015 Yu and co-workers accomplished the first total 
synthesis of the two dimeric natural products (+)-illicidione A 1.5 and (+)-illihendione 
A 3.23 in eight and nine steps respectively141 from known compound 3.28. Initial 
phenol double-protection as the TBS-ether and Shi epoxidation afforded epoxide 3.29 
with good enantioselectivity. Acid and base-promoted intramolecular cyclisations then 
gave bicycles 3.30 and 3.31 respectively. These were separately converted into their 
corresponding allylated analogues 3.32 and 3.33 via a sequence of iodination, 
protection of the hydroxyl groups, Suzuki coupling to install the allyl group and phenol 
deprotection. By subjecting equimolar quantities of two phenols 3.32 and 3.33 to SIBX 
oxidative dearomatisation conditions, Yu and co-workers found that the Diels–Alder 
cycloadditions occur spontaneously at room temperature to produce the framework of 
the two natural products. Final benzyl-ether deprotection afforded (+)-illicidione A 1.5 
and (+)-illihendione A 3.23 in 8% and 13% overall yield respectively (scheme 3.9). 
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Scheme 3.9: Yu’s total synthesis of (+)-illicidione A 1.5, (+)-illihendione A 3.23. 
The facile nature of this final transformation could explain why the two putative 
monomeric units 3.26 and 3.27 (see scheme 3.8 on page 97) have never been isolated 
from natural sources. Interestingly, when subjecting benzyl-ether 3.33 to the same 
dearomatisation conditions, no homo-dimerisation was observed, thus suggesting 
enone 3.33 cannot serve as a diene, but solely as a dienophile (scheme 3.10). 
 






3.3 Our Biosynthetic Proposal 
To date, more than 100 different prenylated phenylpropanoids have been isolated from 
plants of the illicium genus, differing with regard to the position of the allyl and prenyl 
groups on the phenolic ring and variations in their oxidation state. Most of these 
compounds (81) can be seen as biosynthetically derived from a common precursor. 
The structural diversity present in the core frameworks of the prenylated 
phenylpropanoids can be, formally at least, explained through two divergent 
biosynthetic pathways distinguished by either a normal or reverse O-prenylation. In an 
effort to compartmentalise this structural diversity we propose that an oxygenated 
phenyl propanoid moiety, derived from the shikimate pathway, could undergo               
O-prenylation or O-reverse-prenylation, leading to what we herein classify as type A0 
and type B0 structures. Subsequently, a Claisen rearrangement could occur, leading to 
type A1 and type B1 structures, with twelve known natural products belonging to the 
type A1. It should be noted that no examples of type A0 and B1 prenylated 
phenylpropanoids have been isolated to date. Finally, a Cope rearrangement would 
give type A2 and type B2 structures, with type B2 being the most commonly 
encountered framework for natural prenylated phenylpropanoids. Our proposed 
conceptual biosynthetic network with examples of known natural products possessing 
type B0, type A1, type A2 and type B2 structures is shown in scheme 3.11. 
It is important to note that this proposal is provided principally as a conceptual 
framework through which we can better understand the molecular diversity of 
prenylated phenylpropanoid natural products. In reality, there might be specific prenyl 
transferase enzymes142 that can install the prenyl group selectively and directly at all 
relevant positions. Indeed, there may be prenyl transferase enzymes that install the 




Scheme 3.11: Our proposed biosynthetic network and some example of natural products. 
Most members of this family of compounds can be related through redox processes. 
However, there are higher order structures that result, for example, from 
intramolecular carbocyclisations, as (−)-illioliganone A 1.2 and (±)-tricycloillicinone 
1.4, or Diels–Alder reactions (−)-spirooliganone A 1.7, (−)-spirooliganone B 3.9 (see 
section 3.2.2 on pages 93-94), (+)-cycloillicinone 1.6, (+)-illihendione A 3.23 and         
(+)-illicidione A 1.5 (see section 3.2.3 on pages 96-97). Some examples are depicted 
in scheme 3.12.  
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Scheme 3.12: Proposed biosyntheses of select higher-order prenylated phenylpropanoids. 
3.3.1 Our Synthetic Strategy 
Nature, over billions of years, has developed very efficient strategies to achieve 
selectivity in the synthesis of organic compounds. We aim to achieve selectivity in the 
laboratory with the standard techniques employed by organic chemists such as the use 
of protecting groups and the careful choice of reagents and reactions conditions. Thus, 
our synthetic plan is slightly different from our proposed biosynthesis, but has 
incorporated its strategic implications, in accordance with the biogenetic-type 
philosophy described by Van Tamelen (discussed in section 1.2 on page 18). 
Therefore, we will make extensive use of specific biomimetic reactions such as [3,3]-





3.3.2 Synthesis of the Precursors 
To be able to access all our targets, we will need two different precursors ((±)-3.34 or 
(±)-3.35, and (±)-3.36 or (±)-3.37) which differ in the relative positions of the allyl and 
prenyl side chains. Precursors ortho-quinol (±)-3.35 and para-quinol (±)-3.36 possess 
the framework of the structures we classified as type A2, while enone (±)-3.38, 
potentially accessible from ortho-quinol (±)-3.35, belongs to type A1. Finally, para-
quinol (±)-3.34 and ortho-quinol (±)-3.37 would lead to type B2 structures. We propose 
that all precursors could be accessed from the same commercially available starting 
material (4-bromo-3-methoxyphenol, 3.39) through a sequence of allyl or reverse-
prenyl ether formations, [3,3]-sigmatropic rearrangements, allylation or prenylation 
and then regio and chemo-selective oxidative dearomatisations. It is worth noting that, 
in principle, both type A2 and type B2 frameworks could potentially be accessed from 
the same phenol (3.40 or 3.41) via deprotection of the methyl ether group, provided 




Scheme 3.13: Our proposed synthesis for the precursors to type A1, A2 and B2 structures. 
If successful, this approach would potentially allow access to all the framework types 
via a unified strategy, and would therefore exploit even more the divergent nature of 
our strategy. 
3.3.3 Planned Synthesis of Selected Molecular Targets 
Given the large number of isolated prenylated phenylpropanoid natural products, focus 
will be devoted to the total synthesis of a group of them. To demonstrate the generality 
of our strategy we aim to prepare a selection of targets having diverse molecular 
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scaffolds. Given the non-enantioselective nature of the oxidative dearomatisation we 
are planning to use, our targets will be prepared in racemic form. We envisage that the 
use of carefully selected reagents and reaction conditions could allow us to control the 
relative stereochemistry in the subsequent transformations. Our proposed synthetic 
plan for the most interesting and complex structures involves a relatively small number 
of transformations: deprotections, Knoevenagel condensations, prenyl side-chain 
oxidations, cyclisations and Diels–Alder cycloadditions, as shown below (schemes 
3.14–3.16, sections 3.3.4 and 3.3.5). 
3.3.4 Planned Synthesis of Selected Type A2 Structures 
The synthesis of (±)-illihendione A 3.23 and (±)-illicidione A 1.5 starting from type A2 
precursor (±)-3.35 would involve a diastereoselective epoxidation of the prenyl side-
chain to give quinol (±)-3.46, followed by a cyclisation leading to the formation of 
either a five or six-membered ether (±)-3.26 or (±)-3.27. A Diels–Alder cycloaddition 
could then occur giving the homo-dimer (±)-illihendione A 3.23 and the hetero-dimer 
(±)-illicidione A 1.5 (scheme 3.14). Based on the literature precedent discussed in 
section 3.2.3 on pages 97-98, it is reasonable to expect this final transformation to 
occur spontaneously at room temperature.141  
 
Scheme 3.14: Proposed synthesis of (±)-illihendione A 3.23 and (±)-illicidione A 1.5. 
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3.3.5 Planned Synthesis of Selected Type B2 Structures 
The majority of our targets belong to the type B2 framework. For example, we propose 
then that (±)-illioliganone A 1.2 could be accessed by deprotection followed by 
oxidative carbocyclisation from type B2 precursor (±)-3.37. Alternatively, this natural 
product could be accessed from diol (±)-3.47 via a sequence of diastereoselective 
epoxidation and intramolecular epoxide-ring opening. Intermediate (±)-3.46 could 
also be methylenated to give the bridged natural product illicinone A 1.3 in racemic 
form. This could then be reacted with trans-β-ocimene (a naturally occurring and 
commercially available monoterpene) through a Diels–Alder cycloaddition leading to 
(±)-cycloillicinone 1.6, or cyclise to give (±)-tricycloillicinone 1.4 (scheme 3.15), as 
shown by Fukuyama118 and Danishefsky120 (see section 3.2.1 on pages 91-92). 
 
Scheme 3.15: Proposed synthesis of (±)-illioliganone A 1.2, (±)-cycloillicinone 1.6 and (±)-
tricycloillicinone 1.4. 
We propose that (±)-illicidione B 3.3 and spirooliganones A (±)-1.7 and B (±)-3.9 
could also be accessed from the same type B2 precursor (±)-3.37. (±)-Illicidione B 3.9 
could be prepared through a sequence involving deprotection, Knoevenagel 
condensation with formaldehyde (or a synthetic analogue) and Michael addition 
leading to dimer (±)-3.48. We anticipate this transformation could be challenging, as 
there are issues of selectivity (homo vs. hetero dimers) to address. Dimer (±)-3.48 
could be subjected to diastereoselective epoxidation of the prenyl side-chains and 
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finally intramolecular double cyclisation. Alternatively, precursor (±)-3.37 could be 
diastereoselectively epoxidised first to give alcohol (±)-3.49. Spirocyclic compound 
(±)-3.50 could then be formed via intramolecular epoxide ring opening and, after 
deprotection and Knoevenagel condensation with formaldehyde, would be converted 
into enone (±)-3.51. Based on literature precedent (see section 3.2.2 on pages 94-96), 
we envisage this could undergo a Diels–Alder cycloaddition with (−)-sabinene (a 
natural occurring monoterpene) to give (±)-spirooliganones A 1.7 and B 3.9 (scheme 
3.16).  
 
Scheme 3.16: Proposed syntheses of (±)-illicidione B 3.3 and (±)-spirooliganones A 1.7 and B 3.9. 
The order in which these reactions are performed could be modified to overcome 
regio- and/or stereo-selectivity issues which could arise during the synthesis. For 
example, removal of the methyl ether functionality on epoxide (±)-3.49 could be 
performed after the hetero-Diels–Alder cycloaddition to avoid formation of undesired 
regioisomers. 
 107 
3.4 Results and Discussion 
3.4.1 Synthesis of the Precursor to Type A1 and A2 Structures 
Our planned synthesis for precursor (±)-3.35 to type A1 and A2 structures from 
commercially available phenol 3.39 involved the formation of allyl ether 3.42, which 
would be prenylated to give arene 3.44. A Claisen rearrangement would afford phenol 
3.40, which would then be subjected to regioselective oxidative dearomatisation to 
give ortho-quinol (±)-3.35 (scheme 3.17). 
 
Scheme 3.17: Our planned synthesis for the precursor (±)-3.35 to type A1 and A2 structures. 
The synthesis of compound (±)-3.35 began with the formation of allyl ether 3.39,143 
which proceeded smoothly to give expected product 3.42 in 92% isolated yield on a 
5-gram scale (scheme 3.18). 
 
Scheme 3.18: Formation of allyl ether 3.42. 
The next step, involving prenylation of aryl bromide 3.42 to give compound 3.44, 
proved to be more challenging. The first attempts were performed using the Stille 
reaction.144 This palladium catalysed coupling between aryl bromide 3.42 and tributyl-
(3-methyl-2-butenyl)tin proved to be unsuccessful, giving just reverse-prenylated 
compound 3.52 in a very low isolated yield, along with 40% of recovered starting 




Scheme 3.19: Attempted prenylation of arene 3.42 with Stille reaction. 
The prenylation of arene 3.42 was then attempted following a procedure involving a 
lithium-halogen exchange to give the aryl lithium species 3.53, which would then be 
quenched with 3,3-dimethylallyl bromide145 to give product 3.44. 1H NMR analysis of 
the crude reaction mixture indicated a 76% yield of the expected product along with 
15% of protonated species 3.54 and 5% of compound 3.55, the result of allylic double 
bond isomerisation. Following flash chromatography targeted compound 3.44 was 
isolated in 50% yield (scheme 3.20). It is proposed that the proton source could either 
be water present in the reaction mixture or the methylene protons in the allyl group, as 
suggested by the isomerisation of the double bond. Nevertheless, larger quantities of 
product 3.44 could be isolated by repeating the purification. 
 
Scheme 3.20: Prenylation of allyl ether 3.42. 
We then focused on the Claisen rearrangement of allyl ether 3.44, targeting phenol 
3.40. Thermal Claisen rearrangements are known in the literature to be not particularly 
regioselective,146 we therefore decided to use allyl ether 3.42 as a model system in an 
attempt to find suitable conditions. Ishikawa and co-workers in 2007 reported the use 
of boron trichloride as an efficient reagent for the regioselective Claisen rearrangement 
of resorcinol derivatives, with a strong preference for the C6 position.147 Treatment of 
compound 3.42 with three equivalents of boron trichloride gave a mixture of the two 
possible regioisomers 3.56 and 3.57, allylated at C6 or at C2, with a 20:1 ratio in favour 
of desired regioisomer 3.56 (scheme 3.21). 
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Scheme 3.21: BCl3 mediated Claisen rearrangement of allyl ether 3.42. 
Given these promising results, the same conditions were applied to prenylated allyl 
ether 3.44, but this resulted in decomposition. Thermal conditions were therefore 
investigated. It was found that simply heating the neat ether 3.44 at 190 ºC overnight 
resulted in the formation of a 6:1 mixture of C6 allylated phenol 3.40 and C2 allylated 
phenol 3.58. Pleasingly, the two regioisomers were found to be separable by flash 
chromatography and targeted phenol 3.40 was obtained in 71% isolated yield (scheme 
3.22). 
 
Scheme 3.22: Thermal Claisen rearrangement of ether 3.44. 
Several reaction conditions were screened for the oxidative dearomatisation of phenol 
3.40. Reactions using Oxone148 and [bis-(trifluoacetoxy)-iodo]benzene (PIFA)149 as 
the oxidants gave mixture of products which we could not identify, while lead 
tetraacetate150 gave ortho-quinol acetate (±)-3.59 in 30% isolated yield (scheme 3.23). 
Analysis of the crude 1H NMR spectrum for this reaction suggested formation of both 
ortho- and para-quinol acetates (±)-3.59 and (±)-3.60 in an approximately 1:1 ratio, 
but only the former could be isolated. 
 
Scheme 3.23: Pb(OAc)4 -mediated oxidative dearomatisation of phenol 3.40. 
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Then (diacetoxyiodo)benzene (PIDA) was tested using a modified literature 
procedure,151 but the only identified and isolated compound among the complex 
mixture of products was epoxide (±)-3.61, in low yield (scheme 3.24). 
 
Scheme 3.24: Oxidative dearomatisation of phenol 3.40 with PIDA to give epoxide (±)-3.61. 
 
Stabilised 2-iodoxybenzoic acid (SIBX) is a known reagent for the regioselective 
formation of ortho-quinols from phenols.152 Therefore, a reaction was performed using 
phenol 3.40 and 2.4 equivalents of SIBX as the oxidant, with ortho-quinol (±)-3.35 
being the only observed product in the crude 1H NMR spectrum (scheme 3.25).  
Attempts to separate ortho-quinol (±)-3.35 from the residual unreacted IBX and the 
stabilisers by flash chromatography failed. When the crude reaction mixture was 
washed with aqueous sodium bicarbonate solutions ortho-quinol (±)-3.35 proved to be 
highly prone toward Cope rearrangement to give dienone (±)-3.38. However, the crude 
material was sufficiently pure that analysis of 1D and 2D NMR spectra allowed us to 
unambiguously determine the structure of compound (±)-3.35. The facile 
rearrangement of ortho-quinol (±)-3.35 would enable direct investigation into the 
synthesis of type A1 structures. Dienone (±)-3.38, in fact, possesses the correct 
framework for this group and can also conveniently be prepared with the same 
procedure used for ortho-quinol (±)-3.38, by letting the reaction proceed for longer 
(scheme 3.25). 
 
*crude 1H NMR yield. 
Scheme 3.25: SIBX oxidative dearomatisation of phenol (±)-3.40. *crude 1H NMR yield. 
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Considering the small number and complexity of natural product targets belonging to 
type A1 frameworks, their synthesis was not pursued. To the best of our knowledge 
there are just twelve known prenylated phenylpropanoids isolated from Illicium plants, 
and they differ only for subtle modifications of the prenyl side-chain (see appendix 
on page 426). The inability to access the precursor to type B2 structures, which would 
require selective oxidative dearomatisation of phenol 3.40 in the para-position (see 
section 3.3.2 on page 103), and the instability of ortho-quinol (±)-3.35, precursor to 
type A2 structures, led us to abandon this route. However, we envisaged that the results 
obtained so far could provide useful information about the reactivity of these structures 
and inspiration for the synthesis of the precursor to type B2 frameworks. 
3.4.2 Synthesis of the Precursor to Type B2 Structures 
In our proposed biosynthetic network the majority of our molecular targets could be 
seen as derived from type B2 precursor (±)-3.37. We initially hypothesised that it was 
possible to access this compound through a short sequence involving a direct calcium-
catalysed mild Friedel–Crafts prenylation153 at C6, allylation at C4 to afford phenol 
3.41 and SIBX-mediated oxidative dearomatisation (scheme 3.26). 
 
Scheme 3.26: Our initial proposed synthesis of precursor (±)-3.37 to type B2 structures. 
The direct C-prenylation of arene 3.39 was attempted under the conditions recently 
developed by Niggemann and co-workers,153 involving the use of calcium triflimide 
as a mild Lewis-acid catalyst. This methodology was applied to couple a series of 





Scheme 3.27: Example of Niggemann’calcium-catalysed Friedel–Crafts prenylation.153 
Unfortunately, after several trials varying the reaction conditions, no desired 
prenylation was observed. It was, therefore, decided to undertake the slightly longer 
approach akin to the one used for type B2 precursor. Our new planned synthesis for 
the synthesis of precursor (±)-3.37 from phenol 3.39 involved a reverse-prenyl ether 
formation to give bromoarene 3.43. Direct allylation would then afford ether 3.45, 
which could be subjected to Claisen rearrangement to produce phenol 3.41. Finally, an 
ortho-oxidative dearomatisation would provide ortho-quinol (±)-3.37 (scheme 3.28). 
 
Scheme 3.28: Alternative proposed synthesis for precursor (±)-3.37 to type B2 structures. 
 
The preparation of reverse-prenyl ether 3.43 was initially attempted by reacting phenol 
3.39 with carbonate 3.62, which could be prepared following a literature procedure.154  
Unfortunately, palladium-catalysed reverse O-prenylation of phenol 3.39 proved to be 
unselective. 1H NMR analysis of the crude reaction mixture revealed reverse-prenyl 
ether 3.43 to be present as the major product. However, unwanted C4 prenylated 




Scheme 3.29: Attempted O-reverse prenylation of phenol 3.39. * 1H NMR yield. 
Attempts to isolate reverse-prenyl ether 3.43 from the other components of the reaction 
mixture through flash chromatography met with failure. and varying the reaction 
conditions proved unproductive. It was therefore decided to undertake a more secure 
albeit less elegant route to access reverse-prenyl ether 3.43, to avoid selectivity issues. 
A two-step sequence involving O-propargylation155 of phenol 3.39 followed by partial 
hydrogenation of alkyne 3.65 using Lindlar’s catalyst156 proved to be a reliable method 
to access alkene 3.43 (scheme 3.30). 
 
Scheme 3.30: Preparation of reverse-prenyl ether 3.43. 
The moderate yield for the propargyl ether formation is ascribed to difficulties in the 
separation of the product from allene 3.66, which, under optimised conditions, was 
formed only as a minor product (< 5%). This is proposed to be formed from 
deprotonation of propargyl ether 3.65, followed by a SN2ꞌ reaction with another 
molecule of alkyne electrophile (scheme 3.31). 
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Scheme 3.31: Proposed mechanism for the formation of allene 3.66. 
The subsequent attempt of allylation145 of alkene 3.43 via lithium-halogen exchange 
and quenching with allyl bromide proved difficult. The formation of a mixture of 
products, some of them with loss of the prenyl group, was observed in the crude           
1H NMR spectrum.  Protonation at C4 was also observed, thus suggesting we were 
facing the same issues we had encountered in the prenylation of allyl ether 3.42 (see 
scheme 3.20 on page 108) (scheme 3.32).  
 
*Ratios based on 1H NMR spectrum of the crude reaction mixture. 
Scheme 3.32: Attempted allylation of reverse-prenyl ether 3.43.  
We therefore decided to investigate the allylation process further, with a different 
starting material. It was envisaged that a longer sequence involving protection of the 
phenolic hydroxyl functionality as the MOM-ether followed by allylation of arene 3.68 
would allow us to overcome the issues related to the protonation at C4. Subsequent 
cleavage of the MOM group on 3.69 to give phenol 3.70, followed by                                  
O-propargylation and partial reduction of alkyne 3.71 would then afford prenyl-ether 
3.45 (scheme 3.33).  
 
Scheme 3.33: Proposed alternative synthesis of ether 3.45. 
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MOM-ether 3.68 was easily prepared under standard conditions157 in 86% yield on a 
10-gram scale and subjected to the same allylation conditions used with prenyl-ether 
3.43 (see scheme 3.42 on page 114).145 Lithium-halogen exchange followed by 
quenching with allyl bromide proceeded smoothly, affording MOM-ether 3.69 in 95% 
yield on a 480-mg scale (attempts on scaling up the allylation resulted in a far less 
clean reaction). This was then subjected to hydrolytic cleavage of the MOM-ether to 
afford phenol 3.70 in 84% yield on a 370-mg scale (scheme 3.34). 
The O-propargylation/reduction sequence was then employed to access reverse-prenyl 
ether 3.45. Etherification of phenol 3.70 using the previously employed conditions 
with phenol 3.39 (see scheme 3.30 on page 113), gave compound 3.71 in 68% yield 
on a 100-mg scale, along with a small amount of allene 3.72. Subsequent partial 
hydrogenation of alkyne 3.71 to the alkene using the Lindlar’s catalyst afforded ether 
3.45 in 94% yield on a 110-mg scale. 
Ether 3.45 was then subjected to thermal Claisen rearrangement; heating ether 3.45, 
neat, to 190 °C resulted in the formation of two isomeric products. Phenol 3.41 was 
isolated in 45% yield, along with a small amount of its regioisomer 3.73 (6% yield) 
(scheme 3.34).  
 
Scheme 3.34: Synthesis of phenol 3.41. 
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The SIBX-mediated oxidative dearomatisation was then attempted on phenol 3.41 on 
a small scale (6 mg of starting material) in deuterated DMSO. The reaction was 
monitored by 1H NMR spectroscopy and was found to reach completion in between 
two to four hours (see page 378 for stacked 1H NMR spectra) to afford ortho-quinol 
(±)-3.37. Unfortunately, attempts on separating the residual SIBX from the product by 
repetitive washings with saturated aqueous NaHCO3 resulted in the formation of a 
complex mixture of products (scheme 3.35). 
 
Scheme 3.35: SIBX-mediated oxidative dearomatisation of phenol 3.41. 
The apparent instability of ortho-quinol (±)-3.37, along with the step-count and the 
overall lack of efficiency and scalability of the steps led us to completely re-consider 
our biomimetic approach. 
3.5 Alternative Approach  
Inspired by Danishefsky’s previously discussed synthesis of (±)-tricycloillicinone,120 
we envisaged we could access both type A2 and type B2 structures from the two 
alternative precursors (±)-illicinone A 1.3 and compound (±)-3.74, prepared following 
an analogous approach. Starting from the commercially available and cheap sesamol 
(£ 1.5/g), type B2 structures could be accessed via cleavage of the methylene bridge 
on (±)-illicinone A 1.3, which could be prepared using literature procedures.120 The 
preparation of type A2 framework (±)-3.74 would involve the use of the same reaction 
types, but in a different order. O-reverse-prenylation of sesamol would give ether 3.75, 
which could undergo a Claisen rearrangement to afford phenol 3.76. O-allylation 
would then produce ether 3.77, which would then be subjected to the MABR-mediated 
Claisen-Cope rearrangement to produce dienone (±)-3.74. Finally, cleavage of the 
methylene bridge would provide the type A2 framework (scheme 3.36). 
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Scheme 3.36: Revised approach to access type A2 and type B2 frameworks. 
3.5.1 Approach to Type B2 Structures 
It was envisaged that our investigation toward the total synthesis of the most 
interesting members of the prenylated phenylpropanoids family would require a 
substantial amount of material. Thus, we repeated the known sequence leading to      
(±)-illicinone A 1.3 in a far larger scale than previously reported. Allylation of sesamol 
proceeded smoothly to afford ether 3.4 in nearly quantitative yield on a 25-gram scale, 
which was used directly in the next step, without purification. The subsequent thermal 
Claisen rearrangement afforded 25 grams of crude reaction mixture containing phenol 
3.5, which was directly subjected to prenyl-ether formation conditions (affording 22 
grams of illicinole 3.6 in 65% isolated yield over 3 steps), with final purification by 
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column chromatography required. This represents a >20-fold scale-up with respect to 
the previous synthesis, which was accomplished in 75% yield on a 930-mg scale. The 
smaller yield in our case has to be ascribed to the longer times required for the Claisen 
rearrangement in this scale, which led to some decomposition occurring. The 
conditions developed by Danishefsky and co-workers were then applied for the 
preparation of (±)-illicinone A 1.3. Treatment of illicinole 3.6 with in situ generated 
MABR, a bulky Lewis acid, resulted in a 75% yield on a 1.7-gram scale (scheme 3.37).  
 
Scheme 3.37: Our scale-up of Danishefsky’s synthesis of (±)-illicinone A 1.3. 
With (±)-illicinone A 1.3 in hand, we started our investigation into the synthesis of 
more complex phenylpropanoid natural products. As discussed previously,                  
(±)-illicinone A 1.3 is the putative precursor to the majority of our molecular targets. 
It was decided to initially focus on those retaining the methylene bridge, as there are a 
number of structures closely related to one another containing that functionality (a few 
examples are depicted in figure 3.2). 
 
Figure 3.2: Examples of targeted bridged prenylated phenylpropanoids. 
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3.5.2 Total Synthesis of (±)-Cycloillicinone 1.6 
(+)-Cycloillicinone 1.6 was isolated for the first time in 2011 by Fukuyama and co-
workers from the twigs of Illicium anisatum.127 Preliminary studies showed that this 
compound showed moderate neurite-outgrowth promoting activity in rat neurons. This 
compound features a tricyclic framework and 4 contiguous stereogenic centers. The 
relative stereochemistry was elucidated with nOe experiments and polarimetric 
measurements indicated natural cycloillicinone 1.6 to be the dextrorotatory 
enantiomer. However, it was not possible to establish its absolute configuration. 
Fukuyama and collaborators proposed two divergent biosynthetic pathways for its 
formation, both starting from allylated sesamol 3.5. Initial direct C-prenylation of 
allylated sesamol 3.5 would produce the known natural product illicinone A 1.3, the 
common intermediate in these two biosynthetic hypotheses. At this point two 
alternative routes were proposed. The first one involved geranylation of illicinone A 
1.3 to afford a geranylated intermediate, which would then undergo a cyclisation to 
provide (+)-cycloillicinone 1.6 (path a), with no detail on the exact mechanism of this 
transformation provided by the authors. Given the non-nucleophilic character of 
illicinone A 1.3 at C3, we consider the second proposed pathway, a Diels–Alder 
cycloaddition between illicinone A 1.3 and trans-β-ocimene (path b), to be a more 
likely possibility (scheme 3.38).  
 
 
Scheme 3.38: Fukuyama’s proposed biosynthesis of (+)-cycloillicinone 1.6.127 
Intrigued by this second hypothesis, we set out to investigate the feasibility of this 
highly selective Diels–Alder cycloaddition. Heating (±)-illicinone A 1.3 at 140 °C for 
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2 hours in the presence of ten equivalents of β-ocimene (as a 6:4 mixture of trans/cis 
isomers) resulted in the formation of a small amount (~8%) of targeted                             
(±)-cycloillicinone 1.6, along with a complex mixture of unidentified products and 
recovered starting material (~6%), based on the 1H NMR spectrum of the crude 
reaction mixture. As Diels–Alder cycloadditions are known to be catalysed by Lewis 
acids, we speculated that a one-pot synthesis of (±)-cycloillicinone 1.6 from illicinole 
3.6 was possible. Thus, the conditions previously employed for the formation of            
(±)-illicinone A 1.3 were used until complete conversion of the starting material to give 
(±)-illicinone A 1.3 was observed by TLC analysis. Five equivalents of β-ocimene 
were then added and the reaction mixture was allowed to slowly warm to room 
temperature and stirred overnight before being quenched. To our delight, the Diels–
Alder cycloaddition proceeded with complete control of regio and stereo-selectivity, 
affording (±)-cycloillicinone 1.6 as the sole product, isolated in 43% yield from 
illicinole 3.6 (scheme 3.39).  
 
Scheme 3.39: Our synthesis of (±)-cycloillicinone 1.6. 
The relative stereochemistry proposed by Fukuyama and co-workers was confirmed 
to be correct by X-ray crystallography. When achieved, this represented the first total 
synthesis of (±)-cycloillicinone 1.6 at the time, accomplished in 28% yield over 4 
steps. Unfortunately, shortly after this accomplishment, Rahman and co-workers 
published the synthesis of this compound employing the same strategy.158 However, 
in this slightly longer and less efficient synthesis (5 steps, 24% yield from sesamol), 
the Diels–Alder cycloaddition was performed as an additional step after the MABR-
promoted prenyl-group migration. A different Lewis acid was used to catalyse the 
Diels–Alder reaction: upon extensive screening of conditions and catalysts, they found 
that treatment of (±)-illicinone A 1.3 with 20 mol% of (S)-o-tolyl-CBS-
oxazaborolidine in CH2Cl2 at −40 °C for 8 hours gave the best results, affording             
(±)-cycloillicinone 1.6 in 55% yield from (±)-illicinone A 1.3 (scheme 3.40).158 
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Scheme 3.40: Rahman’s 2015 synthesis of (±)-cycloillicinone 1.6.158 
Although disappointing to see this synthesis published, it is important to remember 
that the aim of our project is not to access a particular compound. We aim to achieve 
the synthesis of a selection of natural product targets featuring diverse molecular 
frameworks. The emphasis is in the number and structural diversity of molecules 
prepared using a unified strategy. 
3.5.3 Synthesis of (±)-Illicinone C 3.78 and (±)-epi-Illicinone C 3.79 
(+)-Illicinone E 3.80, (−)-epi-illicinone E 3.2 and the closely related natural products 
(+)-13-O-methylillicinone E 3.81 and (−)-illioliganfunone A 3.82 have been isolated 
from Illicium oligandrum and Illicium tashiroi between 1992 and 2011.117,119,125 These 
are part of a large group of compounds extracted from different plants belonging to 
the Illicium genus, some in enantiopure form and others as racemic mixtures. A 
number of permutations with regard to the relative stereochemistry have also been 
encountered for these frameworks, in compounds isolated from different species.135 
We envisaged that these structures could be accessed from either epoxide                      
(±)-illicinone C 3.78 or (±)-epi-illicinone C 3.79 (figure 3.3).  
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Figure 3.3: (+)-Illicinone E 3.80 and related structures. 
It should be noted that (+)-Illicinone C 3.78 and (−)-epi-illicinone C 3.79 are both 
known natural products, isolated from Illicium tashiroi and Illicium arborescens 
respectively.135 We propose that both of these compounds could be prepared in racemic 
form via non-diastereoselective epoxidation of (±)-illicinone A 1.3. Therefore, our 
investigation toward the total synthesis of this group of natural products began with 
the epoxidation of (±)-illicinone A 1.3. Treatment with m-CPBA in dichloromethane 
at room temperature smoothly afforded a nearly 1:1 mixture of diastereoisomeric 
epoxides (±)-illicinone C 3.78 and (±)-epi-illicinone C 3.79 in 94% yield on a 1.8-
gram scale (scheme 3.41).  
 
Scheme 3.41: Epoxidation of (±)-illicinone A 1.3. 
The lack of diastereoselectivity was not considered a problem, as both stereoisomers 
were potential precursors to known natural products. More disappointing was the 
difficulty encountered in separating the two diastereoisomers; the (4S-11R/4R-11S)-
diastereoisomer ((±)-epi-illicinone C 3.79) was isolated in a modest yield of 34%, 
whereas (±)-illicinone C 3.78 was isolated in only 17% yield following flash 
chromatography. 
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3.5.4 Synthesis of (±)-epi-Illicinone E 3.2 and Related Structures 
Due to the low yield of (±)-illicinone C 3.78, resulting from the difficulties in 
purification, we decided to proceed with our investigations using its diastereoisomer 
(±)-epi-illicinone C 3.79, which we could access in larger quantities. A first attempt to 
access (±)-epi-illicinone E 3.2 was performed by reacting (±)-epi-illicinone C 3.79 
with a catalytic amount of p-toluenesulfonic acid in a 95:5 mixture of ethanol and 
water. The reaction was quenched after complete consumption of the starting material 
was observed by TLC analysis. Chromatographic purification afforded four different 
compounds, one of which was identified as (±)-epi-illicinone E 3.2, a known natural 
product. Another fraction consisted of the ethyl ether of (±)-epi-illicinone E 3.2          
(±)-epi-13-O-ethylillicinone E 3.83, while 1H NMR analysis of the other two 
compounds revealed the absence of the methylene bridge. Comparison with the NMR 
data reported for related natural products isolated from Illicium genus plants suggested 
these compounds corresponded to structures (±)-3.84 and (±)-3.85 (scheme 3.42). 
Ethyl ether (±)-3.84 was fully characterised, while diol (±)-3.85 was not deemed 
sufficiently pure for these purposes. However, by comparing their 1H NMR spectra 
with that reported for the known natural product 2,3-dehydroillifunone C 3.86, it is 
reasonable to assign the structures shown in scheme 3.42, which possess a different 
relative stereochemistry with respect to the known natural product.  
 
Scheme 3.42: Preliminary attempt on accessing (±)-epi-illicinone E 3.2 and related structures. 
We propose that these structures could be produced via acid-catalysed regioselective 
ring-opening of the epoxide by either ethanol or water. Intramolecular addition of the 
free secondary alcohol functionality to C5 would then produce the oxa-Michael 
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reaction products. This sequence would lead to (±)-epi-illicinone E 3.2 and (±)-epi-13-
O-ethylillicinone E 3.83 (scheme 3.43).  
 
Scheme 3.43: Proposed mechanism for the formation of (±)-epi-illicinone E 3.2 and                        
(±)-epi-13-O-ethylillicinone E 3.83. 
It is envisaged that an analogous sequence could be used to access (±)-illicinone E and 
the related natural products with the same relative stereochemistry at C4 and C11.  
We then attempted to rationalise the formation of tertiary alcohols (±)-3.84 and           
(±)-3.85, which lack of methylene bridge. Diol (±)-3.85 has not yet been extracted 
from natural sources, but its diastereoisomer 2,3-dehydroillifunone C has been co-
isolated with both (+)-illicinone E 3.80 and (−)-epi-illicinone E 3.2. It is therefore 
reasonable to assume that (±)-epi-2,3-dehydroillifunone C 3.85 could also exist in 
nature. The formation of (±)-epi-2,3-dehydroillifunone C 3.85 and (±)-epi-13-O-ethyl-
2,3-dehydroillifunone C 3.84 was detected via TLC analysis of the crude reaction 
mixture, taken at various times, well before complete consumption of the starting 
material. With regard to (±)-epi-2,3-dehydroillifunone C 3.85, we hypothesise that it 
could be formed via acetal hydrolysis and elimination from (±)-epi-illicinone E 3.2 
(scheme 3.44). An analogous mechanism would account for the formation of (±)-epi-
13-O-ethyl-2,3-dehydroillifunone C 3.84 from (±)-13-O-ethylillicinone C 3.83. 
 
Scheme 3.44: Proposed mechanism for the formation of (±)-epi-2,3-dehydroillifunone C 3.85. 
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3.5.5 Synthesis of (±)-epi-Illicinone E 3.2 
It was envisaged that (±)-epi-illicinone E 3.2 could be accessed selectively by reacting 
(±)-epi-illicinone C 3.2 with water as the nucleophile in the presence of a catalytic 
amount of acid. Therefore, epoxide 3.79 was dissolved in a mixture of water and THF, 
for solubility reasons, and a small amount of p-toluenesulfonic acid was added. 
Pleasingly, (±)-epi-illicinone E 3.2 was isolated as a product of this reaction in 19% 
yield. Unfortunately, attempts to isolate analytically pure samples of (±)-epi-2,3-
dehydroillifunone C 3.85, the presence of which was detected in the 1H NMR spectrum 
of the crude reaction mixture, failed (scheme 3.45). 
 
Scheme 3.45: Synthesis of (±)-epi-illicinone E 3.2. 
3.5.6 Synthesis of (±)-epi-13-O-Methylillicinone C 3.87 
It was reasoned that (±)-epi-13-O-methylillicinone C 3.87, the diastereoisomer of the 
known natural product 13-O-methylillicinone C 3.81 (see figure 3.3 on page 122),117 
could be accessed using a similar approach, using methanol as the nucleophile. 
Therefore, the reaction of epoxide (±)-epi-illicinone C 3.79 in anhydrous methanol 
with a small amount of p-toluenesulfonic acid was attempted. As a result, (±)-epi-13-
O-methylillicinone C 3.87 was isolated, along with alcohol (±)-3.88, in 40 and 13% 
yield respectively (scheme 3.46).  
 
Scheme 3.46: Synthesis of (±)-epi-13-O-methylillicinone E 3.87 and alcohol (±)-3.88. 
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Alcohol (±)-3.88 was detected by TLC analysis of the crude reaction mixture as soon 
as the formation of (±)-epi-13-O-methylillicinone E 3.87 was detected. Attempts to 
suppress its formation by lowering the temperature were unsuccessful. 
Similarly to (±)-epi-2,3-dehydroillifunone C 3.85, we propose alcohol (±)-3.88 to be 
the result of the solvent-mediated cleavage of the methylene bridge on the 
corresponding ether (±)-3.87. To confirm this hypothesis, we re-subjected (±)-epi-13-
O-methylillicinone C 3.87 to the same conditions. Deuterated methanol was used as 
the solvent to enable monitoring of the reaction by 1H NMR. A first control after 30 
minutes indicated the presence of trace amounts of alcohol (±)-3.89, which reached 
21% conversion after another hour (scheme 3.47), thus supporting our mechanistic 
proposal (see scheme 3.44 on page 124). 
 
Scheme 3.47: Formation of alcohol (±)-3.89 from (±)-epi-13-O-methylillicinone E 3.87. 
3.5.7 Synthesis of ether 3.84 
It was envisaged that this methodology could be used to access a wide range of 
differently substituted analogues. We therefore expanded the scope of this 
transformation by performing a similar reaction using ethanol as the solvent. The only 
product isolated after 24 hours in this case (±)-epi-13-O-ethyl-2,3-dehydroillifunone 
C 3.84, in 20% yield (scheme 3.48). 
 
Scheme 3.48: Preparation of (±)-epi-13-O-ethyl-2,3-dehydroillifunone C 3.84. 
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3.6 Concluding Remarks 
In conclusion, we designed and implemented two biomimetic approaches toward the 
total synthesis of a family of prenylated phenylpropanoids from plants of the Illicium 
genus based on our proposed biosynthetic pathway. The first approach involved the 
oxidative dearomatisation of two already assembled prenylated phenylpropanoid 
moieties 3.40 and 3.41 which differed by the relative position of the allyl and prenyl 
group in the aromatic ring. Different routes were investigated in an attempt to access 
these two aromatic intermediates in our synthesis. Phenol 3.40 was prepared in three 
steps from commercially available arene 3.39 via a sequence involving allyl-ether 
formation, prenylation of the aromatic ring and Claisen rearrangement. Ortho-quinol 
(±)-3.35, our putative precursor to the natural products we classified as type A2 
structures, was prepared via oxidative dearomatisation of phenol 3.40. However, 
ortho-quinol (±)-3.35 underwent facile Cope rearrangement to produce dienone         
(±)-3.38, precursor to type A1 frameworks (scheme 3.49).  
 
*Crude yield. 
Scheme 3.49: Preparation of ortho-quinol (±)-3.35 and dienone (±)-3.38. 
Phenol 3.41 was accessed following a different approach from the same starting 
material. The successful sequence began with phenolic MOM-protection, followed by 
allylation and propargyl-ether formation. Partial reduction of alkyne 3.71 and Claisen 
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rearrangement of the resulting alkene 3.45 then afforded phenol 3.41 in six steps from 
arene 3.39. Oxidative dearomatisation of prenylated phenylpropanoid 3.41 produced 
the corresponding ortho-quinol (±)-3.37, precursor to the type B2 frameworks, 
however, this compound was found to be not stable (scheme 3.50). 
 
Scheme 3.50: Preparation of phenol ortho-quinol (±)-3.37. 
The instability of intermediates (±)-3.35 and (±)-3.37, along with the overall low 
efficiency of the synthetic sequences, especially with regard to the precursor to type 
B2 structures (±)-3.37, lead us to undertake our second biomimetic approach. We 
therefore adopted Danishefsky’s previous synthesis of (±)-illicinone A 1.3 from 
sesamol, discussed in section 3.2.1. This involved a sequence of O-allylation, thermal 
Claisen rearrangement, O-prenylation and MABR-mediated prenyl migration. This 
afforded the alkylative dearomatisation product (±)-illicinone A 1.3 in four steps from 
sesamol (scheme 3.51). 
 
Scheme 3.51: Our synthesis of (±)-illicinone A 1.3. 
(±)-Illicinone A 1.3 possesses a type B2 structure, therefore we started our 
investigation toward the total synthesis of more complex natural products belonging 
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to this group. We prepared (±)-cycloillicinone 1.6 in 4 steps and 28% yield from 
sesamol via a one-pot sequence of migration of the prenyl group on illicinole 3.6 and 
Diels–Alder cycloaddition with the natural occurring terpene β-ocimene (scheme 
3.52). m-CPBA epoxidation of (±)-illicinone A 1.3 produced a 1:1 mixture on 
diastereomeric epoxides illicinone C (±)-3.78 and (±)-epi-illicinone C 3.79. As both 
epoxides are precursors to natural products, this could enable a stereodivergent 
synthesis of our molecular targets. (±)-epi-Illicinone C 3.79 was subjected to a one-
pot epoxide ring-opening/oxa-Michael reaction in different nucleophilic solvents. This 
reaction produced (±)-epi-illicinone E 3.2, (±)-epi-13-O-methylillicinone E 3.87, and 
ethyl-ether (±)-3.83 along with small amounts of (±)-epi-2,3-dehydroillifunone C 3.85 
and related structures (scheme 3.51). We envisage that (±)-illicinone C 3.78 could be 
used to prepare other natural products, epimers of compounds (±)-epi-illcinone 3.2 and 
(±)-3.87 at C11.  
 








3.7 Future Work 
3.7.1 Illicinone E (±)-3.80 and Related Structures 
Future work on this group of natural products will focus on the optimisation of the 
reaction conditions in an attempt to improve yield and selectivity. Furthermore, there 
are other natural products potentially accessible from epoxides (±)-illicinone C 3.78 
and (±)-epi-illicinone C 3.79 under similar reaction conditions (see section 3.5.4). In 
particular, (±)-illicinone E 3.80, (±)-2,3-dehydroillifunone C 3.86 and 13-O-
methylillicinone E 3.81 could be accessed using (±)-illicinone C 3.78 as the starting 
material. Furthermore, the more complex (±)-illioliganfunones A 3.90 and B 3.91 
could be prepared by reacting epoxide (±)-illicinone C 3.78 with allylated sesamol 3.5 
in a non-nucleophilic solvent. Finally, a group of natural products containing the core 
structure of (±)-3.92159 could be accessed in racemic form via hydrogenation of          
(±)-2,3-dehydroillifunone C 3.86 and related frameworks. A selection of targets is 
depicted in figure 3.4. 
 
Figure 3.4: Selection of targets potentially accessible from (±)-illicinone C 3.78. 
It is envisaged that large quantities of epoxide (±)-illicinone C 3.78 will be required to 
investigate and optimise the reaction conditions to selectively access each one of these 
structures. In this regard, priority will be given to the optimisation of the purification 
process used to separate the two diastereomeric epoxides (±)-illicinone C 3.78 and    
(±)-epi-illicinone C 3.79. We propose that preparative HPLC could be a suitable 
method for this purpose. 
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3.7.2 (±)-Spirooliganones A 1.7 and B 3.9 
As discussed in section 3.2.2 on pages 93-96, to date the asymmetric total synthesis 
of (−)-spirooliganones A 1.7 and B 3.9 has been reported three times.138-140 However, 
we aim to exploit our divergent approach by targeting these natural products as well. 
We hypothesise that we could access them as racemates along with two of their 
diastereoisomers (the four stereochemical combinations at C4 and C17) in five steps 
from illicinole 3.6. This could be achieved via initial cleavage of the methylene bridge 
of illicinole 3.6 to produce catechol 3.93. Knoevenagel condensation with 
formaldehyde or a synthetic equivalent would then afford ortho-quinone methide 
intermediate 3.94, which could undergo hetero-Diels–Alder cycloaddition as 
suggested by literature precedent.138-140 This would afford a mixture of epimers at C17, 
which would then be subjected to prenyl group migration (sequence of Claisen–Cope 
rearrangements), generating a new stereocenter at C4. Diastereoselective epoxidation 
of the prenyl side-chain would then produce a mixture of four diastereomeric epoxides, 
which could undergo intramolecular ring-opening upon addition of the hydroxyl group 
at C4 (scheme 3.52). 
Scheme 3.52: Our proposed synthesis of (±)-spirooliganones A 1.7 and B 3.9 and other 
diastereoisomers. 
If successful, this could represent the shortest (seven steps vs. eight, twelve and eleven 
steps)138-140 synthesis of these two natural products and two natural product-like related 
structures. 
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3.7.3 (±)-Illicidione B 3.3 
(−)-Illicidione B 3.3 was isolated in 2011 by Liu and  co-workers from the stem bark 
of Illicium oligandrum.126 We propose we could synthesise it in racemic form from 
the ready accessible (±)-illicinone A 1.3 through initial cleavage of the methylene 
bridge, followed by Knoevenagel condensation of the resulting dienone (±)-3.95 with 
formaldehyde. The so formed dienone (±)-3.96 could then undergo Michael addition 
with another molecule of dienone (±)-3.95 followed by tautomerisation. Finally, 
diastereoselective double epoxidation of bis-ketone (±)-3.97 to install the correct 
relative stereochemistry between C4 and C11 (and C4' and C11') and a final double 
cyclisation would produce (±)-illicidione B 3.3 (scheme 3.53). 
 
Scheme 3.53: Our proposed synthesis of (±)-illicidione B 3.3. 
3.7.4 Type A2 Structures 
We propose that the precursor (±)-3.74 to the type A2 frameworks could be accessed 
in four steps from sesamol. The sequence would mirror the preparation of                     
(±)-illicinone A 1.3 (scheme 3.54). 
 133 
 
Scheme 3.54: Our proposed synthesis of precursor (±)-3.74 to type A2 structures. 
Perhaps the most interesting members of this group are (+)-illicidione A 1.5 and         
(+)-illihendione A 3.23, the first asymmetric total syntheses of which has been reported 
in 2015 by Yu and co-workers (see section 3.2.3 on pages 96-98).141 These syntheses 
were accomplished in eight and nine steps respectively from a known starting material, 
which, however, needed to be prepared in two steps. We envisage there is potential to 
access (±)-illicidione A 1.5 and (±)-illihendione A 3.23 in two steps from precursor 
(±)-3.74, six steps from commercially available sesamol (see section 3.3.4 on page 
104) (scheme 3.55). 
Scheme 3.55: Our proposed synthesis of (±)-illicidione 1.5 and (±)-illihendione 3.23. 
The full picture of all  the prenylated phenylpropanoids isolated to date from Illicium 
plants potentially accessible via our unified strategy can be found in the appendix on 
pages 426-428. The synthesis of all of them would represent a considerable challenge 
and would necessitate huge amounts of time and resources with limited benefits. The 
aim of this project is to demonstrate the power and the generality of our biomimetic 
divergent approach by accessing the most complex and structurally diverse members 
of type A2 and type B2 natural products. Therefore, we reason that accessing the 
molecular targets described in this section would fulfil our aim.  
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4 Experimental Section 
4.1 General Experimental Conditions 
NMR spectra 
1H NMR spectra were recorded at 600 MHz, 500 MHz, and 400 MHz using a Bruker 
AVANCE 600, Bruker AVANCE 500, Bruker PRO 500, Varian INOVA 500 or 
Bruker AVANCE 400 spectrometer. Residual solvent peaks were used as an internal 
reference for 1H NMR spectra (CDCl3 δ 7.26 ppm, (CD3)2CO δ 2.05 ppm, (CD3)2SO 
δ 2.50 ppm). Coupling constants (J) are quoted to the nearest 0.1Hz. Assignment of 
proton signals was assisted by 1H-1H COSY, HSQC, HMBC and NOESY 
experiments. 13C NMR spectra were recorded at 151 MHz, 126 MHz or 100 MHz 
using a Bruker AVANCE 600, Bruker AVANCE 500, Bruker PRO 500, Varian 
INOVA 500 or Bruker AVANCE 400 spectrometer. Solvent peaks were used as an 
internal reference for 13C NMR spectra (CDCl3 δ 77.16 ppm, (CD3)2CO δ 206.13 





IR spectra of solids and liquids were recorded as neat samples on a Shimadzu 




Melting points were measured on a Gallenkamp Melting Point System or a Stanford 




High resolution mass spectra were recorded on a Bruker microTOF instrument using 





Analytical TLC was performed with Merck silica gel plates, precoated with silica gel 
60 F254 (0.2 mm). Visualisation was effected by quenching of UV fluorescence (λmax= 
254 nm) and by staining with p-anisaldehyde or KMnO4 standard TLC stain solutions, 




Flash chromatography employed Merck Kiesegel 60 (230–400 mesh) silica gel. When 
mentioned, the silica gel was pre-neutralised using a 1% solution of trimethylamine in 




Preparative HPLC was conducted on a Shimadzu system using a LC-20AP pump, a 
DGU-20A3R degassing unit, an FRC-10A fraction collector and monitored by an SPD-
20A UV-Vis detector. An ACE-321-2520 C18 preparative column was used.   
 
Experimental procedures, reagents and glassware 
 
Reactions were conducted under a positive pressure of dry argon or nitrogen and the 
glassware was dried with a heat gun. Anhydrous solvents were obtained from 
commercial sources. Commercially available chemicals were used as purchased.  The 
yields reported in this paper are shown as isolated yields unless otherwise stated. We 
provide experimental details for the largest scale procedures conducted (Note: the 
stated scale corresponds to the quantity of product isolated). 
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4.2 Specific Experimental Procedures for Chapter 2 
 
 
Compound 2.24 was prepared using a modified literature procedure.64 
m-Cresol (10.0 mL, 94.7 mmol) was dissolved in anhydrous CH2Cl2 (200 mL).               
i-Pr2NEt (49.5 mL, 284 mmol) was then added at rt. The mixture was cooled to 0 °C 
and MOM-Cl (18.1 mL, 237 mmol) was added dropwise. The mixture was stirred at 0 
°C for 30 min, then allowed to warm to rt and stirred for 11 h. After this time the 
reaction was quenched with sat. aq. NaHCO3 (150 mL), diluted with diethyl ether (200 
mL) and stirred at 0 °C for another 30 min. The mixture was then extracted with diethyl 
ether (3 × 150 mL), the combined organic layers were washed with sat. aq. NH4Cl 
(400 mL), brine (400 mL), 1 M aq. NaOH (400 mL) and dried over anhydrous Na2SO4. 
The solvent was removed under reduced pressure to afford a yellow oil (11.2 g, 73.7 
mmol, 78% yield). The crude material was deemed sufficiently pure (see 1H NMR 
spectrum on page 236) to be used directly in the next step. All data for compound 2.24 
matched literature values.64 
 
Rf 0.61 (70:30 petroleum spirit 40-60 / ethyl acetate); 
1H-NMR (500 MHz, CDCl3) δ 7.18 (apparent t, J = 7.8 Hz, 1H), 6.92-6.85 (m, 3H), 
5.17 (s, 2H), 3.49 (s, 3H), 2.34 (s, 3H) ppm; 





In a 3-necked round bottom flask MOM-protected cresol 2.24 (5.49 g, 36.1 mmol) was 
dissolved in anhydrous hexane (24.0 mL). The solution was cooled to 0 °C then t-BuLi 
(23.3 mL, 39.7 mmol, 1.7 M in pentane) was added slowly. The mixture was stirred at 
0 °C for 3 h then cooled to −78 °C. Ethylene oxide (30.0 mL, 75.8 mmol, 2.5 M in 
THF) and a solution of LiBr (3.45 g, 39.7 mmol) in anhydrous THF (24.0 mL) were 
added and the mixture was allowed to warm to rt and stirred for 1.5 h. The reaction 
was then quenched adding sat. aq. NH4Cl and extracted with diethyl ether (3 × 60 mL). 
The combined organic layers were washed with brine, dried over anhydrous MgSO4 
and the solvent was removed under reduced pressure. Flash chromatography (75:25 
petroleum spirit 40-60 / ethyl acetate) gave alcohol 2.25 as a colourless oil (5.92 g, 




Rf 0.21 (75:25 petroleum spirit 40-60 / ethyl acetate); 
1H-NMR (500 MHz, CDCl3): δ 7.06 (d, J = 7.6 Hz, 1H), 6.93-6.91 (m, 1H), 6.78 (dm, 
J = 7.6, 1H), 5.20 (s, 2H), 3.82 (apparent q, J = 6.3 Hz, 2H), 3.49 (s, 3H), 2.89 (t, J = 
6.6 Hz, 2H), 2.32 (m, 3H), 1.82 (s, broad, 1H) ppm; 
13C-NMR (126 MHz, CDCl3): δ 155.3, 137.9, 130.8, 124.5, 122.6, 115.0, 94.5, 63.0, 
56.2, 33.9, 21.5 ppm; 
HRMS (ESI+) 197.1176, (calculated [M+H]+ 197.1217); 




Alcohol 2.25 (2.38 g, 12.1 mmol) was dissolved in anhydrous CH2Cl2 (28 mL). Et3N 
(10.5 mL, 75.6 mmol), DMSO (5.37 mL, 75.6 mmol) and pyr•SO3 (4.81 g, 30.3 mmol) 
were added at 0 °C. The reaction was allowed to warm to rt and stirred for 2 h.  The 
Eschenmoser salt (2.02 g, 21.8 mmol) was added and the mixture was stirred for 
another 2 h. The reaction was then quenched with sat. aq. CuSO4 (30 mL) and 
extracted with ethyl acetate (3 × 60 mL). The combined organic layers were washed 
with 1 M aq. HCl (150 mL) and brine (150 mL) and then dried over anhydrous Na2SO4. 
The solvent was removed under reduced pressure. Flash chromatography (70:30 to 
50:50 petroleum spirit 40-60 / CH2Cl2) gave enal 2.27 as a pale-yellow oil (1.88 g, 
9.03 mmol, 75% yield).  
 
Rf 0.29 (70:30 petroleum spirit 40-60 / ethyl acetate); 
1H-NMR (500 MHz, CDCl3) δ 9.73 (d, J = 0.6 Hz, 1H), 7.06 (d, J = 7.6 Hz, 1H), 6.99-
6.98 (m, 1H), 6.85 (dm, J = 7.6 Hz, 1H), 6.36 (d, J = 0.9 Hz, 1H), 6.27 (d, J = 0.8 Hz, 
1H), 5.11 (s, 2H), 3.44 (s, 3H), 2.36 (m, 3H) ppm; 
13C-NMR (126 MHz, CDCl3) δ 192.6, 154.7, 147.4, 140.7, 133.8, 130.3, 122.8, 122.2, 
115.5, 94.8, 56.3, 21.7 ppm; 
HRMS (ESI+) 229.0837 (calculated [M+Na]+ 229.0835); 




Enal 2.27 (1.878 g, 9.10 mmol), neat, was placed in a round bottom flask. K2CO3 (570 
mg, 4.12 mmol) was added and the mixture was stirred at 80 °C under an argon 
atmosphere for 22 h. The mixture was then allowed to cool to rt, then diluted with 
CH2Cl2 (100 mL) and filtered through a short pad of celite. The solvent was removed 
under reduced pressure. Flash chromatography using neutralised silica gel (see general 
experimental) (85:15 to 75:25 petroleum spirit 40-60 / diethyl ether) afforded 
dihydropyran dimer (±)-2.28 as a pale-yellow oil (1.45 g, 3.51 mmol, 77% yield). 
 
Rf 0.54 (70:30 petroleum spirit 40-60 / ethyl acetate); 
1H NMR (500 MHz, CDCl3) δ 9.76 (d, J = 0.8 Hz, 1H, H9
Ꞌ), 7.44 (d, J = 7.9 Hz, 1H, 
H5Ꞌ), 7.02 (d, J = 7.7 Hz, 1H, H5), 6.97-6.96 (m, 1H, H2Ꞌ), 6.92-6.91 (m, 1H, H9), 
6.90-6,87 (m, 2H, H2 + H6Ꞌ), 6.78 (dm, J = 7.7 Hz, 1H, H6), 5.20-5.16 (m, 2H, H11 
or H11Ꞌ), 5.13 (s, 2H, H11 or H11Ꞌ), 3.47 (s, 3H, H12 or H12Ꞌ), 3.46 (s, 3H, H12 or 
H12Ꞌ), 2.64-2.57 (m, 1H, H10Ꞌ), 2.55-2.45 (m, 1H, H10), 2.42-2.36 (m, 1H, H10Ꞌ), 2.35 
(s, 3H, H7Ꞌ), 2.32 (s, 3H, H7), 2.29-2.26 (m, 1H, H10) ppm; 
13C NMR (126 MHz, CDCl3) δ 198.6 (C9
Ꞌ), 154.8 (C3), 153.9 (C3Ꞌ), 141.2 (C9), 140.5 
(C1 or C1Ꞌ), 138.0 (C1 or C1Ꞌ), 129.2 (C5), 127.8 (C5Ꞌ), 126.5 (C4), 124.6 (C4Ꞌ), 122.9 
(C6Ꞌ), 122.8 (C6), 116.0 (C2), 115.3 (C2Ꞌ), 113.0 (C8), 94.8 (C11 or C11Ꞌ), 94.5 (C11 
or C11Ꞌ), 82.0 (C8Ꞌ), 56.6 (C12 or C12Ꞌ), 56.3 (C12 or C12Ꞌ), 26.2 (C10Ꞌ), 21.9 (C10), 
21.6 (C7Ꞌ), 21.5 (C7) ppm; 
HRMS (ESI+) 435.1778 (calculated [M+Na]+ 435.1778); 
IR (film, cm-1) 2922, 2653, 2361, 2342, 1724, 1670, 1609. 
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Compound (±)-2.29 was prepared using a modified literature procedure.70 
A solution of oxone (256 mg, 0.42 mmol) in H2O (1.2 mL) was slowly added (25 min) 
to a vigorously stirred solution of dihydropyran (±)-2.28 (57 mg, 0.14 mmol) in 
CH2Cl2 (1.7 mL), sat. aq. NaHCO3 (2.75 mL) and acetone (0.55 mL) at 0 °C. The 
mixture was stirred at 0 °C for 1 h and then allowed to slowly warm to rt and stirred 
for another 6 h. After this time the mixture was transferred into a separating funnel and 
extracted with CH2Cl2 (3 × 4 mL). The combined organic layers were dried over 
anhydrous Na2SO4. Removal of the solvent under reduced pressure afforded of epoxide 
(±)-2.29 as a 1:1 diastereomeric mixture (colourless oil, 45 mg, 0.11 mmol, 76% 
yield). The crude material was deemed sufficiently pure (see 1H NMR spectrum on 
page 244) to be used in the next step.  
 
Rf 0.56 (50:50 petroleum spirit 40-60 / ethyl acetate); 
1H NMR (500 MHz, CDCl3) δ 9.88 (d, J = 1.3 Hz, 1H, H9
Ꞌ†), 9.53 (s, 1H, H9Ꞌ†), 7.60 
(d, J = 7.9 Hz, 1H, H5†), 7.51 (d, J = 8.0 Hz, 1H, H5†), 7.19 (d, J = 7.7 Hz, 1H, H5Ꞌ†), 
7.16 (d, J = 7.7 Hz, 1H, H5Ꞌ†), 6.97-6.96 (m, 1H, H2Ꞌ†), 6.95-6.90 (m, 3H, H6† + H2† + 
H2Ꞌ†), 6.91-6.88 (m, 1H, H6†), 6.88-6.87 (m, 1H, H2†), 6.82-6.78 (m, 2H, H6Ꞌ‡), 5.27-
5.23 (m, 2H, H11† or H11Ꞌ†), 5.17-5.14 (m, 2H, H11† or H11Ꞌ†), 5.13 (s, 2H, H11† or 
H11Ꞌ†), 5.08-4.99 (m, 4H, H11‡ or H11Ꞌ‡, H9‡, H9Ꞌ‡), 3.52 (s, 3H, H12† or H12Ꞌ†), 3.47 
(s, 3H, H12† or H12Ꞌ†), 3.44 (s, 3H, H12† or H12Ꞌ†), 3.36 (s, 3H, H12† or H12Ꞌ†), 2.60-
2.46 (m, 3H, H10‡ or H10Ꞌ‡ + H10† or H10Ꞌ†), 2.37 (s, 3H, H7† or H7Ꞌ†), 2.33 (s, 3H, 
H7† or H7Ꞌ†), 2.33 (s, 3H, H7† or H7Ꞌ†), 2.31 (s, 3H, H7† or H7Ꞌ†), 2.36-1.30 (m, 1H, 
H10† or H10Ꞌ†), 2.29-2.19 (m, 4H, H10‡ or H10Ꞌ‡) ppm; 
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13C NMR (126 MHz, CDCl3) δ 199.5
† (C9Ꞌ), 196.2† (C9Ꞌ), 154.1† (C3 or C3Ꞌ), 154.0† 
(C3 or C3Ꞌ), 154.0† (C3 or C3Ꞌ), 153.6† (C3 or C3Ꞌ), 140.5† (C1), 140.3† (C1), 139.6† 
(C1Ꞌ), 139.6† (C1Ꞌ), 128.5† (C5), 127.6† (C5), 127.4† (C5Ꞌ), 127.3† (C5Ꞌ), 125.6† (C4 or 
C4Ꞌ), 125.5† (C4 or C4Ꞌ), 125.3† (C4 or C4Ꞌ), 123.7† (C4 or C4Ꞌ), 123.2† (C6), 122.7† 
(C6), 122.4‡ (C6Ꞌ), 115.3‡ (C2Ꞌ), 114.3† (C2), 114.1† (C2), 94.5† (C11 or C11Ꞌ), 94.3† 
(C11 or C11Ꞌ), 93.8† (C11 or C11Ꞌ), 93.7† (C11 or C11Ꞌ), 82.4† (C9), 82.4† (C9), 81.3† 
(C8Ꞌ), 81.1† (C8Ꞌ), 60.1† (C8), 59.0† (C8), 56.5† (C12 or C12Ꞌ), 56.5† (C12 or C12Ꞌ), 56.3† 
(C12 or C12Ꞌ), 56.0† (C12 or C12Ꞌ), 26.4† (C10 or C10Ꞌ), 24.8† (C10 or C10Ꞌ), 24.4† (C10 
or C10Ꞌ), 23.5† (C10 or C10Ꞌ), 21.7† (C7 or C7Ꞌ), 21.6† (C7 or C7Ꞌ), 21.5‡ (C7 or C7Ꞌ) 
ppm; 
HRMS (ESI+) 451.1733 (calculated [M+Na]+ 451.1733). 




Compound (±)-2.29 was prepared using a modified literature procedure.72 
Dihydropyran (±)-2.28 (57 mg, 0.13 mmol), Shi lactone (11 mg, 0.04 mmol) and 
(Bu4N)•HSO4 (0.7 mg, 2 µmol) were dissolved in a 2:1 mixture of dimethoxyethane 
and acetonitrile (1.2 mL). An aqueous pH 9.3 buffer (0.75 mL) was added. The mixture 
was cooled to −10 °C, then a solution of Oxone (123 mg, 0.20 mmol) in aq. 
Na2(EDTA) (4 × 10
-3 M, 0.55 mL) and a solution of K2CO3 (107 mg, 0.77 mmol) in 
water (0.55 mL) were added at the same time within 2 h. The reaction was allowed to 
warm to rt and vigorously stirred for another 1.5 h, then CH2Cl2 (2.5 mL) and water 
(2 mL) were added and the aqueous layer was extracted with CH2Cl2 (3 × 5 mL). The 
combined organic layers were washed with brine (15 mL), dried over anhydrous 
Na2SO4 and the solvent was removed under reduced pressure. 
1H NMR analysis of the 




Lactol (±)-2.30 was prepared using a modified literature procedure.73 
Dihydropyran (±)-2.28 (50 mg, 0.12 mmol) was dissolved in a mixture of THF (1.5 
mL), tert-butanol (50 µL) and water (30 µL). The mixture was cooled to 0 °C then N-
methylmorpholine-N-oxide (22 mg, 0.20 mmol) and a catalytic amount of OsO4 (2 
small crystals) were added. The mixture was allowed to warm to rt and stirred for 5 h, 
then the reaction was quenched adding solid Na2S2O5 (80 mg, 0.41 mmol). The 
mixture was stirred for 1 h at rt, filtered through a short pad of silica gel and extracted 
with ethyl acetate (3 × 5 mL). The combined organic layers were washed with brine 
(15 mL), dried over anhydrous Na2SO4 and the solvent was removed under reduced 
pressure. Flash chromatography (70:30 petroleum spirit 40-60 / ethyl acetate) afforded 
lactol (±)-2.30 as a single diastereoisomer (amorphous solid, 19 mg, 0.041 mmol, 35% 
yield). 
 
Rf 0.20 (50:50 petroleum spirit 40-60/ ethyl acetate); 
1H NMR (500 MHz, CDCl3) δ 7.58 (d, J = 7.8 Hz, 1H, H5
Ꞌ), 7.34 (d, J = 7.9 Hz, 1H, 
H5), 6.99 (s, 1H, H2), 6.95 (s, 1H, H2Ꞌ), 6.87 (d, J = 7.7 Hz, 1H, H6Ꞌ), 6.85 (d, J = 8.1 
Hz, 1H, H6), 5.96 (d, J = 1.4 Hz, 1H, H9), 5.73 (d, J = 10.5 Hz, 1H, H9Ꞌ), 5.38-5.25 
(m, 2H, H11 or H11Ꞌ), 5.25-5.11 (m, 2H, H11 or H11Ꞌ), 4.23 (broad s, 1H, OH at C9Ꞌ), 
3.51 (s, 3H, H12 or H12Ꞌ), 3.51 (s, 3H, H12 or H12Ꞌ), 2.45-2.34 (m, 2H, H10 and H10Ꞌ), 
2.35 (s, 3H, H7 or H7Ꞌ), 2.33 (s, 3H, H7 or H7Ꞌ), 2.15-2.02 (m, 2H, H10 and H10Ꞌ) ppm; 
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13C NMR (126 MHz, CDCl3) δ 155.4 (3C), 152.9 (C3
Ꞌ), 139.5 (C1 or C1Ꞌ), 139.4 (C1 
or C1Ꞌ), 127.9 (C4), 127.3 (C5), 126.9 (C5Ꞌ), 125.6 (C4Ꞌ), 123.0 (C6), 122.6 (C6Ꞌ), 115.5 
(C2), 114.7 (C2Ꞌ), 103.5 (C9), 96.8 (C9Ꞌ), 94.7 (C11 or C11Ꞌ), 94.6 (C11 or C11Ꞌ), 86.0 
(C8Ꞌ), 72.2 (C8), 56.7 (C12 or C12Ꞌ), 56.4 (C12 or C12Ꞌ), 28.5 (C10), 28.4 (C10Ꞌ), 21.6 
(C7 or C7Ꞌ), 21.4 (C7 or C7Ꞌ) ppm; 
HRMS (ESI+) 469.1833 (calculated [M+Na]+ 469.18330); 
IR (film, cm-1) 3402 (broad), 2934, 1614, 1578, 1508; 





Bis-lactone 2.31 was prepared using a modified literature procedure.66 
The crude diastereomeric mixture of epoxide (±)-2.29 (45 mg, 0.11 mmol) was 
dissolved in 1:1 mixture of anhydrous CH2Cl2 and CH3CN (2.8 mL) at rt. The solution 
was cooled to 0 °C, then TMSCl (94 µL, 1.05 mmol) and NaI (112 mg, 1.05 mmol) 
were added.  The mixture was stirred at 0 °C for 20 min, then quenched with sat. aq. 
Na2S2O3 (5 mL), extracted with ethyl acetate (3 × 4 mL). The combined organic layers 
were washed with water (10 mL) and brine (10 mL), dried over anhydrous Na2SO4 
and the solvent was removed under reduced pressure. Flash chromatography (75:25 
petroleum spirit 40-60 / diethyl ether) afforded bis-lactone 2.31 as a 1:1 mixture of 
diastereoisomers (colourless oil, 29 mg, 86% yield) (see 1H NMR spectrum on page 
248). Recrystallisation from petroleum spirit 40-60 / ethyl acetate gave meso-bis-
lactone 2.31 as a single diastereoisomer (white solid, 12 mg, 36% yield) (CCDC 
1530570) (see page 423 for X-ray crystal structure).  
 
Rf 0.56 (75:25 petroleum spirit 40-60 / diethyl ether); 
1H NMR (500 MHz, CDCl3) δ 7.14-7.12 (m, 2H), 7.02-6.94 (m, 2H), 6.93 (m, 2H), 
3.75-3.60 (m, 2H), 2.39-2.38 (m, 6H), 2.13-1.91 (m, 4H) ppm; 
13C NMR (126 MHz, CDCl3) δ 177.1, 154.0, 139.8, 125.2, 124.0, 123.4, 111.6, 43.1, 
27.2, 21.8 ppm; 
HRMS (ESI+) 323.1263 (calculated [M+H]+ 323.1278); 




MOM-protected dihydropyran (±)-2.28 (332 mg, 0.806 mmol) was dissolved in 
methanol (12 mL). 12 M aq. HCl (130 µL) was added and the mixture was stirred at 
rt for 20 h. After complete consumption of starting material, judged by TLC analysis 
(20 h), the reaction was quenched by adding sat. aq. NaHCO3 (5.0 mL) and extracted 
with CH2Cl2 (5 × 10 mL). The organic layers were dried over anhydrous Na2SO4. Flash 
chromatography (80:20 petroleum spirit 40-60 / ethyl acetate) gave compound            
(±)-2.36 as a 1:1 mixture of diastereoisomers (pale yellow oil, 273 mg, 0.744 mmol, 
92% yield). 
  
Rf 0.37 (70:30 petroleum spirit 40-60 / ethyl acetate); 
1H NMR (500 MHz, CDCl3) δ 7.41 (s, broad, 2H, OH at C18
‡), 7.02 (d, J = 7.5 Hz, 
2H, H5‡), 6.97 (d, J = 7.6 Hz, 1H, H14†), 6.95 (d, J = 7.6 Hz, 1H, H14†), 6.72-6.67 (m, 
8H, H2‡ + H6‡ + H15‡ + H17‡), 5.26 (d, J = 1.9 Hz, 1H, H9†), 5.22 (d, J = 1.9 Hz, 1H, 
H9†), 3.76-3.71 (m, 2H, H12‡), 3.73 (s, 6H, H21‡), 3.51 (s, 3H, H22†), 3.50 (s, 3H, 
H22†), 3.13-3.10 (m, 2H, H8‡), 2.32 (s, 3H, H7†), 2.31 (s, 3H, H7†), 2.28 (s, 6H, H19‡), 
2.25-2.14 (m, 2H, H10Ꞌ‡), 2.06-1.94 (m, 2H, H10ꞋꞋ‡), 1.60-1.43 (m, 4H, H11‡) ppm; 
13C NMR (126 MHz, CDCl3: δ 177.0 (C20
†), 176.9 (C20†), 158.1 (C3‡), 154.6 (C18†), 
154.5 (C18†), 139.4 (C16†), 139.3 (C16†), 138.7 (C1†), 138.6 (C1†), 129.9 (C14†), 
129.8 (C14†), 126.3 (C4‡), 124.3 (C5‡), 121.8 (CAr†), 121.7 (CAr†), 121.0 (C13†), 
120.8 (C13†), 118.6 (CAr†), 118.5 (CAr†), 112.4 (C9‡), 110.8 (CAr‡), 55.9 (C22‡), 52.7 
(C21‡), 48.3 (C12‡), 48.2 (C8‡), 31.4 (C11†), 31.3 (C11†), 28.7 (C10†), 28.5 (C10†), 
21.6 (C7‡), 21.1 (C19‡) ppm;  
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IR (film, cm-1) 3404, 2949, 2924, 1732, 1707, 1620, 1591; 
HRMS (ESI+) 393.1681 (calculated [M+Na]+ 393.1673). 




n-BuLi (2.5 M in hexanes, 146 µL, 0.36 mmol) was added dropwise at 0 °C to a 
suspension of methyltriphenylphosphonium bromide (133 mg, 0.36 mmol) in 
anhydrous THF (12 mL) and the mixture was stirred at the same temperature for 1 h. 
A solution of aldehyde (±)-2.28 (100 mg, 0.24 mmol) in anhydrous THF (2 mL) was 
then added at 0 °C and the mixture was stirred for another 2 h. The reaction was then 
quenched with sat. aq. NH4Cl (2 mL), then diethyl ether (5 mL) and water (2 mL) were 
added.  The mixture was extracted with diethyl ether (3 × 15 mL) and the combined 
organic layers were washed with water (15 mL), brine (15 mL) and dried over 
anhydrous Na2SO4. The solvent was removed under reduced pressure. Flash 
chromatography (75:25 petroleum spirit 40-60 / diethyl ether) gave compound           
(±)-2.38 as a pale-yellow oil (14 mg, 33 µmol, 14% yield) as well as recovered starting 
material (±)-2.28 (9 mg, 22 µmol, 9% yield). 
 
Rf 0.37 (75:25 petroleum spirit 40-60 / diethyl ether); 
1H NMR (500 MHz, CDCl3) δ 7.42 (d, J = 7.9 Hz, 1H, H5
Ꞌ), 6.99 (d, J = 7.7 Hz, 1H, 
H5), 6.95-6.93 (m, 1H, H2Ꞌ), 6.92-6.91 (m, 1H, H2), 6.87 – 6.83 (m, 1H, H9), 6.81-
6.79 (dm, J = 8.0 Hz 1H, H6Ꞌ), 6.76-6.75 (dm, J = 7.8 Hz, 1H, H6), 6.38 (dd, J = 17.2, 
10.7 Hz, 1H, H9Ꞌ), 5.30 (dd, J = 17.3, 1.5 Hz, 1H, H13), 5.21 (s, 2H, H11Ꞌ), 5.11 (dd, 
J = 6.5 Hz, 1H, H13), 5.06 (q, J = 6.5 Hz, 2H, H11), 3.50 (s, 3H, H12), 3.42 (s, 3H, 
H12Ꞌ), 2.66 – 2.61 (m, 1H, H10), 2.32 (s, 3H, H7Ꞌ), 2.30 (s, 3H, H7), 2.29 – 2.23 (m, 
2H, H10 + H10Ꞌ), 2.14 – 2.04 (m, 1H, H10Ꞌ) ppm; 
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13C NMR (126 MHz, CDCl3) δ 154.7 (C3), 153.6 (C3
Ꞌ), 141.3 (C9), 140.2 (C9Ꞌ), 138.6 
(C1), 137.3 (C1Ꞌ), 129.0 (C5), 128.4 (C4Ꞌ), 127.5 (C4), 127.4 (C5Ꞌ), 122.8 (C6Ꞌ), 122.5 
(C6), 116.4 (C2Ꞌ), 115.3 (C2), 113.5 (C13), 111.9 (C8), 94.9 (C11), 94.4 (C11Ꞌ), 79.6 
(C8Ꞌ), 56.4 (C12 or C12Ꞌ), 56.2 (C12 or C12Ꞌ), 30.4 (C10Ꞌ), 22.6 (C10), 21.4 (C7 or C7Ꞌ), 
21.4 (C7 or C7Ꞌ) ppm; 
HRMS (ESI+) 411.2157, 433.1993 (calculated [M+H]+ 411.2166, [M+Na]+ 
433.1985); 




MOM-protected enal 2.28 (211 mg, 1.02 mmol) was dissolved in methanol (7.0 mL). 
12 M aq. HCl (128 µL, 1.5 mmol) was added and the mixture was stirred at rt until 
complete consumption of the starting material, judged by TLC analysis (11 h). The 
reaction was then quenched by adding sat. aq. NaHCO3 (4 mL) and the mixture was 
extracted with CH2Cl2 (5 ×8 mL). The organic layers were dried over anhydrous 
Na2SO4 and the solvent was removed under reduced pressure. Flash chromatography 
(90:10 petroleum spirit 40-60 / ethyl acetate) gave acetal (±)-2.39 as a colourless oil 
(71 mg, 0.40 mmol, 40% yield) and bis-acetal 2.40 as a colourless oil (47 mg, 0.19 
mmol, 18% yield). 
All data for compound 2.39 matched literature values.55 
 
Rf 0.44 (90:10 petroleum spirit 40-60 / ethyl acetate); 
1H NMR (500 MHz, CDCl3) δ 7.28 (d, J = 7.7 Hz, 1H), 6.74 (d, J = 7.7, 1H), 6.71 (d, 
J = 0.7 Hz, 1H), 5.97 (apparent t, J = 1.9 Hz, 1H), 5.62 (d, J = 2.1 Hz, 1H), 5.27 (d, J 
= 1.7 Hz, 1H), 3.51 (s, 3H), 2.34 (s, 3H) ppm; 
13C NMR (126 MHz, CDCl3) δ 161.4, 143.2, 141.6, 122.2, 121.8, 120.8, 111.1, 107.5, 




Rf 0.30 (90:10 petroleum spirit 40-60 / ethyl acetate); 
1H NMR (500 MHz, CDCl3) δ 7.11 (d, J = 7.7 Hz, 1H), 7.00-6.88 (m, 1H), 6.80 (ddd, 
J = 7.5, 1.6, 0.8 Hz, 1H), 5.80-5.47 (m, 1H), 5.34 (apparent q, J = 0.9 Hz, 2H), 5.16 
(s, 2H), 3.48 (s, 3H), 3.32 (s, 6H), 2.33 (d, J = 0.7 Hz, 3H) ppm; 
13C NMR (126 MHz, CDCl3) δ 154.3, 144.1, 139.1, 130.3, 127.1, 122.8, 117.7, 115.5, 
102.5, 94.8, 56.2, 52.9 (2C), 21.6 ppm; 
HRMS (ESI+) 275.1238 (calculated [M+Na]+ 275.1269); 




MOM-protected alcohol 2.25 (2.62 g, 13.4 mmol) was dissolved in a 4:1 mixture of 
methanol and CH2Cl2 (60 mL). 6 M aq. HCl (10 mL) was added and the mixture was 
stirred at rt for 32 h. Upon completion of the reaction, judged by TLC analysis, the 
mixture was diluted with water (60 mL) and extracted with CH2Cl2 (4 × 60 mL).  The 
combined organic layers were washed with sat. aq. NaHCO3 (150 mL) and dried over 
anhydrous Na2SO4. Removal of the solvent under reduced pressure afforded diol 2.41 
as a white crystalline solid (1.98 g, 12.3 mmol, 97% yield). The crude material was 
deemed sufficiently pure (see 1H-NMR spectrum on page 259) to be used directly in 
the next step. 
 
Rf 0.37 (50:50 petroleum spirit 40-60 / ethyl acetate); 
1H-NMR (500 MHz, CDCl3) δ 6.94 (d, J = 7.6 Hz, 1H), 6.73 (d, J = 1.6 Hz, 1H), 6.70-
6.59 (m, 1H), 4.97 (s, broad, 1H+1H), 4.05-3.83 (m, 2H), 2.94-2.69 (m, 2H), 2.28 (s, 
3H) ppm; 
13C-NMR (126 MHz, CDCl3) δ 155.2, 138.5, 130.9, 123.6, 121.4, 117.7, 64.9, 34.3, 
21.1 ppm; 
HRMS (ESI+) 153.0851, 175.0748 (calculated [M+H]+ 153.0910, [M+Na]+ 
175.0730); 
IR (film, cm-1) 3412, 3393, 2951, 2938, 2886, 1628; 




Alcohol 2.41 (189 mg, 1.24 mmol) was dissolved in anhydrous CH2Cl2 (8 mL).  Et3N 
(1.08 mL, 7.75 mmol), DMSO (0.55 mL, 7.75 mmol) and pyr•SO3 (459 mg, 3.11 
mmol) were added at 0 °C. The mixture was stirred at rt. After complete consumption 
of the starting material, judged by TLC analysis (30 min), a 3 mL aliquot of crude 
reaction mixture was submitted to the work up detailed below. To the remaining crude 
reaction mixture, the Eschenmoser salt (148 mg, 1.59 mmol) was added and the 
mixture was stirred for another 2.5 h. The reaction was then quenched with sat. aq. 
CuSO4 (8 mL) and the mixture was extracted with ethyl acetate (3 × 10 mL).  The 
combined organic layers were washed with 1 M aq. HCl and brine and then dried over 
an. Na2SO4 and the solvent was removed under reduced pressure. Flash 
chromatography of the first aliquot (80:20 petroleum spirit 40-60 / ethyl acetate) gave 
compound (±)-2.42 as a white solid (6 mg, 35 µmol, 16% yield based on the aliquot 
worked up). 
 
Rf 0.45 (70:30 petroleum spirit 40-60 / ethyl acetate); 
1H-NMR (500 MHz, CDCl3) δ 7.08 (d, J = 7.4 Hz, 1H, H5
Ꞌ), 6.95 (d, J = 7.5 Hz, 1H, 
H5), 6.88 (s, 1H, OH at C3), 6.80-6.70 (m, 1H, H6Ꞌ), 6.69 (d, J = 1.6 Hz, 1H, H2Ꞌ), 
6.68-6.65 (m, 2H, H2 + H6), 5.68 (dd, J = 6.6, 2.0 Hz, 1H, H9), 4.24 (ddd, J = 9.2, 
5.8, 3.7 Hz, 1H, H9Ꞌ), 3.75 (apparent td, J = 9.2, 3.1 Hz, 1H, H9Ꞌ), 3.32 (dm, J = 16.7, 
Hz, 1H, H8), 3.02 (dm, J = 16.7, 1H, H8), 2.94 (ddd, J = 15.1, 9.4, 3.7 Hz, 1H, H8Ꞌ), 
2.78 (ddd, J = 15.1, 5.8, 3.1 Hz, 1H, H8Ꞌ), 2.32 (s, 3H, H7), 2.28 (s, 3H, H7Ꞌ) ppm; 
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13C-NMR (126 MHz, CDCl3) δ 158.2 (C3), 155.3 (C3
Ꞌ), 138.7 (C1 or C1Ꞌ), 138.6 (C1 
or C1Ꞌ), 130.9 (C5), 124.7 (C5Ꞌ), 123.3 (C4Ꞌ), 122.3 (C6Ꞌ), 121.8 (C4), 121.5 (C6), 117.8 
(C2Ꞌ), 110.8 (C2), 106.4 (C9), 70.6 (C9Ꞌ), 36.8 (C8), 32.2 (C8Ꞌ), 21.8 (C7), 21.3 (C7Ꞌ) 
ppm; 
IR (film, cm-1) 3352, 2928, 2160, 2029, 1624, 1578; 
HRMS (ESI+) 307.1320 (calculated [M+Na]+ 307.1305); 




Flash chromatography of the second aliquot (85:15 petroleum spirit 40-60 / ethyl 
acetate) gave compound 2.1 as a white solid (17 mg, 105 µmol, 14% yield). All data 
for compound (±)-2.1 matched the available literature values.55 
 
Rf 0.45 (70:30 petroleum spirit 40-60 / ethyl acetate); 
1H-NMR (500 MHz, CDCl3) δ 7.26 (s, 1H), 6.76 (ddd, J = 7.7, 1.5, 0.8 Hz, 1H), 6.71 




Carbamate 2.43 was prepared using a modified literature procedure.160 
m-Cresol (4.84 mL, 45.8 mmol) was dissolved in anhydrous acetonitrile (300 mL) at 
rt. The solution was cooled to 0 °C and K2CO3 (127 g, 920 mmol) was added as a solid 
followed by dropwise addition of N,N-diethylcarbamoyl chloride (6.59 mL, 50.4 
mmol). The mixture was warmed to 85 °C and stirred until complete consumption of 
the starting material, judged by TLC analysis (24 h). Then the reaction mixture was 
cooled to 0 °C, diluted with water (420 mL) and the mixture was extracted with diethyl 
ether (3 × 50 mL). The organic layer was washed with 1 M aq. NaOH (100 mL), water 
(100 mL) and brine (100 mL), then dried over anhydrous MgSO4 and the solvent was 
removed under reduced pressure. Flash chromatography (90:10 petroleum spirit 40-60 
/ ethyl acetate) gave carbamate 2.43 as a colourless oil (8.65 g, 417 mmol, 91% yield). 
All data for compound 2.43 matched literature values.160 
 
Rf 0.35 (90:10 petroleum spirit 40-60 / ethyl acetate); 
1H NMR (500 MHz, CDCl3) δ 7.23 (t, J = 7.0 Hz, 1H), 6.99 (d, J = 7.6 Hz, 1H), 
6.95 (d, J = 1.8 Hz, 1H), 6.92 (dd, J = 8.1, 2.3 Hz, 1H), 3.46-3.37 (m, 4H), 2.35 (s, 
3H), 1.25 (t, J = 7.3 Hz, 3H), 1.20 (t, J = 7.3 Hz, 3H) ppm; 
13C NMR (126 MHz, CDCl3) δ 154.5, 151.6, 139.4, 129.0, 126.0, 122.5, 118.8, 42.3, 




Carbamate protected phenol 2.43 (209 mg, 1.01 mmol) was dissolved in anhydrous 
THF (4 mL). The solution was cooled to −78 °C then TMEDA (167 µL, 1.11 mmol) 
was added. A solution of s-BuLi (1.4 M in hexane, 0.79 mL, 1.11 mmol) was added 
dropwise and the mixture was stirred at −78 °C for 1 h. Then ethylene oxide (2.5 M in 
THF 0.81 mL, 2.02 mmol) and a solution of LiBr (96 mg, 1.11 mmol) in anhydrous 
THF (1 mL) were added. The mixture was stirred at −78 °C for 3.5 h then the reaction 
was quenched with sat. aq. NH4Cl (5 mL) and extracted with diethyl ether (3 × 8 mL). 
The combined organic layers were washed with brine (20 mL), dried over anhydrous 
Na2SO4 and the solvent was removed under reduced pressure. Flash chromatography 
(80:20 petroleum spirit 40-60 / ethyl acetate) gave phenol 2.45 as a pale-yellow oil (67 
mg, 0.33 mmol, 32% yield). 
All data for compound 2.45 matched literature values.161 
 
 
Rf 0.08 (90:10 petroleum spirit 40-60/ ethyl acetate); 
1H NMR (500 MHz, CDCl3) δ 9.95 (s, 1H), 7.16 (d, J = 7.9 Hz, 1H), 6.81 (dd, J = 1.7, 
0.8 Hz, 1H), 6.65 (ddd, J = 8.0, 1.8, 0.7 Hz, 1H), 3.52 (q, J = 7.1 Hz, 4H), 2.32 (s, 3H), 
1.27 (t, J = 7.1 Hz, 6H) ppm; 
13C NMR (126 MHz, CDCl3) δ 171.8, 159.3, 143.3, 127.3, 119.5, 118.5, 115.2, 42.3, 





TBSCl (990 mg, 6.57 mmol) and imidazole (447 mg, 6.57 mmol) were dissolved in 
anhydrous THF (8.0 mL). Alcohol 2.41 (400 mg, 2.63 mmol) was added as a solid and 
the reaction was stirred at rt for 80 h. Then the mixture was diluted with water (15 mL) 
and extracted with diethyl ether (3 × 10 mL). The combined organic layers were 
washed with brine (20 mL) and water (20 mL), dried over anhydrous Na2SO4 and the 
solvent was removed under reduced pressure. Flash chromatography (95:5 petroleum 
spirit 40-60 / ethyl acetate) afforded compound 2.51 as a colourless oil (954 mg, 2.50 
mmol, 95% yield). 
 
Rf 0.61 (95:5 petroleum spirit 40-60 / ethyl acetate); 
1H NMR (500 MHz, CDCl3) δ 7.04 (dd, J = 7.7, 0.9 Hz, 1H), 6.69 (d, , J = 7.7 Hz, 
1H), 6.60 (s, 1H), 3.75 (td, J = 7.4, 1.1 Hz, 2H), 2.80 (t, J = 7.4 Hz, 2H), 2.27 (s, 3H), 
1.02 (d, J = 1.1 Hz, 9H), 0.88 (s, 9H), 0.24 (d, J = 1.1 Hz, 6H), -0.01 (d, J = 1.1 Hz, 
6H) ppm; 
13C NMR (126 MHz, CDCl3) δ 153.8, 137.1, 131.1, 126.4, 121.7, 119.3, 63.4, 34.1, 
26.1 (3C), 26.0 (3C), 21.3, 18.5, 18.4, −3.9 (2C), −5.2 (2C) ppm; 
IR (film, cm-1) 2955, 2928, 2857, 1614, 1578; 




Compound 2.51 (467 mg, 1.23 mmol) was dissolved in anhydrous methanol (8.0 mL). 
I2 (29 mg, 0.12 mmol) was added as a solid at rt. The mixture was stirred at rt for 3 h 
then the reaction was quenched by adding a 10% w/w aq. Na2S2O4 (5 mL). The 
methanol was removed under reduced pressure and the residue was taken up in diethyl 
ether. The organic layer was washed with brine and dried over anhydrous Na2SO4. 
Removal of the solvent under reduced pressure gave compound 2.49 as a colourless 
oil (301 mg, 1.13 mmol, 92% yield). The crude material was deemed sufficiently pure 
(see 1H and spectrum on page 272) to be used directly in the next step.  
 
Rf 0.12 (95:5 petroleum spirit 40-60 / ethyl acetate); 
1H NMR (500 MHz, CDCl3) δ 7.04 (d, J = 7.5 Hz, 1H), 6.72 (dm, J = 7.6 Hz, 1H), 
6.63-6.62 (m, 1H), 3.80 (t, J = 6.5 Hz, 2H), 2.84 (t, J = 6.5 Hz, 2H), 2.28 (m, 3H), 1.02 
(s, 9H), 0.25 (s, 6H) ppm; 
13C NMR (126 MHz, CDCl3) δ 153.9, 137.6, 130.9, 126.0, 122.1, 119.6, 63.1, 34.0, 
25.9 (3C), 21.3, 18.4, −4.0 (2C) ppm;  
IR (film, cm-1) 3347 (broad), 2955, 2928, 2856, 1612, 1576; 




Alcohol 2.49 (311 mg, 1.17 mmol) was dissolved in anhydrous CH2Cl2 (7 mL). Et3N 
(1.02 mL, 7.31 mmol), DMSO (519 µL, 7.31 mmol) and pyr•SO3 (465 mg, 2.92 mmol) 
were added at 0 °C. The mixture was stirred at rt until complete consumption of the 
starting material, judged by TLC analysis (2.5 h), then the Eschenmoser salt (196 mg, 
2.11 mmol) was added. The mixture was stirred at rt for another 2.5 h, then the reaction 
was quenched by adding sat. aq. CuSO4 (8.0 mL). The mixture was extracted with 
ethyl acetate (3 × 10 mL), the combined organic layers were washed with 1 M aq. HCl 
(20 mL) and brine (20 mL) and dried over anhydrous Na2SO4. The solvent was 
removed under reduced pressure. Flash chromatography (85:15 petroleum spirit 40-60 
/ ethyl acetate) afforded enal 2.47 as a pale-yellow oil (166 mg, 0.53 mmol, 46% yield). 
 
Rf 0.59 (70:30 petroleum spirit 40-60 / ethyl acetate); 
1H NMR (500 MHz, CDCl3) δ 9.71 (s, 1H), 7.05 (d, J = 7.6 Hz, 1H), 6.80 (dm, J = 
7.7 Hz, 1H), 6.68 (m, 1H), 6.33 (d, J = 1.3 Hz, 1H), 6.27 (d, J = 1.3 Hz, 1H), 2.32 (m, 
3H), 0.92 (s, 9H), 0.16 (s, 6H) ppm; 
13C NMR (126 MHz, CDCl3) δ 192.9, 153.1, 147.4, 140.1, 133.6, 130.6, 123.8, 122.2, 
120.1, 25.9 (3C), 21.5, 18.2, −4.0 (2C) ppm; 
IR (film, cm-1) 2955, 2928, 2857, 1742, 1611; 




K2CO3 (69 mg, 0.50 mmol) was added to neat enal monomer 2.47 (87 mg, 0.33 mmol). 
The mixture was stirred at 100 °C for 32 h., then diluted with CH2Cl2 (10 mL) and 
filtered. The solvent was removed under reduced pressure. Flash chromatography 
(96:4 to 90:10 petroleum spirit 40-60 / diethyl ether) gave aldehyde (±)-2.52 as a pale-
yellow oil (18 mg, 34 µmol, 21% yield) and side product (±)-2.53 as a 67:33 mixture 
of diastereoisomers (pale yellow oil, 15 mg, 28 µmol, 17% yield). 
 
Rf 0.30 (95:5 petroleum spirit 40-60 / diethyl ether); 
1H NMR (500 MHz, CDCl3) δ 9.81 (d, J = 0.7 Hz, 1H, H9
Ꞌ), 7.37 (d, J = 7.9 Hz, 1H, 
H5Ꞌ), 6.97 (d, J = 7.7 Hz, 1H, H5), 6.83-6.82 (m, 1H, H9), 6.80 (dm, J = 7.9 Hz, 1H, 
H6Ꞌ), 6.71 (dm, J = 7.7 Hz, 1H, H6), 6.68-6.66 (m, 1H, H2Ꞌ), 6.61-6.60 (m, 1H, H2), 
2.50 (m, 1H, H10Ꞌ), 2.48-2.39 (m, 1H, H10), 2.38-2.32 (m, 2H , H10 + H10Ꞌ), 2.30 (s, 
3H, H7Ꞌ), 2.27 (s, 3H, H7), 1.02 (s, 9H, H13 or H13Ꞌ), 0.97 (s, 9H, H13 or H13Ꞌ), 0.32 
(s, 3H, 6.8Hz, H11 or H11Ꞌ), 0.31 (s, 3H, H11 or H11Ꞌ), 0.19 (s, 3H, 7.9 HZ?, H11 or 
H11Ꞌ), 0.17 (s, 3H, H11 or H11Ꞌ) ppm; 
13C NMR (126 MHz, CDCl3) δ 199.3 (C9
Ꞌ), 153.2 (C3), 152.9 (C3Ꞌ), 141.2 (C2), 139.9 
(C1Ꞌ), 137.5 (C1), 129.7 (C5), 128.1 (C4), 127.9 (C5Ꞌ), 126.3 (C4Ꞌ), 122.1 (C6Ꞌ), 121.9 
(C6), 120.7 (H2), 119.5 (C2Ꞌ), 113.2 (C8), 81.9 (C8Ꞌ), 26.2 (3C, C13 or C13Ꞌ), 26.1 
(C10Ꞌ), 26.0 (3C, C13 or C13Ꞌ), 21.8 (C10), 21.4 (C7Ꞌ), 21.3 (C7), 18.8 (C12 or C12Ꞌ), 
18.5 (C12 or C12Ꞌ), −3.6 (C11 or C11Ꞌ), −3.9 (C11 or C11Ꞌ), −4.0 (C11 or C11Ꞌ), −4.0 
(C11 or C11Ꞌ) ppm; 
IR (film, cm-1) 2953, 2928, 2857, 1740, 1611; 
HRMS (ESI+) 553.3168 (calculated [M+H]+ 553.3164). 
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Rf 0.39 (95/5 petroleum spirit 40-60 / diethyl ether); 
1H-NMR (500 MHz, CDCl3) δ 7.20 (d, J = 7.6 Hz, 1H, H5
Ꞌ†), 7.17 (d, J = 7.6 Hz, 1H, 
H5Ꞌ‡), 7.02 (d, J = 7.6 Hz, 1H, H5†), 7.01 (d, J = 7.6 Hz, 1H, H5‡), 6.78 (dm, J = 7.6 
Hz, 1H, H6Ꞌ†), 6.78-6.71 (m, 4H, H6† + H6‡, H6Ꞌ‡, H2Ꞌ‡), 6.71-6.70 (m, 1H, H2Ꞌ†), 6.66-
6.65 (m, 1H, H2‡), 6.64 (m, 2H, H2† + H9‡), 6.60 (d, J = 1.7 Hz, 1H, H9†), 5.76 (s, 
1H, H9Ꞌ†), 5.56 (s, 1H, H9Ꞌ‡), 2.64-2.44 (m, 4H, H10Ꞌ† + H10Ꞌ‡), 2.35 (s, 3H, H7Ꞌ†), 2.33 
(s, 3H, H7Ꞌ‡), 2.29 (s, 6H, H7† + H7‡), 2.27-2.21 (m, 2H, H10Ꞌ†), 2.19-2.12 (m, 1H, 
H10Ꞌ‡), 1.97 (ddd, J = 13.7, 5.8, 4.5 Hz, 1H, H10Ꞌ‡), 1.02 (s, 9H, H13‡ or H13Ꞌ‡), 1.01 
(s, 9H, H13† or H13Ꞌ†), 0.92 (s, 9H, H13‡ or H13Ꞌ‡), 0.89 (s, 9H, H13† or H13Ꞌ†), 0.22 
(s, 3H, H11‡ or H 11Ꞌ‡), 0.21 (s, 6H, H11† or H 11Ꞌ† + H11‡ or H 11Ꞌ‡), 0.21 (s, 3H, 
H11† or H 11Ꞌ†), 0.19 (s, 3H, H11† or H 11Ꞌ†), 0.18 (s, 3H, H11‡ or H 11Ꞌ‡), 0.15 (s, 3H, 
H11‡ or H 11Ꞌ‡), 0.14 (s, 3H, H11† or H 11Ꞌ†) ppm; 
13C-NMR (126 MHz, CDCl3) δ 159.5
† (C3Ꞌ), 157.6‡ (C3Ꞌ), 153.2† (C3), 153.2‡ (C3), 
142.9‡ (C9), 141.6† (C9), 141.4† (C1Ꞌ), 140.7‡ (C1Ꞌ), 137.5† (C1), 137.3‡ (C1), 129.8 
(1C† + 1C‡, C5), 129.5‡ (C4), 128.4† (C4), 126.8‡ (C4Ꞌ), 126.3† (C4Ꞌ), 124.1 (1C† + 1C‡, 
C5Ꞌ), 122.2† (C6 or C6Ꞌ), 122.2‡ (C6 or C6Ꞌ), 122.1† (C6 or C6Ꞌ), 122.1‡ (C6 or C6Ꞌ), 
120.8† (C2), 120.8‡ (C2), 112.4† (C8Ꞌ), 111.4† (C2Ꞌ), 111.1‡ (C2Ꞌ), 110.4‡ (C8Ꞌ), 105.7† 
(C9Ꞌ), 105.6‡ (C9Ꞌ), 84.3† (C8Ꞌ), 80.5‡ (C8Ꞌ), 30.2‡ (C10Ꞌ), 26.07 (3C‡, C13 or C13Ꞌ), 26.04 
(3C†, C13 or C13Ꞌ), 25.9 (3C† + 3C‡, C13 or C13Ꞌ), 24.2† (C10Ꞌ), 22.1† (C10), 21.9† (C7 
or C7Ꞌ), 21.8‡ (C10), 21.3‡ (C7 or C7Ꞌ), 21.3 (1C† + 1C‡, (C7 or C7Ꞌ), 18.5‡ (C12 or 
C12Ꞌ), 18.5† (C12 or C12Ꞌ), 18.3‡ (C12 or C12Ꞌ), 18.1† (C12 or C12Ꞌ), −3.9‡ (C11 or 
C11Ꞌ), −3.9† (C11 or C11Ꞌ), −3.9† (C11 or C11Ꞌ), −4.0† (C11 or C11Ꞌ), −4.0‡ (C11 or 
C11Ꞌ), −4.1‡ (C11 or C11Ꞌ), −4.6‡ (C11 or C11Ꞌ), −5.1† (C11 or C11Ꞌ) ppm; 
IR (film, cm-1) 2953, 2928, 2886, 2857, 1754, 1611; 
HRMS (ESI+) 553.3169 (calculated [M+H]+ 553.3169). 
† Major diastereoisomer, ‡ minor diastereoisomer. 
 162 
 
A solution of triazolopyridine 2.54 (88 mg, 0.53 mmol) in anhydrous THF (1 mL) was 
added to a stirred solution of diol 2.41 (81 mg, 0.53 mmol) in anhydrous THF (1 mL) 
and 1 M aq. NaOH (0.5 mL). The mixture was stirred at rt until complete consumption 
of the starting material, judged by TLC analysis (3 h), then the reaction was quenched 
with 2 M aq. HCl (2 mL) and extracted with diethyl ether (3 × 3 mL). The combined 
organic layers were washed with water (8 mL), dried over anhydrous Na2SO4 and the 
solvent was removed under reduced pressure. Flash chromatography (99:1 CH2Cl2 / 
methanol) gave monoacetate 2.55 as a white solid (34 mg, 0.17 mmol, 33% yield) and 
diacetate 2.56 as a colourless oil (24 mg, 0.10 mmol, 20% yield). 
 
Rf 0.42 (99:1 CH2Cl2 / methanol); 
1H NMR (500 MHz, CDCl3) δ 6.98 (d, J = 7.5 Hz, 1H), 6.69-6.67 (m, 1H), 6.66 (s, 
1H), 4.25 (t, J = 7.1 Hz, 2H), 2.91 (t, J = 7.0 Hz, 2H), 2.28 (s, 3H), 2.08 (s, 3H) ppm; 
13C NMR (126 MHz, CDCl3) δ 171.7, 154.5, 138.5, 130.8, 121.5, 120.6, 116.8, 64.9, 
29.9, 21.2 (2C) ppm; 
IR (film, cm-1) 3262 (broad), 2932, 1737, 1697, 1667, 1618; 
HRMS (ESI+) 217.0857 (calculated [M+Na]+ 217.0835); 




Rf 0.52 (99:1 CH2Cl2 / methanol); 
1H NMR (500 MHz, CDCl3) δ 7.15 (d, J = 7.7 Hz, 1H), 7.00 (ddd, J = 7.7, 1.8, 0.8 
Hz, 1H), 6.87 (dd, J = 1.8, 0.8 Hz, 1H), 4.21 (t, J = 7.2 Hz, 2H), 2.82 (t, J = 7.2 Hz, 
2H), 2.33 (s, 3H), 2.32 (s, 3H), 2.03 (s, 3H) ppm; 
13C NMR (126 MHz, CDCl3) δ 171.1, 169.8, 149.3, 138.2, 130.6, 127.2, 126.6, 123.2, 
64.0, 29.5, 21.1, 21.0 (2C) ppm; 
IR (film, cm-1) 2959, 2926, 1727, 1736, 1508; 





Diol 2.41 (753 mg, 4.83 mmol) was dissolved in anhydrous THF at rt. Imidazole (329 
mg, 4.83 mmol) was added, then the solution was cooled to 0 °C. A solution of tert-
butyldimethylsilyl-chloride (728 mg, 4.83 mmol) in anhydrous THF (2.5 mL) was 
added within 1 h via syringe pump at 0 °C. The mixture was then allowed to warm to 
the rt and stirred for another 1.5 h. The reaction was then quenched with sat. aq. NH4Cl 
(5 mL). The aqueous layer was extracted with diethyl ether (3 × 6 mL), the combined 
organic layers were dried over anhydrous Na2SO4 and the solvent was removed under 
reduced pressure. Flash chromatography (90:10 petroleum spirit 40-60 / ethyl acetate) 
gave phenol 2.57 as a colourless oil (1.01 g, 3.80 mmol, 79% yield). 
 
Rf 0.54 (70:30 petroleum spirit 40-60 / ethyl acetate); 
1H NMR (500 MHz, CDCl3) δ 8.22 (s, 1H), 6.90 (d, J = 7.6 Hz, 1H), 6.75 (s, 1H), 
6.64 (d, J = 7.5 Hz, 1H), 3.92-3.89 (m, 2H), 2.91-02.76 (m, 2H), 2.29 (s, 3H), 0.92 (s, 
9H), 0.09 (s, 6H) ppm;   
13C NMR (126 MHz, CDCl3) δ 155.9, 138.4, 130.7, 124.1, 120.9, 117.8, 66.1, 35.5, 
26.0 (3C), 21.2, 18.4, −5.5 (2C) ppm; 
IR (film, cm-1) 3292 (broad), 2953, 2928, 2859, 1630; 





Phenol 2.57 (1.01 g, 3.8 mmol) was dissolved in anhydrous pyridine (4 mL). Acetic 
anhydride (0.39 mL, 4.0 mmol) was added and the mixture was stirred at rt until 
complete consumption of the starting material, judged by TLC analysis (14 h). The 
reaction mixture was then extracted with CH2Cl2 (3 × 5 mL) and washed with 1 M aq. 
HCl (2 × 8 mL). The combined organic layers were dried over anhydrous Na2SO4 and 
the solvent was removed under reduced pressure to afford compound 2.58 as a 
colourless oil (1.14 g, 3.7 mmol, 97% crude yield).  The crude material was deemed 
sufficiently pure (see 1H NMR spectrum on page 286) to be used directly in the next 
step. 
 
Rf 0.55 (75:25 petroleum spirit 40-60 / ethyl acetate); 
1H NMR (500 MHz, CDCl3) δ 7.15 (d, J = 7.7 Hz, 1H), 6.99-6.97 (m, 1H), 6.84 (s, 
1H), 3.73 (t, J = 7.4 Hz, 2H), 2.71 (t, J = 7.4 Hz, 2H), 2.32 (s, 3H), 2.31 (s, 3H), 0.89 
(s, 9H), 0.01 (s, 6H) ppm; 
13C NMR (126 MHz, CDCl3) δ 169.8, 149.2, 137.6, 131.1, 127.6, 127.0, 122.9, 63.4, 
33.8, 26.1 (3C), 21.1, 21.0, 18.5, −5.2 (2C) ppm; 
IR (film, cm-1) 2953, 2928, 2857, 1769, 1508; 





Protected diol 2.58 (32 mg, 0.10 mmol) was dissolved in anhydrous THF (0.4 mL). 
TBAF (1 M in THF, 0.12 mL, 0.12 mmol) was added at rt and the mixture was stirred 
until complete consumption of the starting material, judged by TLC analysis (2.5 h). 
The reaction was then quenched with water (1 mL) and extracted with ethyl acetate (3 
× 2 mL). The combined organic layers were dried over anhydrous Na2SO4 and the 
solvent was removed under reduced pressure. Flash chromatography (50:50 petroleum 





Protected alcohol 2.58 (1.10 g, 3.56 mmol) was dissolved in anhydrous methanol (20 
mL). I2 (100 mg, 0.39 mmol) was added as a solid and the mixture was stirred at rt for 
4.5 h. Then the reaction was quenched by adding sat. aq. Na2S2O4 (20 mL), the 
methanol was removed under reduced pressure and the residue was taken up in diethyl 
ether (20 mL). The organic layer was washed with brine (20 mL), dried over anhydrous 
Na2SO4 and the solvent was removed under reduced pressure. Flash chromatography 
(60:40 petroleum spirit 40-60 / ethyl acetate) gave primary alcohol 2.50 as a colourless 
oil (535 mg, 2.75 mmol, 77% yield), along with recovered starting material 2.58 (73 




Alcohol 2.50 (530 mg, 2.73 mmol) was dissolved in anhydrous CH2Cl2 (10 mL). Et3N 
(2.38 mL, 17.1 mmol), and DMSO (1.22 mL, 17.1 mmol) were added at rt. pyr•SO3 
(1.09 g, 6.82 mmol) was added at 0 °C and the mixture was allowed to warm to rt and 
stirred for 1.5 h. After complete consumption of the starting material, judged by TLC 
analysis (1.5 h), the Eschenmoser salt (456 mg, 4.91 mmol) was added at rt and the 
mixture was stirred for another 2.5 h. The reaction was then quenched with sat. aq. 
CuSO4 (10 mL) and extracted with ethyl acetate (3 × 20 mL). The combined organic 
layers were washed with 1 M aq. HCl (30 mL) and brine (40 mL) and dried over 
anhydrous Na2SO4. The solvent was removed under reduced pressure. Flash 
chromatography (60:40 petroleum spirit 40-60 / ethyl acetate) gave enal 2.48 as a pale-
yellow oil (337 mg, 1.63 mmol, 60% yield). 
 
Rf 0.29 (95:5 to 70:30 petroleum ether 40-60 / ethyl acetate); 
1H NMR (500 MHz, CDCl3) δ 9.70 (s, 1H), 7.14 (d, J = 7.8 Hz, 1H), 7.08 (ddd, J = 
7.8, 1.7, 0.8 Hz, 1H), 6.99-6.95 (m, 1H), 6.44 (d, J = 0.9 Hz, 1H), 6.31 (d, J = 0.9 Hz, 
1H), 2.37 (s, 3H), 2.17 (s, 3H) ppm; 
13C NMR (126 MHz, CDCl3) δ 192.0, 169.1, 148.0, 146.4, 140.4, 136.1, 130.4, 127.0, 
124.6, 123.4, 21.3, 21.0 ppm; 
IR (film, cm-1) 2924, 2853, 1765, 1736, 1697, 1624; 




Enal 2.48 (39 mg, 0.19 mmol) was transferred in a round bottom flask. K2CO3 (47 mg, 
0.34 mmol) was added to the neat enal. The mixture was warmed to 80 °C and stirred 
for 24 h, then allowed to cool to rt and diluted with CH2Cl2. The suspension was 
filtered through a pad of celite and the solvent was removed under reduced pressure. 
Flash chromatography (80:20 petroleum spirit 40-60 / ethyl acetate) gave compound 
(±)-2.60 as a pale-yellow oil (7 mg, 32 µmol, 17% yield) and compound (±)-2.61 as a 
63:37 diastereomeric mixture (pale brown oil, 5 mg, 13 µmol, 14% yield).  
 
Rf 0.68 (60:40 petroleum spirit 40-60 / ethyl acetate); 
1H NMR (500 MHz, CDCl3) δ 7.31 (d, J = 7.7 Hz, 1H), 7.02 (t, J = 1.7 Hz, 1H), 6.81 
(ddd, J = 7.7, 1.6, 0.8 Hz, 1H), 6.76-6.72 (m, 1H), 5.65 (d, J = 1.9 Hz, 1H), 5.32 (d, J 
= 1.4 Hz, 1H), 2.35 (s, 3H), 2.14 (s, 3H) ppm; 
13C NMR (126 MHz, CDCl3) δ 170.4, 161.3, 142.6, 141.9, 123.1, 121.0, 120.9, 111.5, 
107.1, 98.2, 22.0, 21.3 ppm; 
IR (film, cm-1) 2924, 2361, 1751, 1620, 1595; 




Rf 0.59 (60:40 petroleum spirit 40-60 / ethyl acetate); 
1H-NMR (500MHz, CDCl3) δ 7.25 (d, J = 7.7 Hz, 1H
†, H5Ꞌ), 7.25 (d, 7.5 Hz, 1H‡, 
H5Ꞌ), 7.15 (d, J = 7.8 Hz, 1H†, H5), 7.14 (d, 7.5 Hz, 1H‡, H5), 7.05-7.01 (m, 1H† + 
1H‡, H6), 6.89-6.84 (m, 2H† + 2H‡, H2 + H6Ꞌ), 6.81-6.78 (m, 1H†, H2Ꞌ), 6.75 (d, J = 
1.3 Hz, 1H‡, H2Ꞌ), 6.66 (s, 1H‡, H9Ꞌ), 6.55 (s, 1H†, H9Ꞌ), 6.52-6.50 (m, 1H† + 1H‡, H9), 
2.48 (tdd, J = 10.6, 3.9, 2.4 Hz, 1H†, H10), 2.42-2.39 (m, 1H†, H10), 2.38-2.27 (m, 
2H†, H10Ꞌ + 4H‡, H10 + H10Ꞌ), 2.37 (s, 3H† + 3H‡, H7Ꞌ), 2.35 (s, 3H‡, H12 or H12Ꞌ), 
2.34 (s, 3H† + 3H‡, H7), 2.31 (s, 3H‡, H12 or H12Ꞌ), 2.28 (s, 3H†, H12 or H12Ꞌ), 2.13 
(s, 3H†, H12 or H12Ꞌ) ppm; 
13C-NMR (126 MHz, CDCl3) δ 169.8
‡ (C11 or C11Ꞌ), 169.8 (1C† + 1C‡, C11 or C11Ꞌ), 
169.5† (C11 or C11Ꞌ), 159.6† (C3Ꞌ), 157.4‡ (C3Ꞌ), 148.3‡ (C3), 148.2† (C3), 142.3† (C1Ꞌ), 
141.5‡ (C1Ꞌ), 141.4 (1C† + 1C‡, C9), 138.3† (C1), 138.2‡ (C1), 129.8 (1C† + 1C‡, C5), 
129.5‡ (C4Ꞌ), 129.4† (C4Ꞌ), 127.3‡ (C6) , 127.2† (C6), 125.7‡ (C4), 124.8† (C4), 124.0‡ 
(C5Ꞌ), 123.9† (C5Ꞌ),123.5‡ (C6Ꞌ), 123.4‡ (C2), 123.4† (C6Ꞌ), 123.3† (C2), 111.9† (C2Ꞌ), 
111.6‡ (C2Ꞌ), 110.6† (C8), 110.4‡ (C8), 101.2† (C9Ꞌ), 100.8‡ (C9Ꞌ), 83.2† (C8Ꞌ), 80.9‡ 
(C8Ꞌ), 24.6† (C10Ꞌ), 22.6 (1C† + 1C‡, C10), 21.9† (C7Ꞌ), 21.8‡ (C7Ꞌ), 21.4‡ (C10Ꞌ), 21.3‡ 
(C7), 21.2 (1C† + 1C‡, C12 or C12Ꞌ), 21.1‡ (C12 or C12Ꞌ), 21.1† (C7), 21.0† (C12 or 
C12Ꞌ) ppm; 
IR (film, cm-1) 2924, 2359, 1755, 1647, 1628; 
HRMS (ESI+) 409.1659, 431.1475 (calculated [M+H]+ 409.1646 [M+Na]+ 
431.1465). 




Enal 2.48 (518 mg, 2.54 mmol) was heated, neat, at 80 °C in a round bottom flask for 
42 h. Analysis of the crude 1H NMR spectrum, with inclusion of an internal standard, 
indicated a > 95% yield of the acetyl-protected dimer (±)-2.59. The crude material was 
deemed sufficiently pure (see 1H NMR spectrum on page 296) to be used directly in 
the next step. 
 
Rf 0.36 (70:30 petroleum spirit 40-60 / ethyl acetate); 
1H NMR (500 MHz, CDCl3) δ 9.53 (d, J = 1.1 Hz, 1H, H9
Ꞌ), 7.48 (d, J = 8.1 Hz, 1H, 
H5Ꞌ), 7.12 (dm, J = 8.0 Hz, 1H, H6Ꞌ), 7.07 (d, J = 7.8 Hz, 1H, H5), 7.00 (dm, J = 7.8 
Hz, 1H, H6), 6.91-6.90 (m, 1H, H2Ꞌ), 6.83-6.82 (m, 1H, H2), 6.69 (apparent t, J = 1.7 
Hz, 1H, H9), 2.55-2.45 (m, 1H, H10Ꞌ), 2.41-2.37 (m, 1H, H10), 2.36 (s, 3H, H7 or H7Ꞌ), 
2.32 (s, 3H, H7 or H7Ꞌ), 2.30 (s, 3H, H12 or H12Ꞌ), 2.28-2.24 (m, 1H, H10Ꞌ), 2.20-2.14 
(m, 1H, H10), 2.17 (s, 3H, H12 or H12Ꞌ) ppm; 
13C NMR (126 MHz, CDCl3): δ 197.2 (C9
Ꞌ), 169.6 (C11 or C11Ꞌ), 169.5 (C11 or C11Ꞌ), 
148.3 (C3), 147.8 (C3Ꞌ), 141.0 (C9), 140.6 (C1Ꞌ), 138.4 (C1), 129.7 (C5), 129.4 (C4), 
127.9 (C5Ꞌ), 127.4 (C6Ꞌ), 127.1 (C6), 126.0 (C4Ꞌ), 124.8 (C2Ꞌ), 123.3 (C2), 112.0 (C8), 
82.2 (C8Ꞌ), 26.0 (C10Ꞌ), 22.0 (C10), 21.3 (C12 or C12Ꞌ), 21.1 (C12 or C12Ꞌ), 21.1 (C7 
or C7Ꞌ), 21.0 (C7 or C7Ꞌ) ppm; 
IR (film, cm-1) 2924, 1763, 1740, 1649, 1618; 




Dihydropyran (±)-2.59 (39 mg, 94 µmol) was dissolved in THF (3 mL). Water (1 mL) 
and sat. aq. NaHCO3 (1.5 mL) were then added and the mixture was stirred at rt until 
complete consumption of the starting material, judged by TLC analysis (4 h). The 
reaction was then quenched adding sat. aq. NH4Cl (2 mL) and the mixture was 
extracted with CH2Cl2 (3 × 5 mL). The combined organic layers were dried over 
anhydrous Na2SO4 and the solvent was removed under reduced pressure. Flash 
chromatography (100% CH2Cl2) afforded lactol (±)-2.62 as a 67:33 mixture of 
diastereoisomers (pale yellow oil, 19 mg, 53 µmol, 57% yield), along with acetal            
(±)-2.61 in a 63:37 diastereomeric ratio (pale yellow oil, 9 mg, 21 µmol, 22% yield). 
 
Rf 0.11 (100% CH2Cl2). 
1H NMR (500 MHz, CDCl3) δ 7.23 (d, J = 7.6 Hz, 1H
†, H5Ꞌ), 7.23 (d, J = 7.5 + 1H‡, 
H5Ꞌ), 7.18 (d, J = 7.8 Hz, 1H‡, H5), 7.16 (d, J = 7.8 Hz, 1H†, H5), 7.05(dm, J = 7.7 Hz, 
1H†, H6), 7.07-7.01 (m, 1H‡, H6), 6.87-6.87 (m, 1H†, H2), 6.86-6.86 (m, 1H‡, H2), 
6.83(dm, J = 7.6 Hz, 1H‡, H6Ꞌ), 6.79 (dm, J = 7.6 Hz, 1H†, H6Ꞌ), 6.76-6.75 (m, 1H‡, 
H2Ꞌ), 6.72-6.71 (m, 1H†, H2Ꞌ), 6.57-6.55 (m, 1H‡ + 1H†, H9), 5.76 (d, J = 5.3 Hz, 1H‡, 
H9Ꞌ), 5.52 (d, J = 11.8 Hz, 1H†, H9Ꞌ), 4.08 (d, J = 11.8 Hz, 1H†, OH at C9Ꞌ), 3.14 (d, J 
= 5.3 Hz, 1H‡, OH at C9Ꞌ), 2.73-2.63 (m, 1H‡, H10), 2.57 (tdd, J = 6.1, 5.0, 1.7 Hz, 
2H†, H10), 2.43 (dm, J = 17.3, Hz, 1H‡, H10), 2.35 (s, 3H‡, H7 or H7Ꞌ), 2.35 (s, 3H†, 
H7 or H7Ꞌ), 2.34 (s, 3H† + 3H‡, H7 or H7Ꞌ), 2.33-2.29 (m, 2H‡, H10Ꞌ), 2.28 (s, 3H‡, 
H12), 2.28 (s, 3H†, H12), 2.27-2.22 (m, 1H†, H10Ꞌ), 2.13 (dt, J = 13.8, 6.2 Hz, 1H†, 
H10Ꞌ) ppm; 
 173 
13C NMR (126 MHz, CDCl3) δ 169.9
† (C11), 169.8‡ (C11), 159.3‡ (C3Ꞌ), 157.7† (C3Ꞌ), 
148.3† (C3), 148.1‡ (C3), 142.0‡ (C1Ꞌ), 141.9† (C1Ꞌ), 141.6‡ (C9), 141.1† (C9), 138.4† 
(C1), 138.0‡ (C1), 129.7 (1C† + 1C‡, C5), 129.5‡ (C4), 129.4† (C4), 127.2† (C6), 127.2‡ 
(C6), 125.3‡ (C4Ꞌ), 125.1† (C4Ꞌ), 124.4† (C5Ꞌ), 124.2‡ (C5Ꞌ), 123.4† (C2), 123.4‡ (C2), 
122.8‡ (C6Ꞌ), 122.5† (C6Ꞌ), 111.7‡ (C2Ꞌ), 111.5† (C2Ꞌ), 111.1‡ (C8), 111.0† (C8), 105.0† 
(C9Ꞌ), 104.7‡ (C9Ꞌ), 83.8‡ (C8Ꞌ), 79.7† (C8Ꞌ), 29.3† (C10Ꞌ), 24.3‡ (C10Ꞌ), 22.4‡ (C10), 21.9‡ 
(C7 or C7Ꞌ), 21.9† (C7 or C7Ꞌ), 21.7† (C10), 21.3‡ (C7 or C7Ꞌ), 21.2† (C7 or C7Ꞌ), 21.1† 
(C12), 21.1‡ (C12) ppm; 
IR (film, cm-1) 3433 (broad), 2922, 1755, 1647, 1624; 
HRMS (ESI+) 389.1371 (calculated [M+Na]+ 389.1365). 




Crude acetyl-protected dimer (±)-2.59 (342 mg, 0.838 mmol) was dissolved in THF 
(18 mL). 2 M aq. NaOH (9.0 mL) was added and the mixture was stirred at rt for 3 h. 
After that time the reaction mixture was neutralised with sat. aq. NH4Cl, the THF was 
removed under reduced pressure and the remaining aqueous layer was extracted with 
CH2Cl2 (3 × 10 mL). The combined organic layers were dried over anhydrous Na2SO4 
and the solvent was removed under reduced pressure. Analysis of the crude 1H NMR 
spectrum, with inclusion of an internal standard, indicated a 75% yield (over two steps 
from enal 2.48) for a 78:22 diastereomeric mixture of lactols (±)-2.9. The crude 
material was characterised and used directly in the next step (see 1H and 13C NMR 
spectra on pages 300 and 301). 
Note: d.r. of lactol (±)-2.9 epimers varied with solvent used for the NMR experiments 
(72:28 in CDCl3 and 78:22 in (CD3)2CO). 
 
Rf 0.11 (95:5 petroleum spirit 40-60 / diethyl ether); 
1H NMR (500 MHz, CDCl3) δ 7.24 (d, J = 7.7 Hz, 1H
† + 1H‡, H5Ꞌ), 7.04 (d, J = 8.2 
Hz, 1H‡, H5), 7.02 (d, J = 8.1 Hz, 1H†, H5), 6.82 (dm, J = 7.6 Hz, 1H‡, H6Ꞌ), 6.79 (dm, 
J = 7.6 Hz, 1H†, H6Ꞌ), 6.76-6.69 (m, 3H† + 3H‡, H2, H2Ꞌ, H6Ꞌ), 6.65 (apparent t, J = 1.7 
Hz, 1H†, H9), 6.63 (apparent t, J = 1.7 Hz, 1H‡, H9), 5.83 (s, 1H‡, H9Ꞌ), 5.62 (s (broad), 
1H† OH), 5.57 (s, 1H†, H9Ꞌ), 5.45 (s (broad), 1H‡, OH), 4.17 (s (broad), 1H†, OH), 3.62 
(s (broad), 1H‡, OH), 2.73-2.67 (m, 1H‡, H10), 2.58 (dm, J = 7.8 Hz, 2H†, H10), 2.49-
2.43 (m, 1H‡, H10), 2.42-2.36 (m, 1H† + 2H‡, H10Ꞌ), 2.35 (s, 3H‡, H7Ꞌ), 2.34 (s, 3H†, 
H7Ꞌ), 2.30 (s, 3H† + 3H‡, H7), 2.21-2.10 (m, 1H†, H10Ꞌ) ppm; 
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13C NMR (126 MHz, CDCl3) δ 159.4
‡ (C3Ꞌ), 157.6† (C3Ꞌ), 153.4† (C3), 152.8‡ (C3), 
142.0 (1C† + 1C‡, C7Ꞌ), 141.9† (C9), 141.8‡ (C9), 138.9† (C7), 138.5‡ (C7), 129.3† (C5), 
129.2‡ (C5), 125.3‡ (C4Ꞌ), 124.9† (C4Ꞌ), 124.3† (C5Ꞌ), 124.2‡ (C5Ꞌ), 122.7‡ (C4), 122.6 
(2C†, C6 and C4), 122.4‡,  121.5‡ (C6Ꞌ), 121.4† (C6Ꞌ), 116.3 (1C† + 1C‡, C2 or C2Ꞌ), 
111.7‡ (C2 or C2Ꞌ), 111.4† (C2 or C2Ꞌ), 110.8‡ (C8), 110.7† (C8), 105.2† (C9Ꞌ), 104.8‡ 
(C9Ꞌ), 84.0‡ (C8Ꞌ), 79.9† (C8Ꞌ), 29.5† (C10Ꞌ), 24.4‡ (C10Ꞌ), 23.2‡ (C10), 22.4† (C10), 21.9 
(1C† + 1C‡, (C7Ꞌ), 21.3† (C7), 21.2‡ (C7) ppm; 
IR (film, cm-1) 3345, 2922, 2853, 1667, 1622, 1599, 1501; 
HRMS (ESI+) 347.1268 (calculated [M+Na]+ 347.1254). 




Phenol 2.63 (1.08 g, 6.98 mmol) was dissolved in anhydrous pyridine (12 mL). Acetic 
anhydride (774 µL, 8.03 mmol) was added and the mixture was stirred at rt until 
complete consumption of the starting material, judged by TLC analysis (18 h). The 
mixture was then diluted with CH2Cl2 (50 mL) and washed with 1 M aq. HCl (2 × 50 
mL). The organic layer was dried over anhydrous Na2SO4 and the solvent was removed 
under reduced pressure. Flash chromatography (80:20 petroleum spirit 40-60 / ethyl 
acetate) afforded compound 2.64 as a white solid (1.23 g, 6.39 mmol, 92% yield). 
 
Rf 0.39 (70:30 petroleum ether 40-60 / ethyl acetate); 
1H NMR (500 MHz, CDCl3) δ 7.73 (d, J = 7.9 Hz, 1H), 7.13-7.10 (m, 1H), 6.91 (d, J 
= 1.6 Hz, 1H), 2.52 (s, 3H), 2.39 (s, 3H), 2.34 (s, 3H) ppm; 
13C NMR (126 MHz, CDCl3) δ 197.1, 169.8, 149.4, 145.0, 130.7, 127.8, 126.9, 124.5, 
29.3, 21.5, 21.3 ppm;  
IR (film, cm-1) 1765, 1722, 1682, 1614; 
HRMS (ESI+) 215.0769 (calculated [M+Na]+ 215.0679); 





Compound 2.68 was prepared using a modified literature procedure.162 
Phenol 2.63 (1.08 g, 7.42 mmol) was dissolved in anhydrous CH2Cl2 (20 mL), then 
anhydrous pyridine (900 µL, 11.3 mmol) was added. The reaction mixture was cooled 
to 0 °C, then triflic anhydride (1.50 mL, 8.90 mmol) was added dropwise and the 
mixture was allowed to warm to rt and stirred until complete consumption of the 
starting material, judged by TLC analysis (16 h). The reaction was then quenched with 
1 M aq. HCl (20 mL), the phases were separated and the organic layer was washed 
with sat. aq. NaHCO3 (20 mL) and brine (20 mL). Removal of the solvent under 
reduced pressure afforded triflate 2.68 as a white solid (2.08 g, 7.37 mmol, >95% 
yield). The crude material was deemed sufficiently pure (see 1H and 13C NMR spectra 
on pages 304 and 305) to be used directly in the next step.  
All data for compound 2.68 matched literature values.162 
 
Rf 0.19 (90:10 petroleum ether 40-60 / ethyl acetate); 
1H NMR (500 MHz, CDCl3) δ 7.72 (d, J = 7.9 Hz, 1H), 7.28-7.25 (m, 1H), 7.11 (s, 
1H), 2.59 (s, 3H), 2.43 (s, 3H) ppm; 
13C NMR (126 MHz, CDCl3) δ 196.3, 147.0, 145.6, 131.0, 129.3, 129.2, 123.3, 118.7 




Compound 2.69 was prepared using a modified literature procedure.96 
Ketone 2.68 (282 mg, 1.0 mmol) was dissolved in anhydrous THF (5 mL) at 0 °C. 
Potassium tert-butoxide (266 mg, 2.20 mmol) was added as a solid. The mixture was 
stirred at 0 °C until complete consumption of the starting material, judged by TLC 
analysis (30 min). Then the reaction was quenched by adding 1 M aq. HCl (2.5 mL), 
the mixture was extracted with ethyl acetate (3 × 10 mL) and the combined organic 
layers were washed with sat. aq. NaHCO3 (20 mL) and brine (20 mL). The organic 
layer was eluted through a cotton plug and the solvent was removed under reduced 
pressure. The residue was dissolved in CH2Cl2 and filtered. The filtrate was 
concentrated under vacuum to afford compound 2.69 as a colourless solid (148 mg, 
0.52 mmol, 53% yield). The crude material was deemed sufficiently pure (see 1H and 
13C NMR spectra on pages 306 and 307) to be characterised without further 
purification. 
 
Rf 0.42 (60:40 petroleum ether 40-60 / ethyl acetate); 
1H NMR (500 MHz, CDCl3) δ 11.44 (s, 1H), 7.52 (d, J = 8.3 Hz, 1H), 6.89-6.86 (d, J 
=  1.7 Hz, 1H), 6.82 (dd, J = 8.3, 1.7 Hz, 1H), 4.79 (s, 2H), 2.40 (s, 3H) ppm; 
13C NMR (126 MHz, CDCl3) δ 188.6, 163.9, 151.4, 130.8, 121.6, 119.4 (q, JC-F = 327 
Hz), 119.3, 117.1, 57.0, 22.5 ppm;   
IR (film, cm-1) 3117 (broad), 2994, 2934, 2920, 1626; 
HRMS (ESI+) 283.0254, 305.0072 (calculated [M+H]+ 283.0246, [M+Na]+ 
305.0066); 
m.p. 118-119 °C (CH2Cl2). 
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Compound 2.69 was prepared using a modified literature procedure.96 
Ketone 2.68 (141 mg, 0.50 mmol) was dissolved in anhydrous DMF (5 mL) at rt. DBU 
(150 µL, 1.0 mmol) was then added dropwise. The reaction was stirred at rt until 
complete consumption of the starting material, judged by TLC analysis (18 h). Then 
the reaction was quenched by adding 1 M aq. HCl (13 mL). The mixture was extracted 
with ethyl acetate (3 × 15 mL) and the combined organic layers were washed with sat. 
aq. NaHCO3 (15 mL), water (15 mL) and brine (10 mL). The organic layer was eluted 
through a cotton plug and the solvent was removed under reduced pressure. The 
residue was dissolved in CH2Cl2 and filtered. The filtrate was concentrated under 





Compound 2.73 was prepared using a modified literature procedure.163 
NaH (60% dispersion in mineral oil, 11.1 g, 280 mmol) was dissolved in anhydrous 
THF (120 mL). The solution was cooled to 0 °C then Ph3PCH3•Br (49.9 g, 140 mmol) 
was added slowly as a solid. The mixture was stirred at 0 °C for 1 h, then ketone 2.63 
(10.8 g, 69.8 mmol) was slowly added, using a syringe pump over 45 min. The mixture 
was then allowed to warm to rt and stirred for another 15 h. The reaction was then 
quenched with 1 M aq. HCl (80 ml) and the mixture was extracted with CH2Cl2 (3 × 
100 mL). The combined organic layers were dried over anhydrous Na2SO4 and the 
solvent was removed under reduced pressure. Flash chromatography (90:10 petroleum 
spirit 40-60 / ethyl acetate) gave compound 2.73 as a colourless oil (9.73 g, 65.7 mmol, 
94% yield). All data for compound 2.73 matched the literature values.163 
 
Rf 0.44 (100% CH2Cl2); 
1H NMR (500 MHz, CDCl3) 7.03 (d, J = 7.7 Hz, 1H), 6.76-6.75 (m, 1H), 6.72 (dm, J 
= 7.7 Hz, 1H), 5.64 (s, 1H), 5.38 (apparent qn, J = 1.6 Hz, 1H), 5.12 (dd, J = 1.9, 1.0 
Hz, 1H), 2.31 (s, 3H), 2.11-2.10 (m, 3H) ppm; 
13C NMR (126 MHz, CDCl3) δ 115.9, 142.3, 139.0, 127.7, 126.0, 121.1, 116.3, 115.4, 




Compound 2.70 was prepared using a modified literature procedure.101 
Phenol 2.73 (2.75 g, 18.6 mmol) was dissolved in anhydrous pyridine (20 mL). Acetic 
anhydride (2.06 mL, 21.4 mmol) was added and the mixture was stirred at rt for 15 h. 
The reaction mixture was then diluted with CH2Cl2 (50 mL) and washed with 1 M aq. 
HCl (2 × 40 mL). The organic layer was dried over anhydrous Na2SO4 and the solvent 
was removed under reduced pressure. Flash chromatography (95:5 petroleum ether 40-
60 / ethyl acetate) gave protected phenol 2.70 as a colourless oil (3.02 g, 15.9 mmol, 
86% yield). All data for compound 2.70 matched literature values.101 
 
Rf 0.61 (80:20 petroleum ether 40-60 / ethyl acetate); 
1H NMR (500 MHz, CDCl3) δ 7.17 (d, J = 7.8 Hz, 1H), 7.02 (dm, J = 7.7 Hz, 1H), 
6.85-6.84 (m, 1H), 5.15 (dq, J = 2.1, 1.5 Hz, 1H), 5.01 (dq, J = 1.9, 0.9 Hz, 1H), 2.34-
2.33 (m, 3H), 2.25 (s, 3H), 2.05 (dd, J = 1.5, 0.9 Hz, 3H) ppm; 
13C NMR (126 MHz, CDCl3): δ 169.7, 147.5, 141.7, 138.4, 133.4, 129.1, 127.0, 123.2, 





A solution of alkene 2.70 (104 mg, 0.55 mmol) in CH2Cl2 (0.7 mL) was added to a 
solution of SeO2 (9 mg, 77 µmol), acetic acid (4 µL, 77 µmol) and tert-butyl 
hydroperoxide (70% w/w in H2O, 155 µL, 1.2 mmol) in CH2Cl2 (2 mL). The mixture 
was heated to 40 °C and stirred for 5.5 h. The reaction was then allowed to cool to rt, 
then quenched adding sat. aq. Na2S2O3 (2 mL) and stirred for another 10 min. The 
phases were separated and the organic layer was washed with sat. aq. NaHCO3 (3.0 
mL) and brine (3 mL) and the aqueous layer was back-extracted with ethyl acetate (3 
× 5) mL. The combined organic layers were dried over anhydrous Na2SO4 and the 
solvent was removed under reduced pressure. Flash chromatography (80:20 petroleum 
ether 40-60 / ethyl acetate) afforded phenol 2.72 as a colourless oil (24 mg, 0.12 mmol, 
22% yield) along with recovered starting material 2.70 (53 mg, 0.28 mmol, 51% yield). 
All data for compound 2.72 matched literature values.46 
 
Rf 0.22 (80:20 petroleum ether 40-60 / ethyl acetate); 
1H NMR (500 MHz, CDCl3) δ 6.98 (d, J = 7.6 Hz, 1H), 6.75 (d, J = 1.6 Hz, 1H), 6.70 
(dd, J = 7.7, 1.9 Hz, 1H), 5.48 (s, 1H), 5.29 (s, 1H), 4.77 (s, 2H), 2.30 (s, 3H), 2.14 (s, 
3H) ppm; 
13C NMR (126 MHz, CDCl3) δ 117.8, 153.4, 141.8, 140.1, 129.3, 122.6, 121.1, 116.8, 




To a solution of alkene 2.70 (1.13 g, 5.96 mmol) in anhydrous toluene (25 mL) in the 
presence of activated grounded molecular sieves, SeO2 (993 mg, 8.95 mmol) was 
added as a solid at room temperature. The reaction mixture was then heated to 100 °C 
and stirred at that temperature until complete consumption of the starting material, 
judged by TLC analysis (5 h). The mixture was then filtered through a pad of celite. 
Water (20 mL) was added to the filtrate and the mixture was extracted with CH2Cl2 (3 
× 20 mL). The combined organic layers were dried over anhydrous Na2SO4 and the 
solvent was removed under reduced pressure. Flash chromatography (95:5 to 80:20 
petroleum ether 40-60 / ethyl acetate) afforded compound 2.48 as an orange oil (259 
mg, 1.27 mmol, 21% yield) as well as and lactone 2.76 as a pale brown oil (70 mg, 
0.20 mmol, 7% yield) and benzofuran 2.77 as a pale-yellow oil (60 mg, 0.29 mmol, 
5% yield). Note: Yields of compound 2.48 were dependent on the reaction scale: from 
48-50% on a 30-mg scale and 19-21% on a 260-mg scale. 
 
Rf 0.38 (70:30 petroleum ether 40-60 / ethyl acetate); 
1H NMR (500 MHz, CDCl3) δ 7.32 (d, J = 7.7 Hz, 1H, H5
Ꞌ), 7.19 (d, J = 7.8 Hz, 1H, 
H5), 7.05 (dm, J = 7.8, 1H, H6), 7.02 (dm, J = 7.7, 1H, H6Ꞌ), 6.97 (d, J = 0.9 Hz, 1H, 
H2Ꞌ), 6.89 (d, J = 0.9 Hz, 1H, H2), 6.61 (apparent t, J = 1.7 Hz, 1H, H9), 2.79 (dddd, 
J = 17.3, 7.5, 5.9, 1.9 Hz, 1H, H10), 2.53-2.45 (m, 1H, H10), 2.41 (s, 3H, H7Ꞌ), 2.36 
(s, 3H, H7), 2.32 (s, 3H, H12), 2.30-2.24 (m, 1H, H10Ꞌ), 2.23-2.16 (m, 1H, H10Ꞌ) ppm; 
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13C NMR (126 MHz, CDCl3) δ 173.7 (C9
Ꞌ), 169.9 (C11), 153.3 (C3Ꞌ), 148.4 (C3), 
142.0 (C1Ꞌ), 140.9 (C9), 138.4 (C1), 129.7 (C5), 129.3 (C4), 127.2 (C6), 125.6 (C6Ꞌ), 
125.3 (C4Ꞌ), 124.3 (C5Ꞌ), 123.5 (C2), 112.0 (C2Ꞌ), 110.4 (C8), 74.9 (C8Ꞌ), 29.0 (C10Ꞌ), 
22.0 (C7Ꞌ), 21.3 (C12), 21.1 (C7), 20.5 (C10) ppm; 
HRMS (ESI+) 365.1374, 387.1205 (calculated [M+H]+ 365.1383, [M+Na]+ 
387.1203); 




All data for compound 2.77 matched literature values.164 
 
Rf 0.47 (70:30 petroleum ether 40-60 / ethyl acetate); 
1H NMR (500 MHz, CDCl3) δ ) δ 7.61 (t, J = 0.9 Hz, 1H), 7.51 (d, J = 7.9 Hz, 1H), 
7.31-7.30 (m, 1H), 7.11 (dm, J = 7.9 Hz, 1H), 5.27 (d, J = 0.9 Hz, 2H), 2.49-2.47 (m, 
3H), 2.11 (s, 3H) ppm; 
13C NMR (126 MHz, CDCl3) δ 171.1, 156.1, 143.7, 135.2, 124.5, 124.3, 119.4, 




To a vigorously stirred solution of dihydropyran (±)-2.59 (30 mg, 73 µmol) in CH2Cl2 
(1.5 mL), sat. aq. NaHCO3 (2 mL) and acetone (500 µL) at 0 °C, a solution of oxone 
(135 mg, 0.22 mmol) in water (1 mL) was added via a syringe pump within 20 min.. 
The mixture was allowed to warm to rt and stirred until complete consumption of the 
starting material, judged by TLC analysis (4.5 h). Then the reaction mixture was 
extracted with CH2Cl2 (3 × 5 mL) and the combined organic layers were dried over 
anhydrous Na2SO4. Removal of the solvent under reduced pressure afforded a 
colourless oil (31 mg, 71 µmol, 97% crude yield). Analysis of the crude 1H NMR 
spectrum indicated the presence of a 1:1 mixture of diasteroisomers epoxide (±)-2.78 
(see 1H NMR spectrum of the crude product on page 318) as the sole product. Flash 
chromatography (100% CH2Cl2) afforded epoxide (±)-2.78 as a single diastereoisomer 
(5 mg, 12 µmol, 16% yield). 
 
Rf 0.13 (100% CH2Cl2); 
1H NMR (500 MHz, CDCl3) δ 9.48 (d, J = 1.2 Hz, 1H, H9
Ꞌ), 7.54 (d, J = 8.1 Hz, 1H, 
H5Ꞌ), 7.27 (d, J = 8.0 Hz, 1H, H5), 7.13 (dm, J = 8.1 Hz, 1H, H6Ꞌ), 7.04 (dm, J = 7.8 
Hz, 1H, H6), 6.88-6.87 (m, 1H, H2Ꞌ), 6.85-6.84 (m, 1H, H2), 5.02 (s, 1H, H9), 2.39-
2.33 (m, 2H, H10 or H10Ꞌ), 2.38 (s, 3H, H12 or H12Ꞌ), 2.36 (s, 3H, H7Ꞌ), 2.33 (s, 3H, 
H7), 2.31-2.28 (m, 1H, H10 or H10Ꞌ), 2.27 (s, 3H, H12 or H12Ꞌ), 2.24-2.18 (m, 1H, 
H10 or H10Ꞌ) ppm; 
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13C NMR (126 MHz, CDCl3) δ 196.5 (C9
Ꞌ), 170.0 (C11 or C11Ꞌ), 169.5 (C11 or 
C11Ꞌ), 147.8 (C3), 147.6 (C3Ꞌ), 140.6 (C1Ꞌ), 139.8 (C1), 128.0 (2C, C5 + C4), 127.7 
(C5Ꞌ), 127.6 (C6Ꞌ), 127.2 (C6), 126.8 (C4Ꞌ), 124.5 (C2Ꞌ), 123.4 (C2), 81.8 (C9), 80.4 
(C8Ꞌ), 59.3 (C8), 25.4 (C10 or C10Ꞌ), 24.9 (C10 or C10Ꞌ), 21.3 (C7, C7Ꞌ, C12 or C12Ꞌ), 
21.2 (C7, C7Ꞌ, C12 or C12Ꞌ), 21.2 (C7, C7Ꞌ, C12 or C12Ꞌ), 21.1 (C7, C7Ꞌ, C12 or C12Ꞌ) 
ppm; 
IR (film, cm-1) 2924, 2855, 1767, 1738, 1622; 





Crude lactol (±)-2.9 (250 mg, 0.771 mmol) was dissolved in an 8:2 mixture of 
petroleum spirit / ethyl acetate (40 mL). The mixture was stirred at rt under the light 
from Kosnic Compact Fluorescent Lamp 11 W Ecolight bulb for 72 h (for further 
details, see: http://www.kosnic.com) in a standard desk-type lamp. Removal of the 
solvent under reduced pressure afforded a crude mixture as an orange powder (250 
mg). Analysis of this crude mixture by 1H NMR analysis, with the inclusion of an 
internal standard, indicated a 57% yield of thymarnicol (±)-1.1 over three steps from 
enal 2.48 (see stacked 1H NMR spectra on page 321), along with a 21% internal 
standard yield of peroxide (±)-2.79. Analytically pure samples of thymarnicol (±)-1.1 
and peroxide (±)-2.79 were obtained using column chromatography followed by 
preparative HPLC (70:30 MeOH / H2O, ACE-321-2520 C18 preparative column). Up 
to date we have prepared 40 mg of analytically pure thymarnicol (±)-1.1. Note: d.r. of 
lactol epimers varied with solvent used for the NMR experiments (78:22 in CDCl3 and 
88:12 in (CD3)2CO), for both thymarnicol (±)-1.1  and compound (±)-2.79. 
Recrystrallisation from hot acetonitrile gave crystalline (±)-1.1, the structure of which 












tR  3.52 min (flow rate: 15 mL/min, λ= 254 nm, pressure: 223 bar). 
Rf 0.38 (70:30 hexane / ethyl acetate); 
1H NMR (500 MHz, (CD3)2CO) δ 7.43 (d, J = 7.6 Hz, 1H
‡) 7.39 (d, J = 7.6 Hz, 1H†), 
7.25 (d, J = 7.6 Hz, 1H‡), 7.23 (d, J = 7.5 Hz, 1H†), 6.83 (ddd, J = 7.6, 1.5, 0.8 Hz, 
1H‡), 6.81-6.78 (m, 1H‡), 6.80 (ddd, J = 7.6, 1.5, 0.8 Hz, 1H†), 6.77 (ddd, J = 7.7, 1.5, 
0.8 Hz, 1H†), 6.68 (dd, J = 1.4, 0.7 Hz, 1H‡), 6.66-6.65 (m, 1H†), 6.65-6.64 (m, 1H† + 
1H‡), 6.19 (d, J = 5.8 Hz, 1H†), 5.89 (d, J = 5.5 Hz, 1H†) 5.78 (s, 1H‡), 5.71 (s, 1H†), 
5.39 (d, J = 10.5 Hz, 1H‡), 5.29 (d, J = 10.3 Hz, 1H‡), 4.99 (s, 1H‡), 4.88 (s, 1H†), 2.43 
(ddd, J = 13.4, 11.7, 3.2 Hz, 1H‡), 2.36 (ddd, J = 13.3, 11.7, 3.4 Hz, 1H†), 2.32 (s, 
3H‡), 2.31 (s, 6H†), 2.27-2.22 (m, 1H‡), 2.21 (ddd, J = 13.3, 7.0, 3.4 Hz, 1H†), 2.13-
2.08 (m, 1H‡), 2.11-2.05 (m, 1H†), 2.09 (s, 3H‡), 1.96 (ddd, J = 14.8, 11.7, 3.4 Hz, 
1H†), 1.64 (ddd, J = 14.6, 11.7, 3.2 Hz, 1H‡) ppm; 
13C NMR (126 MHz, (CD3)2CO) δ 160.8 (1C
† + 1C‡), 159.3†, 158.5‡, 141.9‡, 141.7†, 
141.5‡ 141.1†, 129.6†, 129.5‡, 128.6†, 128.1‡, 125.0 (1C† + 1C‡), 124.6‡, 124.5†, 123.5‡, 
123.1†, 122.5‡, 122.5†, 112.1†, 112.1‡, 111.9†, 111.7‡, 111.5†, 111.0‡, 108.2†, 107.5‡, 
83.6†, 83.6‡, 77.3†, 77.2‡, 31.2†, 30.0‡, 28.5‡, 23.5†, 21.8 (1C† + 1C‡), 21.8 (1C† + 1C‡) 
ppm; 
IR (film, cm-1) 3424, 3352, 2926, 1624, 1597; 
HRMS (ESI+) 341.1372 (calculated [M+H]+ 341.1384); 
m.p. 184-185 °C (acetonitrile). 




Comparison of the 1H and 13C NMR Data for Synthetic and Natural (±)-1.1 
Provided below is a tabulated comparison of the NMR data for the major epimer of (±)-thymarnicol 1.1. 
Our 13C NMR spectrum is referenced to the (CD3)2CO peak at 206.26 ppm. All peaks were found to be 
within ± 0.07 ppm.*  
Atom 
Synthetic Thymarnicol (CD3)2CO Natural Thymarnicol (Passreiter)48 (CD3)2CO 
δ 1H (500 MHz) m J (Hz) δ 13C (126 MHz) δ 1H (500 MHz) m J (Hz) δ 13C (126 MHz) 
1 - - 141.09 - - 141.12 
2 6.65-6.64 m 111.93 6.63 s 111.97 
3 - - 159.25 - - 159.97* 
4 - - 129.57 - - 129.57 
5 7.23 d, 7.5 122.50 7.24 d, 7.9 122.54 
6 6.80 
ddd, 7.6, 
1.5, 0.8  
124.95 6.79 d, 7.9 125.00 
7 2.31 s 21.78 2.33 s 21.85 
8 - - 77.24 - - 77.24 
















1’ - - 141.72 - - 141.75 
2’ 6.66-6.65 m 112.11 6.64 d, ˂1 112.10 
3’ - - 160.75 - - 160.78 
4’ - - 128.63 - - 128.66 




124.51 6.77 d, 7.9 124.55 
7’ 2.31 s 21.80 2.33 s 21.83 
8’ - - 83.62 - - 83.63 

















4.88 s - 4.94 s - 
OH at 
C-9’ 
6.19 d, 5.8 - 6.24 d, 10.5* - 
† assignment interchangeable. 
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* The 13C NMR signal for C3 (159.97 ppm) and the coupling constant between H9 and 
the OH at C9’ (J = 10.5 Hz) reported by Passreiter and co-workers differ from what 
we observe (159.25 ppm and J = 5.5/5.8 Hz).48 However, given the otherwise excellent 
agreement between both our NMR spectra and X-ray crystal structure with that 





Rf 0.38 (70:30 hexane / ethyl acetate); 
1H NMR (500 MHz, (CD3)2CO) δ 7.60 (d, J = 7.6 Hz, 1H
‡, H5Ꞌ), 7.56 (d, J = 7.7 Hz, 
1H†, H5Ꞌ), 6.80 (dd, J = 7.7, 1.6 Hz, 1H† + 1H‡, H6Ꞌ), 6.75 (d, J = 8.1 Hz, 1H†, H5), 
6.74 (d, J = 8.1 Hz, 1H‡, H5), 6.71 (s, 1H†, H2Ꞌ), 6.70-6.67 (m, 1H† + 1H‡, H6), 6.69 
(m, 1H‡, H2Ꞌ), 6.64-6.63 (m, 1H†, H2), 6.63-6.62 (m, 1H‡, H2), 6.33 (d, J = 5.9 Hz, 
1H†, OH at C9Ꞌ), 6.15 (s, 1H‡, OOH at C8), 6.11 (s, 1H†, OOH at C8), 5.54 (d, J = 5.8 
Hz, 1H†, H9Ꞌ), 5.44 (d, J = 12.7 Hz, 1H‡, OH at C9Ꞌ ), 5.37 (d, J = 12.6 Hz, 1H‡, H9Ꞌ), 
5.34 (s, 1H‡, H9), 5.23 (s, 1H†, H9), 2.62-2.54 (m, 1H‡, H10 or H10Ꞌ), 2.51 (dd, J = 
13.6, 4.8 Hz, 1H†, H10 or H10Ꞌ), 2.44 (m, 1H† + 1H‡, H10 or H10Ꞌ), 2.38-2.34 (m, 1H†, 
H10 or H10Ꞌ), 2.33 (s, 3H† + 3H‡, H7Ꞌ), 2.26-2.22 (m, 1H‡ H10 or H10Ꞌ), 2.21 (s, 3H‡, 
H7), 2.21 (s, 3H†, H7), 2.10-2.04 (m, 1H†, H10 or H10Ꞌ), 2.04-1.98 (m, 1H‡, H10 or 
H10Ꞌ) ppm; 
13C NMR (126 MHz, (CD3)2CO) δ 161.2 (1C
† + 1C‡,C3Ꞌ), 142.1 (1C† + 1C‡, H1Ꞌ), 
140.9† (C3), 140.8‡ (C3), 139.9 (1C† + 1C‡, C4), 131.8 (1C† + 1C‡, C1), 126.0† (C5Ꞌ), 
126.0‡ (C5), 125.8‡ (C4Ꞌ), 125.7† (C4Ꞌ), 123.3‡ (C6), 123.2† (C6), 121.9 (1C† + 1C‡, C6Ꞌ), 
118.0‡ (C5), 117.9 (1C† + 1C‡, C2), 117.8† (C5), 112.5 (1C† + 1C‡, C2Ꞌ), 107.8† (C9Ꞌ), 
107.7‡ (C9Ꞌ), 92.6† (C9), 92.6‡ (C9), 91.0† (C8), 90.9‡ (C8), 85.9† (C8Ꞌ), 85.8‡ (C8Ꞌ), 
32.6† (C10 or C10Ꞌ), 32.6‡ (C10 or C10Ꞌ), 26.4† (C10 or C10Ꞌ), 26.3‡ (C10 or C10Ꞌ), 21.6‡ 
(C7Ꞌ), 21.6† (C7Ꞌ), 20.7‡ (C7), 20.6† (C7) ppm; 
IR (film, cm-1) 3219, 3211, 2922, 2359, 2342, 2324; 
HRMS (ESI+) 357.1333, 379.1149 (calculated [M+H]+ 357.1333, [M+Na]+ 
379.1152). 
† Major diastereoisomer, ‡ minor diastereoisomer. 
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4.3 Specific Experimental Procedures for Chapter 3 
 
 
4-Bromo-3-methoxyphenol 3.39 (5.25 g, 25.8 mmol) was dissolved in anhydrous 
acetone (100 mL). K2CO3 (3.56 g, 25.8 mmol) and allyl bromide (3.08 mL, 35.6 mmol) 
were then added to this stirred solution. The mixture was heated at 56 °C until complete 
consumption of the starting material, judged by TLC analysis (22 h), then allowed to 
cool to rt, diluted with CH2Cl2 (50 mL) and washed with 2 M aq. NaOH (2 × 50 mL). 
The organic layer was dried over anhydrous Na2SO4, filtered and then the solvent was 
removed under reduced pressure.  Flash chromatography (70:30 petroleum spirit / 
diethyl ether) gave compound 3.42 as a colourless oil (5.48 g, 22.5 mmol, 92% yield). 
 
Rf 0.41 (70:30 petroleum spirit 40-60 / diethyl ether); 
1H NMR (500 MHz, CDCl3) δ 7.39 (d,  J = 8.7 Hz, 1H), 6.52 (d, J = 2.7 Hz, 1H), 6.40 
(dd, J = 8.7, 2.7 Hz, 1H), 6.04 (ddt, J = 17.2, 10.6, 5.3 Hz, 1H), 5.41 (apparent dt, J = 
17.2, 1.6 Hz, 1H), 5.30 (apparent dt, J = 10.5, 1.5 Hz, 1H), 4.53-4.49 (m, 2H), 3.86 (s, 
3H) ppm; 
13C NMR (126 MHz, CDCl3) δ 159.3, 156.7, 133.2, 133.0, 118.1, 106.9, 102.7, 100.8, 
69.3, 56.3 ppm; 
IR (film, cm−1) 2940, 1487, 1304, 1198, 1167;  





Bromoarene 3.42 (100 mg, 0.41 mmol) was dissolved in anhydrous diethyl ether (1.1 
mL).  CsF (125 mg, 0.82), [(t-Bu)3PH]BF4 (4 mg, 14 μmol), Pd2(dba)3 (6 mg, 6.2 
μmol) and tributyl-(3-methyl-2-butenyl)tin (147 µL, 0.43 mmol) were then added. The 
mixture was stirred at rt for 20 h, then diethyl ether (5 mL) and KF·2H2O (500 mg) 
were added and the mixture was stirred for 30 min. The mixture was then filtered 
through silica gel and the filtrate was washed with water (5 mL) The phases were 
separated and the solvent was removed under reduced pressure. Flash chromatography 
(90:10 petroleum spirit 40-60 / diethyl ether) afforded arene 3.52 as a light blue oil (5 
mg, 5% yield) along with recovered starting material 3.42 (38 mg, 0.15 mmol, 38% 
yield). 
 
Rf  0.34 (80:20 petroleum spirit 40-60 / diethyl ether); 
1H NMR (500 MHz, CDCl3) δ 7.15 (d, J = 8.5 Hz, 1H, H5), 6.50 (d, J = 2.5 Hz, 1H, 
H2), 6.42 (dd, J= 8.6, 2.6 Hz, 1H, H6), 6.20-6.14 (m, 1H, H13), 6.06 (ddt, J= 17.3, 
10.6, 5.4 Hz, 1H, H8), 5.42 (apparent dq, J = 17.3, 1.6 Hz, 1H, H9), 5.28 (appartent 
dq, J = 10.5, 1.4 Hz, 1H, H9), 4.93 (m, 1H, H14), 4.91 (dd, J = 5.7, 1.4 Hz, 1H, H14), 
4.52 (apparent dt, J = 5.4, 1.5 Hz, 2H, H7), 3.77 (s, 3H, H10), 1.43 (s, 6H, H12) ppm; 
13C NMR (126 MHz, CDCl3) δ 159.3 (C3), 158.4 (C1), 148.5 (C13), 183.6 (C8), 129.4 
(C4), 127.5 (C5), 117.8 (C9), 109.7 (C14), 104.4 (C6), 100.7 (C2), 69.0 (C7), 55.2 
(C10), 40.2 (C11), 27.5 (2C, C12) ppm; 
IR (film, cm−1) 2961, 2934, 1609, 1582; 




Bromo arene 3.42 (1.0 g, 4.1 mmol) was dissolved in a 2:1 degassed mixture of 
anhydrous diethyl ether and anhydrous benzene (40 mL). n-butyllithium (3.10 mL, 1.6 
M in hexane, 4.85 mmol) was added dropwise at 0 °C. After stirring for 40 min at rt, 
3,3-dimethylallyl bromide (947 µL, 8.2 mmol) was added and the mixture was stirred 
at rt until complete consumption of the starting material, judged by TLC analysis (22 
h). The reaction was then quenched with sat. aq. NH4Cl (25 mL) and the mixture was 
extracted with diethyl ether (3 × 25 mL). The combined organic layers were dried over 
anhydrous Na2SO4, and the solvent was removed under reduced pressure. Flash 
chromatography (97:3 petroleum spirit 40-60/ ethyl acetate) gave compound 3.44 as a 
colourless oil (480 mg, 2.06 mmol, 50% yield) as well as isomer 3.54 as a colourless 
oil (136 mg, 0.58 mmol, 14% yield). 
Note: more material could be recovered via further purification of combined mixed 
fractions containing arene 3.44 coming from different reactions.  
 
Rf 0.58 (70:30 petroleum spirit 40-60 / ethyl acetate); 
1H NMR (500 MHz, CDCl3) δ 7.01 (d, J = 8.2 Hz, 1H, H5), 6.48 (d, J = 2.4 Hz, 1H, 
H2), 6.43 (dd, J = 8.2, 2.4 Hz, 1H, H6), 6.07 (ddt, J = 17.3, 10.6, 5.4 Hz, 1H, H8), 5.41 
(apparent dq, J = 17.3, 1.6 Hz, 1H, H9), 5.32-5.25 (m, 2H, H9 + H12), 4.51 (apparent 
dt, J = 5.5, 1.5 Hz, 2H, H7), 3.81 (s, 3H, H10), 3.26-3.22 (m, 2H, H11), 1.74 (d, J = 
1.3 Hz, 3H, H14 or H15), 1.71-1.70 (m, 3H, H14 or H15) ppm; 
13C NMR (126 MHz, CDCl3) δ 158.2 (C3), 158.2 (C1), 133.7 (C8), 132.2 (C13), 129.5 
(C5), 123.1 (C12), 122.8 (C4), 117.7 (C9), 104.9 (C2), 99.4 (C6), 69.2 (C7), 55.5 
(C10), 27.9 (C11), 25.9 (C14 or C15), 17.9 (C14 or C15) ppm; 
IR (film, cm−1) 2963, 2913, 2857, 1611, 1587; 
HRMS (ESI+) 255.1352 (calculated [M+Na]+ 255.1355). 
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Rf 0.66 (80:20 petroleum spirit 40-60 / ethyl acetate); 
1H NMR (500 MHz, CDCl3) δ 7.04 (d, J = 8.1 Hz, 1H, H5), 6.55 (d, J = 2.4 Hz, 1H, 
H2), 6.51 (dd, J = 8.2, 2.4 Hz, 1H, H6), 6.37 (dq , J = 6.1, 1.7 Hz 1H, H7), 5.31-5.26 
(m, 1H, H12), 4.85 (dq, J= 6.9, 6.1 Hz, 1H, H8), 3.82 (s, 3H, H10), 3.26 (dd, J = 7.4, 
1.4 Hz, 2H, H11), 1.75-1.70 (m, 6H, H14 + H15), 1.72 (dd, J= 6.9, 1.7 Hz, 3H, H9) 
ppm; 
13C NMR (126 MHz, CDCl3) δ 158.2 (C3), 157.0 (C1), 141.4 (C7), 132.4 (C13), 129.6 
(C5), 124.3 (C4), 122.8 (C12), 107.2 (C8), 107.1 (C5), 100.1 (C2), 55.5 (C10), 28.0 
(C11), 25.9 (C14 or C15), 17.8 (C14 or C15), 9.5 (C9) ppm; 
IR (film, cm−1) 2967, 2920, 1670, 1607, 1589; 




To a solution of allyl ether 3.42 (200 mg, 0.82 mmol) in anhydrous CH2Cl2 (2.0 mL), 
boron trichloride solution (2.46 mL, 1 M in CH2Cl2, 2.46 mmol) was added carefully 
at –50 °C and the mixture was stirred at the same temperature for 1 h. Then water (10 
mL) was added carefully, the mixture was allowed to slowly warm to rt and was then 
extracted with CH2Cl2 (3 × 8 mL). The organic layer was washed with brine (20 mL) 
and dried over anhydrous MgSO4. The solvent was removed under reduced pressure. 
Analysis of the 1H NMR of the crude revealed a 20:1 ratio of compounds 3.56 and 
3.57. Flash chromatography (80:20 petroleum spirit 40-60 / diethyl ether) afforded 
phenol 3.56 (160 mg, 0.66 mmol, 80% yield), as well as its regioisomer 3.57 as a 
colourless oil (4 mg, 16 µmol, 2% yield). 
 
Rf 0.15 (70:30 petroleum spirit 40-60 / diethyl ether); 
1H NMR (500 MHz, CDCl3) δ 7.24 (s, 1H), 6.46 (s, 1H), 5.97 (ddt, J = 16.7, 10.5, 6.3 
Hz, 1H), 5.20-5.19 (m, 1H), 5.19-5.16 (m, 1H), 5.03 (broad s, 1H), 3.84 (s, 3H), 3.32 
(apparent dt, J = 6.2, 1.5, 2H) ppm;   
13C NMR (126 MHz, CDCl3): δ 155.6, 154.7, 136.1, 134.2, 118.4, 117.2, 102.1, 101.2, 
56.5, 34.6 ppm; 
IR (film, cm−1) 3489 (broad), 2974, 1610, 1583; 




Rf 0. 25 (70:30 petroleum spirit 40-60 / diethyl ether); 
1H NMR (500 MHz, CDCl3) δ 7.30 (d, J = 8.7 Hz, 1H), 6.56 (d, J = 8.7 Hz, 1H), 6.1 
(ddt, J = 17.1, 10.2, 5.9 Hz 1H), 5.18-5.13 (m, 2H), 5.01 ( broad s, 1H), 3.80 (s, 3H), 
3.52, (apparent dt, J = 5.9, 1.8 Hz, 2H) ppm; 
13C NMR (126 MHz, CDCl3) δ 155.9, 155.1, 135.8, 131.6, 121.1, 116.7, 113.6, 108.3, 
61.5, 29.1 ppm; 
IR (film, cm−1) 3410 (broad), 2941, 2359, 1638, 1580; 




Allyl ether 3.44 (100 mg, 0.41 mmol) was heated, neat, at 190 °C under nitrogen 
atmosphere for 18 h. Analysis of the 1H NMR spectrum of the crude revealed a 6:1 
ratio of compounds 3.40 and 3.58.  Flash chromatography (80:20 petroleum spirit 40-
60 / diethyl ether) afforded compound 3.40 as a pale orange oil (71 mg, 0.31 mmol, 
71% yield) as well as its regioisomer 3.58 as as a pale-yellow oil (5 mg, 0.021 mmol, 
5% yield). 
 
Rf 0.12 (80:20 petroleum spirit 40-60 / diethyl ether); 
1H NMR (500 MHz, CDCl3) δ 6.82 (s, 1H, H5), 6.40 (s, 1H, H2), 6.01 (ddt, J = 17.4, 
10.1, 6.3 Hz, 1H, H8), 5.30-5.25 (m, 1H, H12), 5.21-5.17 (m, 2H, H9), 4.93 (broad s, 
1H, OH at C1), 3.78 (s, 3H, H10), 3.35-3.32 (m, 2H, H7), 3.24-3.21 (m, 2H, H11), 
1.73 (s, 3H, H14 or H15), 1.71 (s, 3H, H14 or H15) ppm; 
13C NMR (126 MHz, CDCl3) δ 157.1 (C3), 153.3 (C1), 137.2 (C8), 132.1 (C13), 131.0 
(C5), 123.3 (C12), 122.5 (C6), 116.4 (C9), 116,0 (C4), 99.7 (C2), 55.7 (C10), 35.1 
(C7), 27.9 (C11), 26.0 (C14 or C15), 17.9 (C14 or C15) ppm; 
IR (film, cm−1) 3438 (broad), 2965, 2913, 2855, 1618, 1508; 




Rf 0.20 (80:20 petroleum spirit 40-60 / diethyl ether); 
1H NMR (500 MHz, CDCl3) δ 6.95 (d, J = 8.3 Hz, 1H, H5), 6.60 (d, J = 8.3 Hz, 1H, 
H6), 6.05 (ddt, J = 17.5, 9.6, 5.9 Hz, 1H, H8), 5.29-5.25 (m, 1H, H12), 5.18-5.15 (m, 
1H, H9), 5.14-5.13 (m, 1H, H9), 4.91 (broad s, 1H, OH at C1), 3.71 (s, 3H, H10), 3.50-
3.48 (m, 2H, H7), 3.31-3.28 (m, 2H, H11), 1.75-1.73 (m, 3H, H14 or H15), 1.73-1.71 
(m, 3H, H14 or H15) ppm; 
13C NMR (126 MHz, CDCl3) δ 157.0 (C3), 153.8 (C1), 136.6 (C8), 132.3 (C13), 128.6 
(C5), 127.1 (C2), 123.5 (C12), 118.7 (C4), 116.2 (C9), 112.0 (C6), 61.7 (C10), 28.7 
(C7), 28.1 (C11), 25.9 (C14 or C15), 18.0 (C14 or C15) ppm; 
IR (film, cm−1) 3372 (broad), 2968, 2914, 1638, 1599; 





Phenol 3.40 (19 mg, 0.08 mmol) was dissolved in acetic acid (2.5 mL). Then Pb(OAc)4 
(50 mg, 0.11 mmol) was added as a solid and the mixture was stirred at rt for 30 min. 
Then ethyl acetate (8 mL) and water (7 mL) were added and the mixture was stirred 
for another 30 min and then was extracted with ethyl acetate (3 × 8 mL) The combined 
organic layers were washed with brine (3 × 30 mL), dried over anhydrous Na2SO4 and 
the solvent was removed under reduced pressure. Analysis of the 1H NMR spectrum 
of the crude revealed a 1:1 mixture of two compounds. Flash chromatography (55:45 
petroleum spirit 40-60 / ethyl acetate) afforded ortho-quinol acetate (±)-3.59 (7 mg, 24 
μmol, 30% yield). It was not possible to obtain a pure sample of the second compound.  
 
 
Rf 0.40 (55:45 petroleum spirit 40-60 / diethyl ether); 
1H NMR (500 MHz, CDCl3) δ 5.91 (t, J = 1.6 Hz, 1H, H5), 5.71 (dddd, J = 17.0, 10.2, 
7.7, 6.8 Hz, 1H, H8), 5.51 (s, 1H, H2), 5.14-5.10 (m, 1H, H12), 5.09-5.04 (m, 2H, H9), 
3.78 (s, 3H, H10), 3.03-2.88 (m, 2H, H11), 2.51-2.42 (m, 2H, H7), 2.08 (s, 3H, H17), 
1.75-1.73 (m, 3H, H14 or H15), 1.61-1.59 (m, 3H, H14 or H15) ppm; 
13C NMR (126 MHz, CDCl3) δ 197.2 (C1), 170.9 (C3), 169.3 (C16), 136.5 (C5), 134.8 
(C13), 133.2 (C4), 130.5 (C8), 120.1 (C12), 119.8 (C9), 100.0 (C2), 80.1 (C6), 56.2 
(C10), 43.5 (C7), 28.2 (C11), 25.9 (C17), 20.9 (C14 or C15), 17.9 (C14 or C15) ppm; 
IR (film, cm−1) 2978, 2914, 2854, 1741, 1662, 1570; 





Arene 3.40 (50 mg, 0.21 mmol) was dissolved in acetonitrile (2 mL) and water (0.5 
mL) at rt.  The solution was cooled to 0 °C then PIDA (PhI(OAc)2) (83 mg, 0.26 mmol) 
was added slowly while stirring vigorously. After 30 min at 0 °C, sat. aq. Na2SO3 (2 
mL) and diethyl ether (2 mL) were added, the phases were separated and the aqueous 
layer was extracted with diethyl ether (2 × 5 mL). The combined organic layers were 
then dried over anhydrous Na2SO4 and the solvent was removed under reduced 
pressure. Flash chromatography (50:50 petroleum spirit 40-60 / diethyl ether) afforded 
epoxide (±)-3.61 as an orange oil (6 mg, 0.024 mmol, 12% yield). 
 
 
Rf 0.18 (50:50 petroleum spirit 40-60 / diethyl ether); 
1H NMR (500 MHz, CDCl3) δ 6.89 (s, 1H, H5), 6.42 (s,1H, H2), 5.99 (ddt, J = 17.2, 
10.1, 6.3 Hz, 1H, H8), 5.21-5.12 (m, 2H, H9), 5.06 (broad s, 1H, OH at C1), 3.78 (s, 
3H, H10), 3.34 (apparent dt, J= 6.3, 1.7 Hz, 2H, H7), 2.96 (apparent t, J= 6.1 Hz, 1H, 
H12), 2.82-2.73 (m, 2H, H11), 1.37 (s, 3H, H14 or H15), 1.31 (s, 3H, H14 or H15) 
ppm; 
13C NMR (126 MHz, CDCl3) δ 157.4 (C3), 154.0 (C1), 137.0 (C8), 131.8 (C5), 118.7 
(C6), 116.7 (C9), 116.5 (C4), 99.7 (C2), 64.2 (C12), 59.0 (C13), 55.6 (C10), 34.9 (C7), 
29.2 (C11), 25.1 (C14 or C15), 19.1 (C14 or C15) ppm; 
IR (film, cm−1) 3390 (broad), 2924, 1614, 1605, 1514; 





In a glass vial SIBX (183 mg, 0.30 mmol, 45% w/w) was dissolved in DMSO-d6 (1.2 
mL). Phenol 3.40 (28 mg, 0.12 mmol) was then added. Aliquotes from the reaction 
mixture were used to monitor the reaction by 1H NMR. After complete consumption 
of the starting material, the reaction mixture was cooled to 0 °C and quenched with 
water (3 mL). The suspension was filtered and the filtrate was extracted with diethyl 
ether (2 × 3 mL). The combined organic layers were washed with sat. aq. NaHCO3, 
dried over anhydrous Na2SO4 and the solvent was removed under reduced pressure. 
Due to the inherent instability of otho-quinol (±)-3.35, it was not possible to purify it, 
thus 1H NMR and 13C NMR data of the crude product are reported (see 1H and 13C 
NMR spectra on pages 345 and 346). Crude yield: 61%. 
 
1H NMR (500 MHz, CDCl3) δ 6.21 (t, J = 1.7 Hz, 1H, H5), 5.75-5.66 (m, 1H, H8), 
5.44 (s, 1H, H2), 5.16-5.12 (m, 1H, H12), 5.11-5.05 (m, 2H, H9), 3.81 (s, 3H, H10), 
3.00-2.90 (m, 2H, H11), 2.44-2.33 (m, 2H, H7), 1.75-1.73 (m, 3H, H14 or H15), 1.62 
(m, 3H, H14 or H15) ppm; 
13C NMR (126 MHz, CDCl3) δ 203.5 (C1), 172.3 (C3), 139.1 (C5), 134.8 (C13), 131.3 
(C4), 129.5 (C8), 120.0 (C12), 119.6 (C9), 97.5 (C2), 76.6 (C6), 56.5 (C10), 47.4 (C7), 




A solution of SIBX (642 mg, 1.03 mmol, 45% w/w) in DMSO (5 mL) was transferred 
into a flask containing phenol 3.40 (100 mg, 0.43 mmol) and the mixture was stirred 
at rt until complete consumption of the starting material, judged by TLC analysis (7 
h). The reaction mixture was then cooled to 0° C and diethyl ether (20 mL) was added. 
The mixture was washed with sat. aq. NaHCO3 (3 × 20 mL) and water (20 mL). The 
organic layer was dried over anhydrous Na2SO4 and the solvent was removed under 
reduced pressure. Flash chromatography (80:20 petroleum spirit 40-60 / ethyl acetate) 
afforded compound (±)-3.38 as a pale-yellow oil (58 mg, 0.23 mmol, 54% yield). 
 
 
Rf 0.13 (80:20 petroleum spirit 40-60 / ethyl acetate). 
1H NMR (500 MHz, CDCl3) δ 6.44 (broad s, 1H, OH at C6), 5.67 (s, 1H, H5), 5.63 
(s, 1H, H2), 5.46 (dddd, J = 16.9, 10.2, 7.9, 6.7 Hz, 1H, H8), 5.00-4.90 (m, 2H, H9), 
4.83-4.80 (m, 1H, H12), 3.72 (s, 3H, H10), 2.61-2.47 (m, 2H, H7 + H11), 2.33 (dd, J 
= 13.4, 6.7 Hz, 1H, H7), 2.25 (dd, J = 13.9, 6.9 Hz, 1H, H11), 1.60 (s, 3H, H14 or 
H15), 1.55 (s, 3H, H14 + H15) ppm; 
13C NMR (126 MHz, CDCl3) δ 183.8 (C1), 180.6 (C3), 146.6 (C6), 135.0 (C13), 132.8 
(C8), 118.1 (2C, C9 + C12), 116.3 (C5), 101.5 (C2), 56.1 (C10), 48.9 (C4), 43.3 (C7), 
37.8 (C11), 25.9 (C14 or C15), 18.0 (C14 or C15) ppm; 
IR (film, cm−1) 3365, 2980, 2914, 2856, 1610, 1593; 




Carbonate 3.62 was prepared using a literature procedure.154 
A solution of methylmagnesium chloride (5.2 mL, 3 M in THF, 15.6 mmol) was diluted 
with anhydrous diethyl ether (20 mL) at 0° C. To the resulting white suspension, a 
solution of 2-methyl-3-buten-2-ol (1.25 mL, 12.0 mmol) in anhydrous diethyl ether (5 
mL) was added dropwise. The mixture was stirred at 0° C for 30 min, then a cool 
solution (0° C) of isobutyl choloroformate (2.34 mL, 18.0 mmol) in diethyl ether (25 
mL) was added rapidly and the mixture was allowed to warm to rt and stirred for 17 
h. The reaction was then quenched with sat. aq. NH4Cl (50 mL), the phases were 
separated and the aqueous layer was extracted with diethyl ether (3 × 50 mL). The 
combined organic layers were dried over anhydrous Na2SO4 and the solvent was 
removed under reduced pressure. Flash chromatography (92:8 petroleum spirit 40-60 
/ diethyl ether) gave carbonate 3.62 as a colourless oil (1.65 g, 8.88 mmol, 74% yield). 
All data for compound 3.62 matched literature values.154 
 
Rf 0.63 (90:10 petroleum spirit 40-60 / diethyl ether); 
1H NMR (500 MHz, CDCl3) δ 6.10 (dd, J = 17.5, 10.9 Hz, 1H), 5.21 (dd, 17.5, 0.7 
Hz, 1H), 5.12 (dd, 10.9, 0.7 Hz, 1H), 3.85 (dd, J = 6.7, 0.6 Hz, 2H), 1.95 (sept, J = 6.7 
Hz, 1H), 1.55 (s, 6H), 0.93 (d, J = 6.7 Hz, 6H)ppm; 





Phenol 3.39 (291 mg, 1.36 mmol) was dissolved in anhydrous acetonitrile (6 mL). 
DBU (224 µL, 1.48 mmol), CuCl2 (2 mg, 15 μmol) and 3-chloro-3-methyl-1-butyne 
(145 µL, 1.24 mmol) were then added in portions at 0 °C. The mixture was allowed to 
warm to rt and stirred for 19 h, then diethyl ether (15 mL) and 1 M aq. HCl (3 mL), 
were added. The layers were separated and the organic phase was washed with brine 
(2 × 15 mL). The organic layer was dried over anhydrous Na2SO4 and the solvent was 
removed under reduced pressure. Flash chromatography (95:5 petroleum spirit 40-60 
/ diethyl ether) afforded alkyne 3.65 (228 mg, 0.85 mmol, 68% yield) along with allene 
3.66 (9 mg, 0.027 mmol, 2% yield). 
 
Rf 0.31 (90:10 petroleum spirit 40-60 / diethyl ether); 
1H NMR (500 MHz, CDCl3) δ 7.40 (d, J = 8.6 Hz, 1H), 6.81 (d,  J = 2.5, 1H), 6.77 
(dd, J = 8.6, 2.6 Hz, 1H), 3.86 (s, 3H), 2.59 (s, 1H), 1.65 (s, 6H) ppm; 
13C NMR (126 MHz, CDCl3) δ 156.3, 156.3, 132.8, 114.3, 106.3, 105.0, 86.0, 74.3, 
72.9, 56.3, 29.7 (2C) ppm; 
IR (film, cm−1) 3435, 2994, 1587; 




Rf 0.58 (80:20 petroleum spirit 40-60 / diethyl ether); 
1H NMR (500 MHz, CDCl3) δ 7.38 (d, J = 8.6 Hz, 1H), 6.91 (d, J = 2.6 Hz, 1H), 6.70 
(dd, J = 8.6, 2.6 Hz, 1H), 5.23 (sept, J = 2.9 Hz, 1H), 3.86 (s, 3H), 1.72 (d, J = 3.0 Hz, 
6H), 1.63 (s, 6H) ppm; 
13C NMR (126 MHz, CDCl3) δ 210.4, 156.5, 156.1, 132.7, 114.8, 106.4, 104.7, 98.0, 
90.5, 80.5, 73.8, 72.8, 56.2, 29.7 (2C), 20.1 (2C) ppm; 
IR (film, cm−1) 2984, 2938, 1584, 1481, 1446; 




Propargylated arene 3.65 (214 mg, 1.05 mmol) was dissolved in ethyl acetate (12 mL). 
Quinoline (1.09 mL, 9.04 mmol) and Lindlar’s catalyst (30 mg) were added at rt. The 
suspension was frozen and the flask was evacuated and then fitted with an H2 balloon. 
The mixture was then allowed to warm to the rt and stirred until complete consumption 
of the starting material, judged by TLC analysis (4.5 h). The mixture was then diluted 
with ethyl acetate (25 mL), filtered through a short pad of celite and the solvent was 
removed under reduced pressure. Flash chromatography (90:10 petroleum spirit 40-60 
/ ethyl acetate) afforded alkene 3.43 (192 mg, 0.71 mmol, 89% yield). 
 
Rf 0.31 (90:10 petroleum spirit 40-60 / ethyl acetate); 
1H NMR (500 MHz, CDCl3) δ 7.32 (d, J = 8.6 Hz, 1H), 6.57 (d, J = 2.6 Hz, 1H), 6.51 
(dd, J = 8.6, 2.6 Hz, 1H), 6.13 (dd, J = 17.6, 10.9 Hz, 1H), 5.21-5.14 (m, 2H), 3.83 (s, 
3H), 1.46 (s, 6H) ppm; 
13C NMR (126 MHz, CDCl3) δ 156.8, 156.2, 144.3, 132.6, 114.4, 113.9, 106.4, 104.1, 
80.2, 56.2, 27.1 (2C) ppm; 
IR (film, cm−1) 2978, 2934, 1726, 1578; 




Phenol 3.39 (10.24 g, 48.3 mmol) was dissolved in anhydrous CH2Cl2 (200 mL) and 
i-Pr2EtN (25.24 mL, 144.9 mmol) was added at rt. MOM-Cl (9.18 mL, 121 mmol) was 
added dropwise at 0 °C and the mixture was stirred for 30 minute and then allowed to 
warm to rt and stirred for another 2 h. The reaction was then cooled to 0 °C, quenched 
with sat. aq. NaHCO3 (200 mL), diluted with diethyl ether (80 mL) and stirred for 30 
minutes. The phases were separated and the aqueous layer was extracted with diethyl 
ether (3 ×200 mL). The combined organic layers were dried over anhydrous Na2SO4 
and the solvent was removed under reduced pressure. Flash chromatography (85:15 
petroleum spirit 40-60 / diethyl ether) afforded MOM-ether 3.68 as a white solid (10.26 
g, 41.5 mmol, 86% yield). 
 
Rf 0.35 (80:20 petroleum spirit 40-60 / diethyl ether); 
1H NMR (500 MHz, CDCl3) δ 7.40 (d, J = 8.7 Hz, 1H), 6.62 (d, J = 2.7 Hz, 1 H), 6.56 
(dd, J = 8.7, 2.7 Hz, 1H), 5.15 (s, 2H), 3.87 (s, 3H), 3.48 (s, 3H) ppm; 
13C NMR (126 MHz, CDCl3) δ 158.0, 156.7, 133.3, 109.0, 103.8, 101.8, 94.8, 56.3, 
56.2 ppm; 
IR (film, cm−1) 2955, 2903, 2825, 1582; 
HRMS (ESI+) 246.9975, 248.9965, 268.9789, 270.9769 (calculated [M + H]+ 




Bromo arene 3.68 (604 mg, 2.44 mmol) was dissolved in a 2:1 degassed mixture of 
anhydrous diethyl ether and anhydrous benzene (12 mL). n-butyllithium (1.69 mL, 2.6 
M in hexane, 4.39 mmol) was added dropwise at rt. After 30 min, allyl bromide (465 
µL, 5.37 mmol) was added and the mixture was stirred at rt for 2 h, then quenched 
with sat. aq. NH4Cl (12 mL) and extracted with diethyl ether (3 × 20 mL). The 
combined organic layers were dried over anhydrous Na2SO4 and the solvent was 
removed under reduced pressure. Flash chromatography (88:12 petroleum spirit 40-60 
/ ethyl acetate) afforded arene 3.69 as a colourless oil (485 mg, 2.33 mmol, 95% yield).  
 
 
Rf 0.46 (80:20 petroleum spirit 40-60 / diethyl ether); 
1H NMR (500 MHz, CDCl3) δ 7.03 (d, J = 8.0 Hz, 1H), 6.62-6.57 (m, 2H), 6.01-5.93 
(m, 1H), 5.16 (d, J = 0.7 Hz, 2H), 5.06-4.99 (m, 2H), 3.81 (s, 3H), 3.49 (d, J = 0.5 Hz, 
3H), 3.32 (d, J = 6.6 Hz, 2H) ppm; 
13C NMR (126 MHz, CDCl3) δ 158.2, 157.1, 137.4, 130.2, 122.3, 115.2, 107.3, 100.3, 
94.9, 56.1, 55.6, 33.8 ppm; 
IR (film, cm−1) 2953, 2935, 2900, 1610, 1587; 




MOM-ether 3.69 (562 mg, 2.70 mmol) was dissolved in diethyl ether (20 mL). MeOH 
(40 mL) and 12 M HCl (1.51 mL) were then added at rt. The mixture was stirred at rt 
until complete consumption of the starting material, judged by TLC analysis (17 h). 
The reaction mixture was then diluted with water (20 mL) and extracted with ethyl 
acetate (3 × 30 mL). The combined organic layers were dried over anhydrous Na2SO4 
and the solvent was removed under reduced pressure. Flash chromatography (80:20 
petroleum spirit 40-60 / ethyl acetate) afforded phenol 3.70 (371 mg, 2.26 mmol, 84% 
yield). 
 
Rf 0.30 (80:20 petroleum spirit 40-60 / ethyl acetate); 
1H NMR (500 MHz, CDCl3) δ 6.96 (d, J = 8.0 Hz, 1H), 6.41 (d, J = 2.4 Hz, 1H), 6.35 
(dd, J = 8.1, 2.5 Hz, 1H), 5.96 (ddt, J = 16.8, 10.2, 6.5 Hz, 1H), 5.06-5.01 (m, 1H), 
5.01-4.99 (m, 1H), 4.67 (broad s, 1H), 3.79 (s, 3H), 3.30 (d, J = 6.5 Hz, 2H) ppm; 
13C NMR (126 MHz, CDCl3) δ 158.4, 155.2, 137.5, 130.4, 121.1, 115.1, 106.8, 99.1, 
55.6, 33.7 ppm; 
IR (film, cm−1) 3308 (broad), 2967, 2911, 1614, 1599;  




Phenol 3.70 (109 mg, 0.66 mmol) was dissolved in anhydrous acetonitrile (3 mL). 
DBU (120 µL, 0.79 mmol), copper chloride (1 mg, 6.0 µmol) and 3-chloro-3-methyl-
1-butyne (67 µL, 0.60 mmol) were added at 0 °C. The mixture was stirred at rt for 16 
h, then diethyl ether (7 mL) and 1 M aq. HCl (1.5 mL), were added. The layers were 
separated and the organic phase was washed with brine (2 × 8 mL). The organic layer 
was dried over anhydrous Na2SO4 and the solvent was removed under reduced 
pressure. Flash chromatography (98:2 petroleum spirit 40-60 / ethyl acetate) afforded 
alkyne 3.71 as a pale-yellow oil (94 mg, 0.41 mmol, 68% yield) along with allene 3.72 
as a pale-yellow oil (4 mg, 0.013 mmol, 2% yield). 
 
Rf 0.36 (85:15 petroleum spirit 40-60 / diethyl ether); 
1H NMR (500 MHz, CDCl3) δ 6.91 (d, J = 8.1 Hz, 1H, H5), 6.70 (dd, J = 8.1, 2.3 Hz, 
1H, H6), 6.66 (d, J = 2.3 Hz, 1H, H2), 5.89 (ddt, J = 16.8, 10.1, 6.6 Hz, 1H, H8), 4.97-
4.91 (m, 2H, H9), 3.70 (s, 3H, H10), 3.23 (dd, J = 6.6, 1.6 Hz, 2H, H7), 2.46 (s, 1H, 
H14), 1.55 (s, 6H, H12) ppm; 
13C NMR (126 MHz, CDCl3) δ 157.6 (C3), 155.2 (C1), 137.4 (C8), 129.4 (C5), 123.2 
(C4), 115.3 (C9), 113.0 (C6), 105.0 (C2), 86.6 (C13), 73.7 (C14), 72.5 (C11), 55.5 
(C10), 33.8 (C7), 29.8 (2C, C12) ppm; 
IR (film, cm−1) 2988, 2936, 1605, 1563; 




Rf 0.52 (85:15 petroleum spirit 40-60 / diethyl ether); 
1H NMR (500 MHz, CDCl3) δ 6.99 (d, J = 8.2 Hz, 1H, H5), 6.84 (d, J = 2.3 Hz, 1H, 
H2), 6.72 (dd, J = 8.2, 2.3 Hz, 1H, H6), 5.99 (ddt, J = 16.8, 10.1, 6.6 Hz, 1H, H8), 5.24 
(sept, J = 2.9 Hz, 1H, H15), 5.06-4.99 (m, 2H, H9), 3.79 (s, 3H, H10), 3.34-3.31 (m, 
2H, H7), 1.72 (d, J = 2.9 Hz, 6H, H18), 1.63 (s, 6H, H12) ppm; 
13C NMR (126 MHz, CDCl3) δ 210.3 (C16), 157.6 (C3), 155.4 (C1), 137.5 (C8), 129.4 
(C5), 123.0 (C4), 115.2 (C9), 113.5 (C6), 105.2 (C2), 97.7 (C17), 91.2 (C13), 79.9 
(C14), 73.4 (C11), 73.0 (C15), 55.5 (C10), 33.9 (C7), 29.8 (2C, C12), 20.1 (2C, C18) 
ppm; 
IR (film, cm−1) 2987, 2936, 1958, 1604, 1568; 




Propargyl ether 3.71 (120 mg, 0.52 mmol) was dissolved in ethyl acetate (10 mL). 
Quinoline (530 µL, 4.47 mmol) and Lindlar’s catalyst (28 mg) were added at rt. The 
suspension was frozen and the flask was evacuated and then fitted with an H2 balloon. 
The mixture was then allowed to warm to the rt and stirred until complete consumption 
of the starting material, judged by TLC analysis (4 h). The mixture was diluted with 
ethyl acetate (15 mL), filtered through a short pad of celite and the solvent was 
removed under reduced pressure. Flash chromatography (90:10 petroleum spirit 40-60 
/ ethyl acetate) afforded alkene 3.45 as a pale-yellow oil (114 mg, 0.49 mmol, 94% 
yield). 
 
Rf 0.56 (80:20 petroleum spirit 40-60 / ethyl acetate); 
1H NMR (500 MHz, CDCl3) δ 6.94 (d, J = 8.1 Hz, 1H, H5), 6.55 (dd, J = 8.2, 2.3 Hz, 
1H, H6), 6.52 (d, J = 2.3 Hz, 1H, H2), 6.16 (dd, J = 17.6, 10.9 Hz, 1H, H13), 5.97 (ddt, 
J = 16.8, 10.2, 6.6 Hz, 1H, H8), 5.18 (dd, J = 17.6, 1.0 Hz, 1H, H14), 5.13 (dd, J = 
10.9, 1.0 Hz, 1H, H14), 5.06-4.99 (m, 2H, H9), 3.76 (s, 3H, H10), 3.32-3.27 (m, 2H, 
H7), 1.45 (s, 6H, H12) ppm; 
13C NMR (126 MHz, CDCl3) δ 157.6 (C3), 155.7 (C1), 145.9 (C13), 137.5 (C8), 129.3 
(C5), 122.4 (C4), 115.2 (C9), 113.3 (C14), 113.1 (C6), 105.2 (C2), 79.6 (C11), 55.5 
(C10), 33.8 (C7), 27.2 (2C, C12) ppm; 
IR (film, cm−1) 2978, 2934, 1607, 1584, 1501; 




Ether 3.45 (113 mg, 0.49 mmol), neat, was heated to 190 °C for 16 h under nitrogen 
atmosphere. The crude was directly subjected to chromatographic purification. Flash 
chromatography (70:30 petroleum spirit 40-60 / diethyl ether) afforded phenol 3.41 as 
a pale-yellow oil (50 mg, 0.22 mmol, 50% yield) and its isomer 3.73 as a pale-yellow 
oil (7 mg, 0.030 mmol, 6% yield). 
 
Rf 0.19 (70:30 petroleum spirit 40-60 / diethyl ether); 
1H NMR (500 MHz, CDCl3) δ 6.82 (s, 1H, H5), 6.40 (s, 1H, H2), 5.97 (ddt, J = 16.7, 
10.1, 6.5 Hz, 1H, H8), 5.32-5.28 (m, 1H, H12), 5.10 (broad s, 1H, OH at C1), 5.05-
4.98 (m, 2H, H9), 3.77 (s, 3H, H10), 3.29-3.27 (m, 4H, H7 + H11), 1.79 (s, 3H, H14 
or H15), 1.77 (d, J = 1.4 Hz, 3H, H14 or H15) ppm; 
13C NMR (126 MHz, CDCl3) δ 156.9 (C3), 153.8 (C1), 137.7 (C8), 134.8 (C13), 131.1 
(C5), 122.5 (C12), 120.6 (C4), 117.9 (C6), 115.0 (C9), 99.7 (C2), 55.7 (C10), 33.7 (C7 
or C11), 29.6 (C7 or C11), 25.9 (C14 or C15), 18.0 (C14 or C15) ppm; 
IR (film, cm−1) 3416 (broad), 2963, 1913, 1616, 1512; 




Rf 0.55 (70:30 petroleum spirit 40-60 / diethyl ether); 
1H NMR (500 MHz, CDCl3) δ 6.93 (d, J = 8.4 Hz, 1H, H5), 6.59 (d, J = 8.3 Hz, 1H, 
H6), 5.97 (ddt, J = 17.9, 9.4, 6.5 Hz, 1H, H8), 5.26-5.22 (m, 1H, H12), 5.14 (broad s, 
1H, OH at C1), 5.08-5.03 (m, 2H, H9), 3.70 (s, 3H, H10), 3.45-3.41 (m, 2H, H11), 
3.37-3.34 (m, 2H, H7), 1.84-1.83 (m, 3H, H14 or H15), 1.76-1.75 (m, 3H, H14 or H15) 
ppm; 
13C NMR (126 MHz, CDCl3) δ 156.8 (C3), 154.5 (C1), 137.9 (C8), 135.1 (C13), 128.6 
(C5), 125.1 (C4), 122.2 (C12), 120.5 (C2), 115.5 (C9), 112.1 (C6), 61.7 (C10), 33.9 
(C7), 25.9 (C14 or C15), 23.6 (C11), 18.1 (C14 or C15) ppm; 
IR (film, cm−1) 3406, 2965, 2913, 1599, 1458, 1423; 




Phenol 3.41 (6 mg, 27 µmol) was dissolved in DMSO-d6 (0.6 mL). SIBX (40 mg, 64 
µmol, 45% w/w) was then added in one portion. The reaction was monitored by 1H 
NMR and judged to be complete after 4 h (see page 378 for stacked 1H NMR spectra). 
Attempts on separating ortho-quinol (±)-3.37 from the residual resulted in the 
formation of a mixture of unidentified products. 
 
1H NMR (500 MHz, CDCl3) δ 6.07 (d, J = 1.3 Hz, 1H), 5.87-5.73 (m, 1H), 5.39 (s, 
1H), 5.10-4.98 (m, 2H), 4.97-4.89 (m, 1H), 3.74 (s, 3H), 3.01-2.88 (m, 2H), 2.34 (dd, 




Compound 3.4 was prepared using a modified literature procedure.165 
Sesamol (19.79 g, 140.4 mmol) was dissolved in anhydrous acetone (400 mL), then 
potassium carbonate (20.35 g, 147.4 mmol) and allyl bromide (17.3 mL, 193.7 mmol) 
were added. The mixture was heated at 56 °C until complete consumption of the 
starting material, judged by TLC analysis (16 h). The mixture was then diluted with 
CH2Cl2 (400 mL) and washed with 2 M aq. NaOH (400 mL). The organic layer was 
dried over anhydrous Na2SO4 and the solvent was removed under reduced pressure to 
afford allyl ether as a colourless oil (25.0 g, 140.3 mmol, 99% crude yield). The crude 
material was deemed sufficiently pure (see 1H and 13C NMR spectra on pages 379 and 
380) to be used in the next step. All data for compound 3.4 matched literature values.165 
 
Rf 0.54 (70:30 petroleum spirit 40-60 / diethyl ether); 
1H NMR (500 MHz, CDCl3) δ 6.70 (d, J = 8.5 Hz, 1H), 6.52 (d, J = 2.5 Hz, 1H), 6.34 
(dd, J = 8.5, 2.5 Hz, 1H), 6.03 (ddt, J = 17.3, 10.6, 5.3 Hz, 1H), 5.91 (s, 2H), 5.42-5.36 
(m, 1H), 5.29-5.25 (m, 1H), 4.46 (dt, J = 5.3, 1.5 Hz, 2H) ppm; 
13C NMR (126 MHz, CDCl3) δ 154.3, 148.4, 141.9, 133.6, 117.8, 108.1, 106.2, 101.3, 




Compound 3.5 was prepared using a modified literature procedure.165 
Crude allyl ether 3.4 (25.0 g, 140.3 mmol) was heated, neat, to 190 °C for 15 h. The 
crude material was directly subjected to the next step without further purification. 
Analytically pure samples could be obtained via flash chromatography (70:30 
petroleum spirit 40-60 / diethyl ether) to afford phenol 3.5 as a pale yellow crystalline 
solid. All data for compound 3.5 matched literature values.165 
 
Rf 0.27 (70:30 petroleum spirit 40-60 / diethyl ether); 
1H NMR (500 MHz, CDCl3) δ 6.58 (s, 1H), 6.43 (s, 1H), 5.97 (ddt, J = 17.6, 9.7, 6.3 
Hz, 1H), 5.88 (s, 2H), 5.18-5.15 (m, 1H), 5.14-5.12 (m, 1H), 4.65 (s, 1H), 3.31 (dt, J 
= 6.3, 1.6 Hz, 2H) ppm; 
13C NMR (126 MHz, CDCl3) δ 148.8, 146.9, 141.7, 136.6, 116.9, 116.6, 109.7, 101.2, 




Compound 3.6 was prepared using a modified literature procedure.120 
Crude phenol 3.5 (24.7 g) was dissolved in anhydrous acetone (500 mL), then 
potassium carbonate (95.7 g, 693 mmol) and prenyl bromide (20.2 mL, 166.4 mmol) 
were added. The mixture was heated at 56 °C until complete consumption of the 
starting material, judged by TLC analysis (16 h). The mixture was then diluted with 
CH2Cl2 (500 mL) and washed with 1 M aq. NaOH (600 mL). The organic layer was 
dried over anhydrous Na2SO4 and the solvent was removed under reduced pressure. 
Flash chromatography (95:5 petroleum spirit 40-60 / ethyl acetate) afforded ether 3.6 
as a pale-yellow oil which solidified when stored at −20 °C (22.15 g, 89.9 mmol) in 
65% yield over 3 steps from sesamol. All data for compound 3.6 matched literature 
values.120 
 
Rf 0.42 (90:10 petroleum spirit 40-60 / ethyl acetate); 
1H NMR (500 MHz, CDCl3) δ 6.65 (s, 1H), 6.53 (s, 1H), 5.93 (ddt, J = 16.8, 10.1, 6.6 
Hz, 1H), 5.88 (s, 2H), 5.47-5.44 (m, 1H), 5.07-4.99 (m, 2H), 4.44 (dm, J = 6.7 Hz, 
2H), 3.31 (dm, J = 6.6 Hz, 2H), 1.79-1.78 (m, 3H), 1.72-1.71 (m, 3H) ppm;  
13C NMR (126 MHz, CDCl3) δ 151.4, 146.3, 141.3, 137.5, 137.5, 121.7, 120.4, 115.4, 




(±)-Illicinone A 1.3 was prepared using a modified literature procedure.120 
4-Bromo-2,6-di-tertbutyl phenol (11.68 g, 40.0 mmol) was dissolved in anhydrous 
CH2Cl2 (80 mL). Trimethylaluminium (10.0 mL, 20.0 mmol, 2 M in hexane) was 
added dropwise at rt and the mixture was stirred for 1 h. A solution of illicinole 3.6 
(2.35 g, 9.52 mmol) in anhydrous CH2Cl2 (10 mL) was then added within 30 min at 
−78 °C. The mixture was stirred at the same temperature until complete consumption 
of the starting material, judged by 1H NMR analysis (3 h). The reaction was then 
carefully quenched adding 1 M aq. HCl (50 mL), then the mixture was extracted with 
diethyl ether (3 × 50 mL). The combined organic layers were washed with brine (150 
mL), dried over anhydrous Na2SO4 and the solvent was removed under reduced 
pressure. Flash chromatography (90:10 petroleum spirit 40-60 / ethyl acetate) afforded 
(±)-illicinone A 1.3 as a pale orange oil (1.74 g, 7.06 mmol, 75% yield). All data for 
compound (±)-1.3 matched literature values.120 
 
Rf 0.30 (90:10 petroleum spirit 40-60 / ethyl acetate); 
1H NMR (500 MHz, CDCl3) δ 6.60 (t, J = 1.5 Hz, 1H, H3), 5.81 (ddt, J = 16.4, 10.8, 
6.8 Hz, 1H, H8), 5.62 (s, 1H, H15), 5.59 (s, 1H, H15), 5.54 (s, 1H, H6), 5.13-5.05 (m, 
2H, H9), 5.03-4.94 (m, 1H, H11), 3.12-2.98 (m, 2H, H7), 2.46 (dm, J = 14.2 Hz, 2H, 
H10), 1.68 (d, J = 1.4 Hz, 3H, H13 or H14), 1.54 (d, J = 1.4 Hz, 3H, H13 or H14) ppm; 
13C NMR (126 MHz, CDCl3) δ 187.0 (C1), 173.9 (C5), 139.5 (C2), 137.8 (C12), 135.0 
(C8), 134.5 (C3), 117.4 (C9), 116.1 (C11), 98.5 (C6), 98.2 (C15), 82.2 (C4), 35.0 
(C10), 33.6 (C7), 26.0 (C13 or C14), 18.0 (C13 or C14) ppm. 
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4-Bromo-2,6-di-tertbutyl phenol (539 mg, 1.85 mmol) was dissolved in anhydrous 
CH2Cl2 (3.5 mL). Trimethylaluminium (460 µL, 0.92 mmol, 2 M in hexane) was added 
dropwise at rt and the mixture was stirred for 1 h. A solution of illicinole 3.6 (114 mg, 
0.46 mmol) in anhydrous CH2Cl2 (1.5 mL) was then added within 30 min at −78 °C. 
The mixture was stirred at the same temperature until complete consumption of the 
starting material, judged by by 1H NMR analysis (2.5 h). β-Ocimene (580 µL, 2.1 
mmol, 60:40 trans/cis mixture of isomers) was then added and the mixture was slowly 
allowed to warm to the rt and stirred for 15 h. The reaction was then carefully quenched 
adding 1 M aq. HCl (4 mL), then the mixture was extracted with diethyl ether (3 × 5 
mL). The combined organic layers were washed with brine (10 mL), dried over 
anhydrous Na2SO4 and the solvent was removed under reduced pressure. Flash 
chromatography (90:10 petroleum spirit 40-60 / ethyl acetate) afforded                           
(±)-cycloillicinone 1.6 as a single diastereoisomer (pale yellow crystalline solid, 77 
mg, 0.20 mmol, 44% yield).  
All data for compound (±)-1.6 matched literature values.127 
 
Rf 0.26 (90:10 petroleum spirit 40-60 / ethyl acetate);  
1H NMR (600 MHz, CDCl3) δ 5.74 (dddd, J = 16.9, 10.0, 8.0, 6.8 Hz, 1H), 5.60-5.56 
(m, 1H), 5.54 (s, 2H), 5.40 (s, 1H), 5.18-5.13 (m, 1H), 5.05-5.01 (m, 1H), 5.01-4.95 
(m, 2H), 2.55 (dd, J = 13.9, 8.0 Hz, 1H), 2.51 (dd, J = 11.5, 5.7 Hz, 1H), 2.52-2.45 (m, 
1H), 2.39-2.32 (m, 1H), 2.22 (ddd, J = 15.2, 7.5, 5.7 Hz, 1H), 2.16 (dd, J = 15.8, 7.7 
Hz, 1H), 2.11 (dd, J = 10.8, 4.4 Hz, 1H), 2.01-1.90 (m, 3H), 1.72 (s, 3H), 1.67 (apparent 
t, J = 1.9 Hz, 3H), 1.62 (s, 3H), 1.57 (s, 3H), 1.50 (s, 3H) ppm; 
 222 
13C NMR (150 MHz, CDCl3) δ 201.6, 172.7, 142.3, 136.5, 135.0, 132.3, 123.6, 121.8, 
118.1, 116.7, 99.5, 98.0, 84.1, 54.1, 51.4, 45.4, 41.0, 37.4, 29.8, 26.0, 25.8, 24.5, 24.1, 
18.5, 17.9 ppm;  
HRMS (ESI+) 382.2504 (calculated [M+H]+ 382.2503); 
IR: (film, cm−1) 2961, 2911, 1667, 1636; 





Synthetic (±)-Cycloillicinone 1.6 (CDCl3) 
Natural (±)-Cycloillicinone 1.6 (Fukuyama)127 
(CDCl3) 
δ 1H (600 MHz) m J (Hz) δ 13C (150 MHz) δ 1H (600 MHz) m J (Hz) δ 13C (150 MHz) 
1 - - 201.6 - - 201.5 








4 - - 84.1 - - 83.9 
5 - - 172.7 - - 172.6 




















5.04 d, 17.0 
118.0 














11 5.18-5.13 m 116.7 5.16 dd, 7.8, 5.8 116.5 
12 - - 136.5 - - 136.4 
13 1.57 s 18.5 1.56 s 18.4 
















2.01-1.90††† m 1.97 
ddd, 15.1, 
11.5, 5.5 




18 - - 142.3 - - 142.1 








21 2.01-1.90††† m 29.8 1.93 m 29.7 
22 5.01-4.95†† m 123.6 4.99 m 123.4 
 23 - - 132.3 - - 132.2 
24 1.50 s 17.9 1.50 s 17.8 
25 1.62 s 25.8 1.63 s 25.6 
†, ††,††† overlapping signals. 
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(±)-Illicinone A 1.3 (1.70 g, 6.90 mmol) was dissolved in anhydrous CH2Cl2 (60 mL), 
then m-CPBA (2.01 g, 8.97 mmol) was added as a solid. The mixture was stirred at rt 
for 5 h, then cooled to 0 °C until precipitation of a white solid (m-CPBA and                     
m-chlorobenzoic acid) was observed and the reaction was quenched with sat. aq. 
Na2S2O3 (40 mL). The mixture was filtered, washed with sat. aq. NaHCO3 (3 × 50 
mL) and the organic layer was dried over anhydrous Na2SO4. Removal of the solvent 
under reduced pressure afforded epoxide as a 55:45 mixture of diastereoisomers 
(colourless oil, 1.77 g, 6.75 mmol, 98% crude yield) (see 1H NMR spectrum on page 
393). Flash chromatography (90:10 to 70:30 petroleum spirit 40-60 / ethyl acetate) 
afforded epoxide (±)-epi–illicinone C 3.79 as a single diastereoisomer (colourless oil, 
619 mg, 2.36 mmol, 34% yield) along with its stereoisomer (±)-illicinone C 3.79 as a 
colourless oil (313 mg, 1.19 mmol, 17% yield). It was possible to isolate further 
quantities of both epoxides (±)-3.79 and (±)-3.78 purifying combined mixed fractions. 
All data for compounds (±)-3.79 and (±)-3.78 matched literature values.135 
 
Rf 0.24 (70:30 petroleum spirit 40-60 / ethyl acetate); 
1H NMR (500 MHz, CDCl3) δ 6.74 (t, J = 1.6 Hz, 1H, H3), 5.84 (ddt, J = 17.2, 10.5, 
6.9 Hz, 1H, H8), 5.65 (s, 1H, H15), 5.59 (s, 1H, H6), 5.59 (s, 1H, H15), 5.17-5.10 (m, 
2H, H9), 3.10 (dd, J = 6.9, 1.4 Hz, 2H, H7), 2.73 (dd, J = 6.5, 5.6 Hz, 1H, H11), 2.22 
(dd, J = 14.3, 5.6 Hz, 1H, H10), 1.82 (dd, J = 14.3, 6.6 Hz, 1H, H10), 1.27 (s, 3H, H13 
or H14), 1.19 (s, 3H, H13 or H14) ppm; 
 225 
13C NMR (126 MHz, CDCl3) δ 186.6 (C1), 173.8 (C5), 140.2 (C2), 134.6 (C8), 134.0 
(C3), 118.0 (C9), 98.6 (C6), 98.3 (C15), 80.0 (C4), 59.2 (C11), 58.4 (C12), 35.8 (C10), 
33.5 (C7), 24.6 (C13 or C14), 18.9 (C13 or C14) ppm. 
 
Rf 0.22 (70:30 petroleum spirit 40-60 / ethyl acetate); 
1H NMR (500 MHz, CDCl3) δ 6.82 (t, J = 1.5 Hz, 1H, H3), 5.89-5.80 (m, 1H, H8), 
5.65 (s, 1H, H15), 5.60 (s, 1H, H6), 5.59 (s, 1H, H15), 5.17-5.09 (m, 2H, H9), 3.12-
3.06 (m, 2H, H7), 2.82 (dd, J = 7.3, 4.7 Hz, 1H, H11), 2.24 (dd, J = 14.4, 4.7 Hz, 1H, 
H10), 1.74 (dd, J = 14.5, 7.3 Hz, 1H, H10), 1.28 (s, 3H, H13 or H14), 1.21 (s, 3H, H13 
or H 14) ppm; 
13C NMR (126 MHz, CDCl3) δ 186.8 (C1), 173.9 (C5), 139.3 (C2), 134.8 (C8), 134.7 
(C3), 117.8 (C9), 98.8 (C6), 98.2 (C15), 80.3 (C4), 59.1 (C11), 58.4(C12), 36.5 (C10), 




Epoxide (±)-epi-illicinone C 3.79 (d.r. 96:4, 22 mg, 84 µmol) was dissolved in a 95:5 
mixture of ethanol/water (4 mL). p-TSA (1 mg, 4 µmol) was added and the mixture 
was hated to 80 °C until complete consumption of the starting material, judged by TLC 
analysis (3 h). The mixture was then extracted with CH2Cl2 (3 × 5 mL), the combined 
organic layers were dried over anhydrous Na2SO4 and the solvent was removed under 
reduced pressure. Flash chromatography (70:30 petroleum spirit 40-60 / ethyl acetate) 
afforded ether (±)-3.83 as a colourless oil (5 mg, 16 µmol, 20% yield), alcohol (±)-epi-
illicinone E 3.2 as a colourless oil (2 mg, 7 µmol, 8% yield), ether (±)-3.84 as a 
colourless oil (2 mg, 7 µmol, 8% yield) and alcohol (±)-3.85 as a colourless oil (1 mg, 
4 µmol, 5% yield). 
 
Rf 0.40 (70:30 petroleum spirit 40-60 / ethyl acetate); 
1H NMR (500 MHz, CDCl3) δ 6.52 (t, J = 1.4 Hz, 1H, H3), 5.80 (ddt, J = 16.9, 10.1, 
6.8 Hz, 1H, H8), 5.19 (s, 1H, H15), 5.14-5.05 (m, 2H, H9), 4.95 (s, 1H, H15), 4.29 
(dd, J = 10.3, 5.3 Hz, 1H, H11), 3.53-3.38 (m, 2H, H16), 3.24 (d, J = 17.0 Hz, 1H, 
H6), 3.00 (ddd, J = 6.8, 2.3, 1.3 Hz, 2H, H7), 2.89 (d, J = 17.0 Hz, 1H, H6), 2.39 (dd, 
J = 13.5, 5.3 Hz, 1H, H10), 2.17 (dd, J = 13.5, 10.3 Hz, 1H, H10), 1.20 (s, 3H, H13 or 
H14), 1.11 (s, 3H, H13 or H14), 1.11 (t, J = 7.0 Hz, 3H, H17) ppm; 
13C NMR (126 MHz, CDCl3) δ 194.7 (C1), 138.7 (C3), 138.4 (C2), 134.5 (C8), 117.7 
(C9), 111.3 (C5), 94.9 (C15), 86.3 (C11), 85.5 (C4), 74.6 (C12), 57.5 (C16), 46.2 (C6), 
37.4 (C10), 33.2 (C7), 22.5 (C13 or C14), 21.7 (C13 or C14), 16.3 (C17) ppm; 
HRMS (ESI+) 331.1521 (calculated [M+Na]+ 331.1521); 
IR: Due to sample contamination, the IR spectrum was not recorded. 
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Rf 0.16 (70:30 petroleum spirit 40-60 / ethyl acetate); 
1H NMR (500 MHz, CDCl3) δ 6.52 (t, J = 1.4 Hz, 1H), 5.78 (td, J = 10.2, 6.8 Hz, 1H), 
5.21 (s, 1H), 5.14-5.06 (m, 2H), 4.94 (s, 1H), 4.26 (dd, J = 10.7, 4.8 Hz, 1H), 3.28 (d, 
J = 16.7 Hz, 1H), 3.00 (dd, J = 6.8, 1.4 Hz, 2H), 2.79 (d, J = 16.7 Hz, 1H), 2.38 (dd, J 
= 13.3, 4.8 Hz, 1H), 2.13 (dd, J = 13.3, 10.7 Hz, 1H), 1.73 (broad s, 1H), 1.31 (s, 3H), 
1.12 (s, 3H) ppm; 
13C NMR (126 MHz, CDCl3) δ 194.2, 139.0, 138.1, 134.3, 117.9, 111.1, 95.0, 86.3, 
85.8, 70.4, 46.5, 37.5, 33.3, 27.7, 24.4 ppm; 
HRMS (ESI+) 281.1400, (calculated [M+H]+ 281.1384); 





Synthetic (±)-epi-illicinone E 3.2 (CDCl3) Natural (±)-epi-illicinone E 3.2 (Kuono)119 (CDCl3) 
δ 1H (600 MHz) m J (Hz) δ 13C (150 MHz) δ 1H (600 MHz) m J (Hz) δ 13C (150 MHz) 
1 - - 194.2 - - 194.1 
2 - - 139.0 - - 138.8 
3 6.52 t, 1.4  138.1 6.52 s 138.0  
4 - - 85.8 - - 85.6 
5 - - 111.1 - - 110.9 
6 
2.79 d, 16.7 
46.5 
2.80 d, 17 
46.3 
3.28 d, 16.7 3.28 d, 17 





ddd, 17, 10 
3 
134.1 
9 5.14-5.06 m 117.9 
5.09 dd, 17, 1 
117.8 















86.3 4.26 dd, 11, 5 86.1 
12 - - 70.4 - - 70.2 
13 1.12 s 24.4 1.12 s 24.3 






5.21 s 5.21 s 
OH at 
C12 
1.73 s (br.) - - - - 
 




Rf 0.22 (70:30 petroleum spirit 40-60 / ethyl acetate); 
1H NMR (600 MHz, CDCl3) δ 6.59 (t, J = 1.5 Hz, 1H, H3), 5.84 (ddt, J = 17.0, 10.3, 
6.9 Hz, 1H, H8), 5.53 (s, 1H, H6), 5.14-5.12 (m, 1H, H9), 5.12-5.09 (m, 1H, H9), 4.87 
(dd, J = 10.0, 4.6 Hz, 1H, H11), 3.53-3.41 (m, 2H, H15), 3.07 (ddd, J = 6.8, 3.5, 1.4 
Hz, 2H, H7), 2.27 (dd, J = 12.8, 4.6 Hz, 1H, H10), 2.05 (broad d, J = 2.6 Hz, 1H, OH 
at C4), 2.02 (d, J = 12.6 Hz, 1H, H10), 1.26 (s, 3H, H13 or H14), 1.19 (s, 3H, H13 or 
H14), 1.12 (t, J = 7.0 Hz, 3H, H15) ppm; 
13C NMR (151 MHz, CDCl3) δ 187.2 (C1), 178.3 (C5), 139.6 (C2), 135.3 (C3), 135.0 
(C8), 117.6 (C9), 99.4 (C6), 91.2 (C11), 74.6 (C12), 73.0 (C4), 57.9 (C15), 36.3 (C10), 
33.5 (C7), 22.6 (C13 or C14), 21.4 (C13 or C14), 16.3 (C16) ppm; 
HRMS (ESI+) 279.1601, 301.1408 (calculated [M+H]+ 279.1591, [M+Na]+ 
301.1410); 
IR: due to insufficient quantities of material, the IR spectrum of compound (±)-3.84 










Rf 0.14 (70:30 petroleum spirit 40-60 / ethyl acetate); 
1H NMR (500 MHz, CDCl3) δ 6.60 (t, J = 1.6 Hz, 1H, H3), 5.83 (ddt, J = 16.8, 10.4, 
6.9 Hz, 1H, H8), 5.54 (s, 1H, H6), 5.14-5.08 (m, 2H, H9), 4.82 (dd, J = 9.9, 4.6 Hz, 
1H, H11), 3.06 (dm, J = 6.9 Hz, 2H, H7), 2.27 (dd, J = 12.6, 4.7 Hz, 1H, H10), 2.06 
(dd, J = 12.8, 10.1 Hz, 1H, H10), 2.04 (broad s, 1H, OH at C4 or C12), 1.65 (broad s, 
1H, OH at C4 or C12), 1.40 (s, 3H, H13 or H 14), 1.18 (s, 3H, H13 or H14) ppm; 
13C NMR: due to sample contamination, the 13C NMR spectrum of compound            
(±)-3.85 was not recorded. 






Epoxide (±)-epi-illicinone C 3.79 (39 mg, 0.15 mmol) was dissolved in THF (7 mL). 
Water (2 mL) and p-TSA (2 mg, 0.01 mmol) was added and the mixture was heated to 
65 °C until complete consumption of the starting material, judged by TLC analysis (22 
h). The mixture was then diluted with water (8 mL) and extracted with CH2Cl2 (3 × 12 
mL). The combined organic layers were dried over anhydrous Na2SO4 and the solvent 
was removed under reduced pressure. Flash chromatography (80:20 petroleum spirit 
40-60 / ethyl acetate) afforded alcohol (±)-epi-illicinone E 3.2 as a colourless oil (8 




Epoxide (±)-epi-illicinone C 3.79 (37 mg, 0.14 mmol) was dissolved in anhydrous 
methanol (7 mL). p-TSA (2 mg, 0.01 mmol) was added and the mixture was heated to 
65 °C until complete consumption of the starting material, judged by TLC analysis (20 
min). The mixture was then diluted with water (10 mL) and extracted with CH2Cl2 (3 
× 10 mL). The combined organic layers were dried over anhydrous Na2SO4 and the 
solvent was removed under reduced pressure. Flash chromatography (80:20 petroleum 
spirit 40-60 / ethyl acetate) afforded ether (±)-3.87 as a colourless oil (16 mg, 56 µmol, 
40% yield) along with alcohol (±)-3.87 as a colourless oil (5 mg, 18 µmol, 13% yield). 
 
Rf 0.56 (60:40 petroleum spirit 40-60 / ethyl acetate); 
1H NMR (600 MHz, CDCl3) δ 6.51 (t, J = 1.5 Hz, 1H, H3), 5.79 (ddt, J = 17.0, 10.1, 
6.8 Hz, 1H, H8), 5.18 (s, 1H, H15), 5.15-5.03 (m, 2H, H9), 4.94 (s, 1H, H15), 4.30 
(dd, J = 10.5, 5.2 Hz, 1H, H11), 3.25 (d, J = 17.0 Hz, 1H, H6), 3.24 (s, 3H, H16), 3.02-
2.96 (m, 2H, H7), 2.85 (d, J = 17.0 Hz, 1H, H6), 2.38 (dd, J = 13.5, 5.2 Hz, 1H, H10), 
2.10 (dd, J = 13.5, 10.5 Hz, 1H, H10), 1.18 (s, 3H, H13 or H14), 1.11 (s, 3H, H13 or 
H14) ppm; 
13C NMR (151 MHz, CDCl3) δ 194.6 (C1), 138.6 (C2), 138.5 (C3), 134.5 (C8), 117.8 
(C9), 111.2 (C5), 94.9 (C15), 86.0 (C11), 85.4 (C4), 74.9 (C12), 50.2 (C16), 46.2 (C6), 
37.6 (C10), 33.3 (C7), 21.5 (C13 or C14), 21.0 (C13 or C14) ppm; 
HRMS (ESI+) 295.1579, 317.1392 (calculated [M+H]+ 295.1540, [M+Na]+ 
317.1360); 
IR: (film, cm−1) 2976, 2941, 2895, 1686, 1641. 
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Rf 0.42 (60:40 petroleum spirit 40-60 / ethyl acetate); 
1H NMR (600 MHz, CDCl3) δ 6.58 (t, J = 1.6 Hz, 1H, H3), 5.84 (ddt, J = 17.2, 10.4, 
6.9 Hz, 1H, H8), 5.53 (s, 1H, H6), 5.13-5.08 (m, 2H, H9), 4.87 (dd, J = 10.0, 4.7 Hz, 
1H, H11), 3.26 (s, 3H, H15), 3.05 (dm, J = 6.9 Hz, 2H, H7), 2.26 (dd, J = 12.8, 4.7 Hz, 
1H, H10), 2.24 (broad d, J = 2.5 Hz, 1H, OH at C4), 2.01 (ddd, J = 12.6, 10.0, 2.4 Hz, 
1H, H10), 1.26 (s, 3H, H13 or H14), 1.17 (s, 3H, H13 or H14) ppm; 
13C NMR (151 MHz, CDCl3) δ 187.3 (C1), 178.2 (C5), 139.6 (C2), 135.3 (C3), 135.0 
(C8), 117.6 (C9), 99.5 (C6), 91.1 (C12), 74.8 (C4), 73.0 (C12), 50.4 (C15), 36.2 (C10), 
33.5 (C7), 21.6 (C13 or C14), 20.8 (C13 or C14) ppm; 
HRMS (ESI+) 265.1458, 287.1275 (calculated [M+H]+ 265.1434, [M+Na]+ 
287.1254); 




Ether (±)-3.88 (5 mg, 17 µmol) was dissolved in deuterated methanol (0.6 mL) in an 
NMR tube. p-TSA (a small crystal, > 1 mg) was added and mixture was heated to 55 
°C and monitored by 1H NMR. Analysis of the crude 1H NMR spectrum after 1 h of 




Epoxide (±)-3.79 (d.r. 72:28) (32 mg, 0.12 mmol) was dissolved in anhydrous ethanol 
(6 mL). p-TSA (2 mg, 0.01 mmol) was added and the mixture was heated to 65 °C for 
24 h. The mixture was then diluted with water (8 mL) and extracted with CH2Cl2 (3 × 
10 mL). The combined organic layers were dried over anhydrous Na2SO4 and the 
solvent was removed under reduced pressure. Flash chromatography (80:20 petroleum 
spirit 40-60 / ethyl acetate) afforded ether (±)-3.84 as a colourless oil (7 mg, 25 µmol, 
20% yield). See page 229 for characterisation data. 
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4.4 NMR Spectra for Chapter 2 
1H NMR Spectrum of Compound 2.24  
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13C NMR Spectrum of Compound 2.24 
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1H NMR Spectrum of Compound 2.43 
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4.5 NMR Spectra for Chapter 3 
1H NMR Spectrum of Compound 3.42 
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1H NMR Spectrum of (±)-Cycloillicinone 1.6 
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13C NMR Spectrum of (±)-Cycloillicinone 1.6 
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1H NMR Spectrum of (±)-epi-Illicinone C 3.79 and (±)-Illicinone C 3.78  
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1H NMR Spectrum of (±)-epi-Illicinone C 3.79 
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13C NMR Spectrum of (±)-epi-Illicinone C 3.79 
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1H NMR Spectrum of (±)-Illicinone C 3.78 
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13C NMR Spectrum of (±)-Illicinone C 3.78
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1H NMR Spectrum of Compound (±)-3.83 
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13C NMR Spectrum of Compound (±)-3.83 
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1H NMR Spectrum of (±)-epi-Illicinone E 3.2 
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13C NMR Spectrum of (±)-epi-Illicinone E 3.2 
 
 401 












1H NMR Spectrum of Compound (±)-3.84 
 
 405 
13C NMR Spectrum of Compound (±)-3.84 
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1H NMR Spectrum of Compound (±)-3.85 
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1H NMR Spectrum of Compound (±)-3.87 
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4.6 Computational Studies (Dr Fernanda Duarte)  
4.6.1 Computational Methods 
Calculations were performed with Gaussian09 rev. E.01166 using the long-range 
corrected hybrid ωB97X-D density functional,167 which incorporates a force-field-like 
pairwise dispersion correction term developed by Grimme,168 in combination with the 
6–31+G(d) basis set. Calculations were repeated using the 6–311++G(d,p) basis set to 
ensure that geometries and energies are not affected by the selection of a smaller basis 
set. All stationary points were verified as either minima or saddle points by the 
presence of zero or a single imaginary harmonic vibrational frequency, respectively. 
In all cases, a quasi-rigid-rotor-harmonic-oscillator approximation was used in which 
the treatment of vibrational entropies switches from the standard rigid-rotor/harmonic-
oscillator (RRHO) model to a free rotor description for frequencies below 100 cm–1, 
as first proposed by Grimme,169 and implemented in Python.170 Relative free energies 
were evaluated at 353 K. 
A two-dimensional scan of the potential energy surface (PES) was performed on the 
model p-N-cis system, constraining the forming C···C and C···O bonds in increments 
of 0.1 Å and 0.2 Å, respectively. This surface allowed us to locate the bis-pericyclic 
Diels–Alder and the [3,3]-sigmatropic rearrangement transition states (TS1 and TS2, 
respectively), which were then optimised without any constraint to obtain the 
corresponding transition state (TS), reactant (RS) and product (PS) complexes. 
4.6.2 Benchmark Study 
Using a simplified model bearing no ortho-substituent (hereinafter referred to as 2.81) 
we explored the transition state (TS) structures for each regioisomeric outcome of the 
Diels–Alder (DA) dimerisation. For this system, there are eight distinct TSs possible; 
Described using a notation where the regiochemical-orientation is meta (m) or para 
(p), the Alder–Stein mode is endo (N) or exo (X), and the dienophile adopts an s-cis 
(cis) or s-trans (trans) conformation. Energies obtained at the ωB97X-D/6–31+G(d), 
were compared to those obtained using the 6–311++G(d,p) basis set (optimisation and 
energy calculations). Both sets of energies lead to the same preference and relative 
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ordering, with the latter being about 1.5 kcal mol–1 higher in energy. Single point 
calculations using the 6–311++G(d,p) basis set on the lower level optimised structures 
lead to slightly higher values to the ones obtained at the ωB97X-D/6–
311++G(d,p)//ωB97X-D/6–311++G(d,p), but once again leading to the same 
preference. Given these results, and the computational cost associated with them, we 
decided to use the ωB97X-D/6–311++G(d,p)//ωB97X-D/6–31+G(d) level of theory as 
a good compromise between accuracy and computational cost for further analysis. 
Table 4.1: Reaction free energies for the dimerisation of the model enal 2.81 (endo arrangement) at 
different levels of theory using the ωB97X-D functional and the 6–31+G(d) and 6–311++G(d,p) basis 
sets. TS and PS denote transition and product states, respectively. OPT and SP denote optimisation and 








OPT + SP 
6–311++G(d,p) 
p-N-trans 
ΔG‡ 35.7  37.2 36.5 
ΔG0 –7.8  –5.4 –6.2 
p-N-cis 
ΔG‡ 29.3  31.1 31.9 
ΔG0 –7.8  –5.4 –6.1 
m-N-trans 
ΔG‡ 42.6  44.1 43.6 
ΔG0 –1.2  0.8 –2.1 
m-N-cis 
ΔG‡ 41.5  43.0 42.3 
ΔG0 –4.1  –1.8 –2.7 
 
4.6.3 Regioselectivity  
Eight different potential TS were obtained and characterised at the ωB97X-D/6–
31+G(d)//ωB97X-D/6–31+G(d) level of theory (figure 4.1 and table 4.2). The 
regioselectivity for this process takes place under kinetic control, in view of the lower 
activation barrier computed for the formation of the p-N-cis adduct. The energy barrier 
for this pathway is ΔG‡ = 31.0 kcal mol–1 and is 2.2 kcal mol–1 lower than the analogous 
p-X-cis pathway. This value agree well with the one obtained for the dimerisation of 




Figure 4.1: Activation free energies (kcal mol–1) at the ωB97X-D/6–311++G(d,p)//ωB97X-D/6–
31+G(d) level of theory for the eight different potential TSs obtained for the hetero-Diels–Alder 
dimerisation of the model enal 2.81. Values are provided in table 4.2 (ΔG‡corr). 
Table 4.2: Reaction energies for the dimerisation process of the model enal 2.81 at the ωB97X-D/6–
31+G(d) level of theory and at the ωB97X-D/6–311++G(d,p)//ωB97X-D/6–31+G(d) level of theory 
(ΔG‡corr). All energies are in kcal mol–1 relative to the independent lower energy reactant at 353K. See 
table 4.7 for absolute values. 
 ΔE‡el ZPE ΔH‡ TΔS‡ ΔG‡ ΔGo ΔG‡corr ΔGocorr 
p-N-trans 15.3 2.3 16.9 –18.9 35.7 –7.8 37.2 –5.4 
p-X-trans 12.6 2.3 14.1 –19.2 33.3 –7.7 34.5 –5.2 
p-N-cis 9.0 2.0 10.3 –19.0 29.3 –7.8 31.0 –5.4 
p-X-cis 10.8 2.6 12.5 –19.5 32.0 –7.3 33.2 –4.8 
m-N-trans 22.0 2.1 23.3 –19.3 42.6 –1.2 44.1 0.8 
m-X-trans 19.3 2.6 20.8 –20.1 40.9 –1.5 41.7 0.6 
m-N-cis 20.8 2.2 22.3 –19.2 41.5 –4.1 43.0 –1.8 
m-X-cis 18.9 2.5 20.4 –19.9 40.4 –3.9 41.3 –1.6 
 
Noteworthy, the lowest energy TS p-N-cis, which displays a C2-symetry, correspond 
to a bis-pericyclic TS as first discovery by Caramella et al.172-175 figure 4.2 shows the 
relative positions of the bis-pericyclic Diels–Alder and [3,3]-sigmatropic 
rearrangement transition states (TS1 and TS2, respectively) for the model 2.81. At TS1 
the C···C bond at the end of the diene moieties is 1.9 Å, while the symmetrical C···O 
4,2 and 2,4 bonds are still rather long (2.84 Å). In this regard, TS1 closely follows the 
bis-pericyclic TS found by Caramella et al. for the dimerisation of methacrolein.172 
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After TS1 the intrinsic reaction coordinate (IRC) calculation leads toward the [3,3]- 
rearrangement transition state (TS2, figure 4.2b) for the interconversion of the two 
products. This TS is only 0.8 kcal mol–1 higher in energy (after inclusion of ZPE and 
entropy effects) and it shows a much shorter C···C bond (1.60 Å) and C···O bonds of 
equal length (2.60 Å). Given the symmetry of the system, the system can exit via either 
of the two degenerate products channels [4 + 2]/[2 + 4]. 
 
Figure 4.2: (left) Calculated potential energy landscapes, at the ωB97X-D/6–311++G(d,p)//ωB97X-
D/6–31+G(d) level of theory, for the Diels–Alder reaction of the model enal 2.81 via p-N-cis TS. 
Approximate transition state position for the bis-pericyclic Diels–Alder and the [3,3]-sigmatropic 
rearrangement transition states (TS1 and TS2) are indicated. (right) Optimised TS1 and TS2 and relevant 
distances obtained at the ωB97X-D/6–31+G(d) level of theory. 
Without exception, the p-TSs were found to be significantly lower in energy than the 
m-TSs, the m-N/X-cis being 10.3 and 12.0 kcal mol–1 higher in energy than the 
analogous p-N-cis. This is due to better orbital overlap and lower distortion penalties. 
Regarding exo/endo-selectivity, most of the TSs showed exo-selectivity, except the      
p-cis-TS, where the endo configuration is the preferred form. The exo-selectivity may 
sound counterintuitive given the well-known preference for the endo cycloadduct in 
Diels–Alder reactions involving maleic anhydride and cyclopentadiene or butadiene. 
Fernandez and Bickelhaupt176 have shown that endo preference is mainly caused by 
unfavourable steric arrangements in the exo pathway, which translates into a more 
destabilising activation strain and a preference for the endo form.  
In order to rationalise these observations we performed a similar distortion/interaction 
analysis,177,178 which has been previously applied in understanding 1,3-dipolar and 




















decomposed into the energy required for the reactants to reach the transition state 
geometry (ΔEdist
‡) and the energy of interaction between these distorted fragments 
(ΔEint
‡). The interaction energy term encompasses all of the stabilising and repulsive 
interactions between the diene and dienophile fragments at the TS.179,180  
Table 4.3. Distortion/interaction analysis at the ωB97X-D/6–311++G(d,p)//ωB97X-D/6–31+G(d) level 
of theory for the different TSs obtained for the hetero-Diels–Alder dimerisation of the model enal 2.81. 
Shown here are the distortion energies of the diene (ΔE‡dist_diene) and dienophile (ΔE‡dist_dienophile), the 
interaction energies (ΔEint‡) and the activation energies (ΔE‡). All energies are given in kcal mol–1. 
 p-trans p-cis m-trans m-cis 
 N X N X N X N X 
ΔE‡dist_diene 15.5 17.8 12.3 14.1 17.6 16.5 15.2 14.8 
ΔE‡dist_dienophile 10.3 13.3 12.3 12.6 11.7 14.7 15.0 15.4 
ΔE‡dist 25.8 31.0 24.7 26.7 29.4 31.2 30.2 30.3 
ΔE‡int –9.0 –17.3 –13.9 –14.7 –5.9 –11.1 –7.9 –10.5 
ΔE‡ 16.7 13.8 10.7 12.0 23.4 20.1 22.3 19.8 
 
 
Figure 4.3: Distortion, interaction and activation energy components for the different TSs obtained for 
the hetero-Diels–Alder dimerisation of the model enal 2.81. The length of the light/dark pink bars 
represents the distortion energy of the diene (ΔE‡dist_diene) and dienophile (ΔE‡dist_dienophile), respectively. 
The blue bars represent the interaction energy (ΔE‡int) and the green bar the activation energy (ΔE‡). All 
energies in kcal mol–1. 
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As graphically shown in figure 4.3, the exo pathway shows in all cases a higher 
distortion penalty, in line with the results previously obtained by Fernandez and 
Bickelhaupt. However, this is overcome by a much larger stabilising interaction 
contribution along this pathway. The nature of these interactions has been explored by 
comparing the noncovalent interaction (NCI)179,180 index for each of the TSs (figure 
4.4). The NCI isosurface shows regions in space corresponding to overlapping atomic 
densities, which may be associated with non-covalent interactions. In this case, green 
regions indicate van der Waals/dispersion interactions, blue regions show strong polar 
interactions and red regions indicate steric repulsion. 
As can be seen from figure 4.4 the exo arrangement leads to attractive non-bonding 
(dispersion) interactions between the aromatic fragments (and in some cases a CH- π 
interaction), which are not present in the N configuration.  
A different scenario is observed when comparing the p-N/X-cis TSs, in this case the 
energy to distort the reactant is the determining factor and the interaction energy 
between the two fragments at the TS is of similar strength. In this case the bis-
pericyclic nature of the p-cis TS allows for a secondary interaction between the lone-
pair of oxygen with the C–C π –bond is comparable in magnitude with the dispersion 
interactions present in the exo TS (figure 4.4). This interaction is also clear when 
visualising the HOMO of the p-cis-TS, which shows an orbital (figure 4.5). Therefore, 
the favorable steric arrangement (23.6 vs 25.8 kcal mol–1) and the presence of 
secondary orbital interactions between the lone-pair of oxygen with the C–C π lead to 
a preference for the p-N-cis pathway. 
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Figure 4.4: Non-Covalent Interaction (NCI) surfaces showing the key NCI interactions at the TS for 
the hetero-Diels–Alder dimerisation of enal 2.81. NCI surfaces correspond to s = 0.5 and a colour scale 
of −0.03 < ρ < +0.03 au. 
 
Figure 4.5: HOMO of the p-N-cis TS (top) and m-N-cis TS (bottom). The former one shows an orbital 
interaction of the lone-pair of oxygen with the C–C π-bond, while the m-N-cis TS lacks such secondary 
orbital interaction. 




















4.6.4 Substituent Effect 
The same regioselectivity was obtained for hetero-Diels–Alder dimerisation of enal 
2.48. Here several potential TS state geometries were explored by considering the 
variable rotations along the aryl and acetal bonds. The activation free energies and 
geometries for the lowest energy TS for each configuration are shown in figure 4.6 
and figure 4.7. 
The lowest energy TS was similarly found to be a p-N-cis TS, which although not C2-
symmetric still has bis-pericyclic character (figure 4.7). Once again a larger distortion 
penalty is generally observed for the exo pathway, however this is compensated by an 
additional interaction contribution due to non-covalent interactions (table 4.5). The 
preference for the p-N-cis TS is the result of a lower distortion penalty and an almost 
equal interaction energy, although different in nature. 
Table 4.4: Reaction energies for the dimerisation process of enal 2.48 at the ωB97X-D/6–31+G(d) level 
of theory and at the ωB97X-D/6–311++G(d,p)/ωB97X-D/6–31+G(d) level of theory (ΔG‡corr). All 
energies are in kcal mol–1 relative to the independent lower energy reactant at 353K. See table 4.8 for 
absolute numbers. 
 ΔE‡el ZPE ΔH‡ TΔS‡ ΔG‡ ΔG
‡
corr 
p-N-trans 16.0 2.6 17.7 –20.0 37.6 38.6 
p-X-trans 13.8 2.9 15.6 –21.0 36.6 37.0 
p-N-cis 11.2 2.2 12.7 –19.5 32.2 33.4 
p-X-cis 12.7 2.5 14.3 –20.0 34.3 35.3 
m-N-trans 24.2 2.5 25.7 –20.4 46.1 47.2 
m-X-trans 19.6 2.5 21.0 –21.0 42.0 42.1 
m-N-cis 20.6 2.3 22.0 –20.0 42.0 43.1 




Figure 4.6: Reaction free energies for the hetero-Diels–Alder dimerisation of enal 2.48 (in kcal mol–1). 
Calculations were carried out at the ωB97X-D/6–31++G(d,p)//ωB97X-D/6–31+G(d) level of theory. 
For absolute values see table 4.7. 
Table 4.5. Distortion/Interaction Analysis at the ωB97X-D/6–311++G(d,p)//ωB97X-D/6–31+G(d) 
level of theory for the different TS for the hetero-Diels–Alder dimerisation of enal 2.48. Shown here 
are the distortion energies of the diene (ΔE‡dist_diene) and dienophile (ΔE‡dist_dienophile), the interaction 
energies (ΔEint‡) and the activation energies (ΔE‡). All energies are given in kcal mol–1. 
  p-trans p-cis m-trans m-cis 
  N X N X N X N X 
ΔE‡dist_diene 17.9 18.4 15.5 15.7 18.0 17.5 16.3 15.6 
ΔE‡dist_dienophile 12.9 16.2 12.0 13.8 14.4 14.9 14.3 15.6 
ΔE‡dist 30.8 34.6 27.5 29.4 32.4 32.4 30.7 31.2 
ΔE‡int –18.1 –20.4 –15.1 –15.7 –10.8 –12.7 –9.0 –10.1 




Figure 4.7: TS geometry and non-Covalent Interaction (NCI) surface for p-N-cis TS for the TS for the 
hetero-Diels–Alder dimerisation of enal 2.48. NCI surfaces correspond to s = 0.5 and a colour scale of 
−0.03 < ρ < +0.03 au. 


















4.6.5 Tables with Absolute Energies 
Table 4.6: Absolute electronic energies (Eel), zero-point energy (ZPE), enthalpy (H), quasi-harmonic 
entropies (Tqh-S) and quasi-harmonic Gibbs energy (qh-G) in atomic units for the dimerisation process. 
RS, TS and PS denote reactant, transition and product states respectively. Reaction free energies are 
given in kcal·mol–1 relative to the independent trans specie. Calculations were carried out at the ωB97X-
D/6–311++G(d,p) level of theory.  
 Eel ZPE H Tqh-S qh-G ν (cm–1) 
Sub-cis –462.24299 0.17115 –462.05677 0.05915 –462.11593 53.5 
Sub-trans 462.24496 0.17145 –462.05855 0.05890 –462.11745 60.2 
p-N-trans-RS –924.49921 0.34417 –924.12383 0.09378 –924.21762 18.1 
p-N-trans-TS –924.46314 0.34577 –924.08835 0.08845 –924.17680 –441.4 
p-N-trans-PS –924.53603 0.35016 –924.15757 0.08714 –924.24471 19.1 
p-N-cis-TS1 –924.47277 0.34551 –924.09821 0.08835 –924.18655 –338.9 
p-N-cis-TS2 –924.47462 0.34795 –924.09878 0.08532 –924.18410 –53.8 
p-N-cis-PS –924.53606 0.35022 –924.15762 0.08698 –924.24460 19.5 
m-N-trans-RS –924.50323 0.34499 –924.12741 0.09226 –924.21968 23.2 
m-N-trans-TS –924.45249 0.34582 –924.07792 0.08748 –924.16540 –605.0 
m-N-trans-PS –924.53094 0.35092 –924.15192 0.08625 –924.23817 34.0 
m-N-cis-RS –924.49815 0.34430 –924.12259 0.09457 –924.21717 4.8 
m-N-cis-TS –924.45424 0.34575 –924.07962 0.08780 –924.16742 –592.0 
m-N-cis-PS –924.53105 0.35052 –924.15213 0.08705 –924.23918 27.1 
 ΔE‡el ZPE ΔH‡ TΔS‡ ΔG‡  
p-N-trans-RS –5.8 0.8 –4.2 –15.1 10.8  
p-N-trans-TS 16.8 1.8 18.0 –18.4 36.5  
p-N-trans-PS –28.9 4.6 –25.4 –19.2 –6.2  
p-N-cis-TS 9.6 3.2 11.5 –20.4 31.9  
p-N-cis-PS –29.0 4.6 –25.4 –19.3 –6.1  
m-N-trans-TS 23.5 1.8 24.6 –19.0 43.6  
m-N-trans-PS –25.7 5.0 –21.9 –19.8 –2.1  
m-N-cis-TS 22.4 1.8 23.5 –18.8 42.3  
m-N-cis-PS –25.8 4.8 –22.0 –19.3 –2.7  
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Table 4.7: Absolute electronic energies (Eel), zero-point energy (ZPE), enthalpy (H), quasi-harmonic 
entropies (Tqh-S), quasi-harmonic Gibbs energy (qh-G) (in atomic units) and the lowest frequency 
value (ν, cm–1) for the dimerisation of 2.81 process. Reaction free energies are given in kcal mol–1 
relative to the independent trans substrate specie at 353 K. TS and PS denote transition and product 
states respectively. Calculations were carried out at the ωB97X-D/6–31+G(d) level of theory. For 
comparison, free energies at the ωB97X-D/6–311++G(d,p)//ωB97X-D/6–31+G(d) level of theory are 
also provided (ΔG‡corr). 
 Eel ZPE H Tqh-S qh-G ν (cm–1) Ecorr 
Sub-cis –462.14142 0.17240 –461.95400 0.05906 –462.01306 54.4 –462.24279 
Sub-trans –462.14310 0.17234 –461.95572 0.05919 –462.01491 40.5 –462.24475 
p-N-trans-TS –924.26177 0.34830 –923.88454 0.08832 –923.97287 –430.4 –924.46282 
p-N-trans-PS –924.33628 0.35260 –923.95548 0.08682 –924.04230 19.9 –924.53572 
p-X-trans-TS –924.26617 0.34839 –923.88898 0.08777 –923.97675 –361.8 –924.46753 
p-X-trans-PS –924.33598 0.35259 –923.95507 0.08708 –924.04215 22.9 –924.53527 
p-N-cis-TS1 –924.27437 0.35011 –923.89638 0.08539 –923.983195 –353.7 –924.47244 
p-N-cis-TS2 –924.27186 0.347827 –923.89504 0.093744 –923.981769 -70.5 –924.47423 
p-N-cis-PS –924.33629 0.35262 –923.95554 0.08673 –924.042264 20.4 –924.53575 
p-X-cis-TS –924.26900 0.34885 –923.89149 0.08727 –923.97875 –407.3 –924.47041 
p-X-cis-PS –924.33611 0.35289 –923.95509 0.08638 –924.04147 23.9 –924.53536 
m-N-trans-TS –924.25113 0.34806 –923.87433 0.08755 –923.96188 –588.3 –924.45217 
m-N-trans-PS –924.32658 0.35323 –923.94531 0.08638 –924.03169 19.7 –924.52674 
m-X-trans-TS –924.25544 0.34878 –923.87829 0.08634 –923.96462 –58.2 –924.45744 
m-X-trans-PS –924.32622 0.35278 –923.94522 0.08695 –924.03217 17.4 –924.52625 
m-N-cis-TS –924.25299 0.34821 –923.87596 0.08775 –923.96371 –585.2 –924.45393 
m-N-cis-PS –924.33120 0.35319 –923.94986 0.08651 –924.03638 19.7 –924.53078 
m-X-cis-TS –924.25610 0.34867 –923.87889 0.08660 –923.96549 –563.9 –924.45790 
m-X-cis-PS –924.33046 0.35318 –923.94910 0.08687 –924.03597 20.1 –924.53015 
 ΔE‡el ZPE ΔH‡ TΔS‡ ΔG‡ ΔG‡corr  
p-N-trans-TS 15.3 2.3 16.9 –18.9 35.7 37.2  
p-N-trans-PS –31.4 5.0 –27.6 –19.8 -7.8 –5.4  
p-X-transTS 12.6 2.3 14.1 –19.2 33.3 34.5  
p-X-transPS –31.2 5.0 –27.4 –19.6 -7.7 –5.2  
p-N-cis-TS1 9.0 2.0 10.3 –19.0 29.3 31.0  
p-N-cis-TS2 7.4 3.4 9.5 –20.7 30.1 32.3  
p-N-cis-PS –31.4 5.0 –27.7 –19.9 -7.8 –5.4  
p-X-cis-TS 10.8 2.6 12.5 –19.5 32.0 33.2  
p-X-cis-PS –31.3 5.2 –27.4 –20.1 -7.3 –4.8  
m-N-trans-TS 22.0 2.1 23.3 –19.3 42.6 44.1  
m-N-trans-PS –25.3 5.4 –21.3 –20.1 –1.2 0.8  
m-X-trans-TS 19.3 2.6 20.8 –20.1 40.9 41.7  
m-X-trans-PS –25.1 5.1 –21.2 –19.7 –1.5 0.6  
m-N-cis-TS 20.8 2.2 22.3 –19.2 41.5 43.0  
m-N-cis-PS –28.2 5.3 –24.1 –20.0 –4.1 –1.8  
m-X-cis-TS 18.9 2.5 20.4 –19.9 40.4 41.3  
m-X-cis-PS –27.8 5.3 –23.6 –19.8 –3.9 –1.6  
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Table 4.8: Absolute electronic energies (Eel), zero-point energy (ZPE), enthalpy (H), quasi-harmonic 
entropies (Tqh-S) and quasi-harmonic Gibbs energy (qh-G) (in atomic units) and the lowest frequency 
value (ν, cm–1) for the dimerisation of 2.48. Activation free energies are given relative to the independent 
cis-cis substrate specie at 353K. Calculations were carried out at the ωB97X-D/6–31+G(d) level of 
theory. For comparison, free energies at the ωB97X-D/6–311++G(d,p)/ωB97X-D/6–31+G(d) are also 
provided (ΔG‡corr). 
 Eel ZPE H Tqh-S qh-G ν (cm–1) Ecorr 
Sub-cis-cis –689.95898 0.21465 –689.72323 0.07225 –689.79549 35.4 -690.11692 
Sub-cis-trans –689.95775 0.21459 –689.72204 0.07239 –689.79444 36.3 -690.11564 
Sub-trans-cis –689.95841 0.21476 –689.72259 0.07249 –689.79508 22.9 -690.11658 
Sub-trans-trans –689.95778 0.21497 –689.72186 0.07203 –689.79389 30.4 -690.11600 
p-N-trans –1379.89243 0.43339 –1379.41832 0.11266 –1379.53099 –380.1 -1379.54009 
p-X-trans –1379.89599 0.43398 –1379.42156 0.11110 –1379.53266 –399.2 -1379.54045 
p-N-cis –1379.90015 0.43287 –1379.42625 0.11346 –1379.53971 –383.5 -1379.54941 
p-X-cis –1379.89767 0.43323 –1379.42365 0.11265 –1379.53630 –413.9 -1379.54550 
m-N-trans –1379.87940 0.43335 –1379.40551 0.11198 –1379.51750 –586.2 -1379.52598 
m-X-trans –1379.88669 0.43332 –1379.41296 0.11110 –1379.52405 –590.5 -1379.53242 
m-N-cis –1379.88511 0.43298 –1379.41133 0.11265 –1379.52399 –564.1 -1379.53315 
m-X-cis –1379.88553 0.43258 –1379.41201 0.11312 –1379.52513 –586.5 -1379.53514 
 ΔE‡el ZPE ΔH‡ TΔS‡ ΔG‡ ΔG‡corr  
p-N-trans 16.0 2.6 17.7 –20.0 37.6 38.6  
p-X-trans 13.8 2.9 15.6 –21.0 36.6 37.0  
p-N-cis 11.2 2.2 12.7 –19.5 32.2 33.4  
p-X-cis 12.7 2.5 14.3 –20.0 34.3 35.3  
m-N-trans 24.2 2.5 25.7 –20.4 46.1 47.2  
m-X-trans 19.6 2.5 21.0 –21.0 42.0 42.1  
m-N-cis 20.6 2.3 22.0 –20.0 42.0 43.1  







4.7.1 Crystal Structure of meso-2.31 
 
Experimental. Single colourless block-shaped 
crystals of meso-2.31 were recrystallised from a 
mixture of DCM and ethyl acetate by slow 
evaporation. A suitable crystal (0.19×0.06×0.04) was 
selected and mounted on a MITIGEN holder in 
Paratone oil on a Agilent Technologies SuperNova 
diffractometer. The crystal was kept at T = 120.0 K 
during data collection. Using Olex2 (Dolomanov et 
al., 2009), the structure was solved with the ShelXS 
(Sheldrick, 2008) structure solution program, using 
the Direct Methods solution method. The model was 
refined with version of ShelXL (Sheldrick, 2008) 
using Least Squares minimisation. 
Crystal Data. C20H18O4, Mr = 322.34, monoclinic, 
P21/c (No. 14), a = 5.1224(2) Å, b = 10.9427(4) Å, c = 
13.8090(5) Å,  = 98.335(4)°,  =  = 90°, V = 
765.87(5) Å3, T = 120.0 K, Z = 2, Z' = 0.5, (MoK) = 
0.097, 32811 reflections measured, 1344 unique 
(Rint = 0.0887) which were used in all calculations. 
The final wR2 was 0.1419 (all data) and R1 was 0.0793 





Compound  meso-2.31  
    
Formula  C20H18O4  
Dcalc./ g cm-3  1.398  
/mm-1  0.097  
Formula Weight  322.34  
Colour  colourless  
Shape  block  
Max Size/mm  0.19  
Mid Size/mm  0.06  
Min Size/mm  0.04  
T/K  120.0  
Crystal System  monoclinic  
Space Group  P21/c  
a/Å  5.1224(2)  
b/Å  10.9427(4)  
c/Å  13.8090(5)  
/°  90  
/°  98.335(4)  
/°  90  
V/Å3  765.87(5)  
Z  2  
Z'  0.5  
min/°  2.982  
max/°  24.997  
Measured Refl.  32811  
Independent Refl.  1344  
Reflections Used  1322  
Rint  0.0887  
Parameters  110  
Restraints  0  
Largest Peak  0.269  
Deepest Hole  -0.247  
GooF  1.344  
wR2 (all data)  0.1419  
wR2  0.1414  
R1 (all data)  0.0807  
R1  0.0793  
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4.7.2 Crystal Structure of (±)-Thymarnicol 1.1  
 
Experimental. Single colourless plate-shaped 
crystals of (±)-1.1 were recrystallised from acetonitrile 
by slow evaporation. A suitable crystal 
(0.51×0.25×0.06) mm3 was selected and mounted on 
a MITIGEN holder in Paratone oil on a Rigaku Oxford 
Diffraction SuperNova diffractometer. The crystal 
was kept at T = 120.0 K during data collection. Using 
Olex2 (Dolomanov et al., 2009), the structure was 
solved with the ShelXS (Sheldrick, 2008) structure 
solution program, using the direct solution method. 
The model was refined with version 2016/6 of ShelXL 
(Sheldrick, 2015) using Least Squares minimisation. 
Crystal Data. C20H20O5, Mr = 340.36, monoclinic, 
P21/c (No. 14), a = 6.0345(2) Å, b = 14.1721(5) Å, c = 
19.3120(8) Å,  = 93.383(4)°,  =  = 90°, V = 
1648.71(11) Å3, T = 120.0 K, Z = 4, Z' = 1, 
(MoK) = 0.098, 22767 reflections measured, 4210 
unique (Rint = 0.0425) which were used in all 
calculations. The final wR2 was 0.1394 (all data) and 
R1 was 0.0570 (I > 2(I)). 
 
  
Compound  (±)-1.1  
    
Formula  C20H20O5  
Dcalc./ g cm-3  1.371  
/mm-1  0.098  
Formula Weight  340.36  
Colour  colourless  
Shape  plate  
Size/mm3  0.51×0.25×0.06  
T/K  120.0  
Crystal System  monoclinic  
Space Group  P21/c  
a/Å  6.0345(2)  
b/Å  14.1721(5)  
c/Å  19.3120(8)  
/°  90  
/°  93.383(4)  
/°  90  
V/Å3  1648.71(11)  
Z  4  
Z'  1  
Wavelength/Å  0.71073  
Radiation type  MoK  
min/°  3.382  
max/°  29.610  
Measured Refl.  22767  
Independent Refl.  4210  
Reflections Used  3541  
Rint  0.0425  
Parameters  234  
Restraints  2  
Largest Peak  0.768  
Deepest Hole  -0.282  
GooF  1.098  
wR2 (all data)  0.1394  
wR2  0.1327  
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